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This report describes ambulatory 
care visits to physician offices, hospital 
outpatient departments (OPDs), and 
hospital emergency departments (EDs) 
as well as factors that may affect where 
care is sought. Ambulatory medical care 
utilization is described in terms of 
patient, practice/facility, and visit 
characteristics. Visits to office-based 
physicians are divided into the 
categories of primary care, surgical 
specialties, and medical specialties. 
Methods 
Data from the 1999 and 2000 
National Ambulatory Medical Care 
Surveys (NAMCS) and National 
Hospital 
Surveys (NHAMCS) were combined to 
produce averaged annual estimates of 
ambulatory medical care utilization. To 
1993 and 1994 NAMCS and NHAMCS. 
Ambulatory Medical Care 
examine changes over time, current 
data were compared with data from the 
Results 
Patients in the United States made an 
estimated 979 million visits per year in 
1999 and 2000 to physician offices,

hospital OPDs, and EDs, an annual rate 
of 3.6 visits per person. The distribution of 
visits by patient age, sex, race, expected 
source of payment, geographic region, 
and metropolitan statistical area (MSA) 
status varied across settings. The 
percentage of visits to office-based 
primary care physicians was similar for the 
characteristics studied, but the percentage 
of visits to office-based surgical and

medical specialists varied considerably. 
Black persons had higher visit rates than 
white persons to hospital OPDs and EDs 
but lower rates to office-based surgical 
and medical specialists. ED visits were 
more likely to be patient-paid or no charge 
than were visits to office-based physicians. 
Visit rates to office-based medical 
specialists decreased between 1993–94 
and 1999–2000. Visit rates increased for 
hypertension and diabetes diagnoses, as 
did prescription rates for central nervous 
system, hormonal, pain relief, and 
respiratory tract drugs. 
Keywords: ambulatory care visits, 
diagnoses, injury, ICD–9–CM Ambulatory Care Visits to 
Physician Offices, Hospital
Outpatient Departments, and 
Emergency Departments:
United States, 1999–2000 
by Catharine W. Burt, Ed.D., and Susan M. Schappert, M.A., Division 
of Health Care Statistics he scope and magnitude of 
examined by analyzing data from 
Introduction 
Tambulatory health care in the United States can best be 
multiple settings. Previous studies that 
combined encounter data from physician 
offices with data from hospital 
emergency and outpatient departments 
(OPDs) found that the majority of visits 
took place in physician offices (1,2). 
This report goes a step further by also 
analyzing office visit data by type of 
physician specialty, categorized as 
primary care, surgical specialty care, 
and medical specialty care. Therefore, in 
addition to estimates of total ambulatory 
care utilization, estimates are provided 
for visits to three types of office-based 
physicians and two types of hospital 
settings. Physician specialty data are not 
collected in the hospital outpatient or 
emergency department (ED) settings. In 
this report, the terms, ‘‘visits to 
office-based physicians’’ and ‘‘visits to 
physician offices’’ are used 
interchangeably, as are the terms ‘‘visits 
to specialists,’’ ‘‘visits to specialty 
offices,’’ and ‘‘visits to specialties.’’ 
This analysis is useful for 
examining factors that affect patient 
access to these different types of care. 
Patients using hospital settings are 
known to differ from those using 
physician offices along several 
dimensions (2). major factor in improving the general 
quality of health care (3). Health 
insurance models that measure patient 
consumer satisfaction (4). Access may 
Access to primary care is seen as a 
satisfaction also have shown that access 
to specialty care is a key component in 
vary according to the patient’s insurance 
status, demographic characteristics, and 
geographic area. For example, the

supply of specialists is often greater in

densely populated urban areas.

Reliance on EDs is also a critical

health services utilization issue. When

care is sought only in the ED, the ability
of one provider to oversee the health of

the patient is in question; the continuity

of care is broken. The situation is

further complicated by the general

volume of care provided in hospital

EDs, which has been increasing because

of the closing of over 1,000 EDs since

1992 (5,6). The extra demand on EDs

has contributed to overcrowding issues

such as increased ambulance diversion,

longer patient waiting times to see an

ED physician, and less post-ED patient

followup (6). EDs often serve as a

safety net for health care of









Medicaid beneficiaries, patients with

special needs, individuals in

geographically remote or economically

disadvantaged communities, race and 
ethnic minorities, and immigrants (7). Page 1 
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Interview Survey (NHIS) indicate that 
about 83 percent of the civilian 
noninstitutionalized population received 
care from a physician office, clinic, or 
hospital emergency or outpatient 
department in 1999 (8), and 17 percent 
made at least one visit to the ED. 
Persons without insurance were less 
likely than the general population to 
make an ambulatory care visit (65 vs. 
83 percent) but were equally likely to 
make an ED visit (approximately 
20 percent). Medicaid enrollees were 
much more likely to make ED visits 
(38 percent) compared with privately-
insured persons (19 percent), Medicare 
enrollees (20 percent), or uninsured 
persons (20 percent). Unfortunately, 
population-based surveys like NHIS do 
not provide details on the kinds of 
providers seen or the nature and content 
of the medical encounters. 
In order to examine the medical 
care and treatment that takes place at 
such visits, it is necessary to examine 
data from the medical providers. For 
this report, patient encounter data from 
the 1999 and 2000 National Ambulatory 
Medical Care Surveys (NAMCS) and 
National Hospital Ambulatory Medical 
Care Surveys (NHAMCS) were 
combined to produce annual estimates 
of ambulatory care in the United States. 
These surveys make up the ambulatory 
care component of the National Health 
Care Survey (NHCS), a provider-based 
family of health surveys. Information on 
the health care visit usually comes from 
the medical record or directly from the 
provider and is recorded on a one-page 
encounter form called the Patient 
Record form (PRF). 
This report contains tables showing 
the distribution of ambulatory care 
across provider settings according to 
various patient and geographic 
characteristics. The characteristics 
selected represent those most salient to 
issues of care by vulnerable populations 
(i.e., those population groups who are 
least likely to have access to primary 
care). Accordingly, in addition to age, 
sex, race, and geographic region, most 
tables present data by expected source 
of payment and density of population 
defined as whether or not the visit took 
place in an MSA. Variation in the distribution of visits 
across provider types by patient 
characteristics provides information on 
how care for vulnerable populations 
varies from the mainstream. The 
discussion section examines survey data 
concerning the relationship between 
these differences and issues of access 
and how these differences may influence 
disparity in quality of care among 
subgroups. With ED visits examined 
separately from visits to the other 
ambulatory care settings, inferences will 
also be drawn concerning how the ED 
functions as a safety-net provider. 
This study also examines other 
salient variables that have been shown 
to be related to utilization, such as 
physician supply as well as patient 
income, education level, and ability to 
speak English. These variables are not 
directly collected by the NHCS; 
however, data from the U.S. Census 
Bureau are linked to the provider-based 
data using patient or provider ZIP Code. 
This report provides summary 
statistics for many of the PRF items that 
are common across the NAMCS and 
NHAMCS. Some aspects of ambulatory 
care visits are not included here because 
their collection is inconsistent across 
providers. For a full discussion of care 
received in each setting, please refer to 
the annual summaries (5,6, 9–12). The 
main sections analyzed here include 
overall visit utilization, reasons for visit, 
diagnoses, injury characteristics, and 
medication therapy. 
It should be noted that community 
health centers, an important provider for 
vulnerable populations, are not included 
in this analysis. Because the NAMCS is 
based on a sample of office-based 
physicians only, such locations are 
included in the sample with a lesser 
likelihood than their total utilization 
would suggest, given that physicians 
account for a smaller proportion of the 
medical providers in such settings. 
Although a doctor working in a 
community health center is eligible for 
selection in the NAMCS, others who 
provide care in this setting, such as 
nurse practitioners, physician assistants, 
or nurse midwives, are outside the scope 
of the survey and are not sampled. 
Community health centers accounted for 
13 million visits in 1994 (13), which means that NAMCS and NHAMCS 
estimates of ambulatory care utilization 
may be slightly underestimated. 
Methods 
This study includes a secondary analysis of data collected in the 1999 and 2000 NAMCS and 
NHAMCS. These are annual national 
probability sample surveys conducted by 
the Division of Health Care Statistics of 
the National Center for Health Statistics 
(NCHS), Centers for Disease Control 
and Prevention. 
The target universe for the NAMCS 
includes visits made in the United States 
to the offices of non-federally employed 
physicians (excluding those in the 
specialties of anesthesiology, radiology, 
and pathology) who were classified by 
the American Medical Association 
(AMA) or the American Osteopathic 
Association (AOA) as office-based, 
patient care. Visits to private, 
non-hospital-based clinics and health 
maintenance organizations (HMOs) were 
within the scope of the survey, but visits 
that took place in federally operated 
facilities and hospital-based OPDs were 
not. Telephone contacts and visits made 
outside the ambulatory care setting were 
excluded from both the NAMCS and 
NHAMCS. 
The target universe for the 
NHAMCS is in-person visits made in 
the United States to OPDs and EDs of 
non-Federal, short-stay hospitals 
(hospitals with an average stay of less 
than 30 days) or those whose specialty 
is general (medical or surgical) or 
children’s general. Only OPD clinics 
that were under the supervision of a 
physician were within the scope of the 
NHAMCS. Clinics specializing in 
radiology, laboratory services, physical 
rehabilitation, or other ancillary services 
were out of scope. The NHAMCS 
sampling frame from 1992 to the 
present consists of hospitals that were 
listed in the April 1991 SMG Hospital 
Database. The hospital data presented in 
this report are representative of 
1999–2000 utilization statistics for 
hospitals existent in 1991. 
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design is used in both surveys; the 
designs are described elsewhere (14,15). 
For the 1999 and 2000 NAMCS, 5,499 
physicians were selected from the AMA 
and AOA master files. Of these, 3,777 
were in-scope (i.e., eligible to participate 
in the survey). Sampled physicians were 
asked to complete PRFs for a systematic 
random sample of office visits occurring 
during a randomly assigned 1-week 
reporting period. The annual average 
response rate was 65 percent, and 
48,129 PRFs were collected. Data 
collection occurred from December 29, 
1998, through December 24, 2000. 
The NHAMCS utilizes a fixed 
panel of 600 hospitals. To preclude 
hospitals participating during the same 
time period each year, the sample was 
randomly divided into 16 subsets of 
approximately equal size. Each subset 
was assigned to 1 of 16, 4-week 
reporting periods beginning December 2, 
1991, that continue to rotate across each 
survey year. Therefore, the entire sample 
does not participate in a given year, and 
each hospital is inducted approximately 
once every 15 months. The 1999 
NHAMCS collected data from 
December 21, 1998, through December 
19, 1999, and consisted of a sample of 
489 hospitals. Of these, 427 were 
in-scope. The overall hospital response 
rate was 95 percent. There were 376 
participating EDs that provided data for 
452 emergency service areas, and 241 
participating OPDs provided data for 
858 clinics. The overall response rate 
was 92 percent for EDs and 82 percent 
for OPDs. Hospital staffs were asked to 
complete PRFs for a systematic random 
sample of patient visits occurring during 
a randomly assigned 4-week reporting 
period. A total of 21,103 ED PRFs and 
29,487 OPD PRFs was collected. 
The 2000 NHAMCS collected data 
from December 27, 1999, through 
December 24, 2000, and consisted of a 
sample of 488 hospitals. Of these, 413 
were eligible to participate. The overall 
hospital response rate was 96 percent. 
There were 376 participating EDs that 
provided data for 446 emergency service 
areas, and 221 participating OPDs 
provided data for 829 clinics. The 
overall response rate was 97 percent for 
EDs and 91 percent for OPDs. A total of 25,622 ED PRFs and 27,510 OPD PRFs 
was collected. 
Because the estimates presented in 
this report are based on a sample rather 
than on the entire universe of 
ambulatory visits, they are subject to 
sampling variability. The ‘‘Technical 
Notes’’ include an explanation of 
sampling errors and guidelines for 
judging the precision of the estimates, as 
well as information on the tests of 
significance used to establish differences 
between survey estimates. 
The PRF is produced in three 
separate versions that have been 
carefully designed for use in each of the 
three ambulatory care settings but that 
contain many data items in common; 
forms used within each setting were 
identical for 1999 and 2000. The 
NAMCS and OPD PRF are nearly 
identical, but the ED PRF differs in 
ways appropriate to that setting. These 
forms are used by medical staff to 
record information about patient visits. 
They are shown in ‘‘Appendix III’’ and 
should serve as a reference for readers 
as they review the survey findings 
presented in this document. 
The PRF item, ‘‘Primary expected 
source of payment for this visit,’’ is 
used to define the method of payment 
expected by the provider for the visit. It 
includes the categories of private 
insurance, Medicare, Medicaid, 
Workers’ Compensation, self-pay, no 
charge, other, and unknown. For the 
purpose of this report, self-pay and no 
charge were combined to yield estimates 
of visits by persons with no health 
insurance. Workers’ Compensation, 
other, and unknown response categories 
were combined into a residual category 
called ‘‘Other.’’ Visit rates by expected 
pay source are based on 1999–2000 
Current Population Survey (CPS) 
estimates of health insurance, which 
include private insurance, Medicare, 
Medicaid, and no insurance. The 
numerator used in calculating rates for 
the no insurance group comes from the 
PRF self-pay and no charge categories. 
Although not all self-pay visits are made 
by uninsured persons, it is the best 
method for matching encounter data to 
insurance status. For NAMCS and 
NHAMCS self-pay and no charge visits, there is no expectation that third-party 
payers will cover the cost. 
This study analyzed ambulatory 
care visit data by type of setting: three 
office-based settings and two hospital 
settings. The three office settings were 
taken from the NAMCS data and 
categorized offices according to the 
physician’s specialty: primary care, 
surgical, and medical. See the 
‘‘Technical Notes’’ for more details and 
the specific specialty codes used to 
define the three office settings. The two 
hospital settings were taken from the 
NHAMCS, which collects information 
on hospital OPDs and EDs. EDs were 
defined as providing 24-hour emergency 
care. Emergency care clinics that are 
open less than 24 hours per day were 
considered part of the OPD. Visits from 
all sampled OPD clinics were combined 
to provide total estimates for OPD 
utilization. This includes clinics defined 
as general medical care (61 percent), 
pediatrics (13 percent), obstetrics/ 
gynecology (7 percent), surgery 
(12 percent), and all other kinds of 
clinics (7 percent). Type of physician 
specialty is not collected in the 
NHAMCS. Clinics specializing in 
ancillary services, treatment only (e.g., 
chemotherapy, dialysis, radiation, or 
physical therapy), and ambulatory 
surgery were all out-of-scope for the 
NHAMCS. Visits to such clinics are not 
included in this report. 
Many of the tables in this report 
present data on rates of ambulatory care 
visits. With the exception of the 
expected source of payment, the 
population figures used in calculating 
these rates are based on U.S. Census 
Bureau monthly postcensal estimates of 
the civilian noninstitutionalized 
population of the United States as of 
July 1, 1999, and July 1, 2000, and have 
been adjusted for net underenumeration 
using the 1990 National Population 
Matrix (see ‘‘Technical Notes’’). 
Population figures are shown in 
‘‘Appendix I,’’ table VI. 
Several medical classification 
systems were used to code data from the 
NAMCS and NHAMCS. Each PRF 
contains an identical item on the 
patient’s expressed reason for the visit. 
In this item, the respondent was asked 
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symptom(s), or other reason(s) for this 
visit in the patient’s (or patient 
surrogate’s) own words.’’ Up to three 
reasons for visit were classified and 
coded for each survey according to ‘‘A 
Reason for Visit Classification for 
Ambulatory Care (RVC)’’ (16). 
Each PRF contains an item on the 
cause of injury for injury-related visits. 
Up to three external causes of injury 
were classified and coded according to 
the ‘‘Supplementary Classification of 
External Causes of Injury and 
Poisoning’’ found in the International 
Classification of Diseases, 9th Revision 
Clinical Modification (ICD–9–CM) (17). 
The edits for the injury-related checkbox 
on each form include combining 
information from the reason for visit, 
cause-of-injury, and diagnosis items to 
ensure that the visit is acknowledged as 
related to an injury (see ‘‘Appendix 
II’’). In addition, each form contains an 
identical item on diagnosis. The 
respondent was asked to record the 
primary diagnosis or problem associated 
with the patient’s most important reason 
for the current visit as well as any other 
significant current diagnoses. Up to 
three diagnoses were classified and 
coded according to the ICD–9–CM. 
In the medication item, also 
identical on all three PRFs, respondents 
were instructed to record all new or 
continued medications ordered, supplied, 
or administered at the visit, including 
prescription and nonprescription 
preparations, immunization and 
desensitizing agents, and anesthetics. Up 
to six medications, referred to in the 
surveys as drug mentions, could be 
coded per visit according to a 
classification system developed at 
NCHS. A report describing the method 
and instruments used to collect and 
process drug information is available 
(18). Therapeutic classification of the 
drugs mentioned on the PRFs was 
determined using the National Drug 
Code Directory, 1995 edition (19). 
The U.S. Census Bureau was 
responsible for data collection for all 
surveys. Constella Group, formerly 
Analytic Sciences, Inc., Durham, North 
Carolina, performed processing 
operations and medical coding. As part 
of the quality assurance procedure, a 10 percent quality control sample of 
survey records was independently 
processed. Error rates (which include 
coding and keying) ranged between 
0.0 percent and 2.0 percent for all 
surveys. 
Patient and provider ZIP Codes 
were used to calculate a mean distance 
traveled for an ambulatory care visit. An 
algorithm was used to measure the 
distance between the latitude and 
longitude of the centroid of the postal 
ZIP Code for the patient and the 
provider. If the patient ZIP Code was 
missing, the record was omitted from 
the analysis. 
Additional information about the 
patient was obtained by linking 
aggregated data for the patient’s 
residential ZIP Code from the sample 
data collected in Census 2000. These 
contextual variables include median 
household income, percentage of 
persons with an education level 
equivalent to a Bachelor’s degree or 
higher (i.e., college graduates), 
percentage of persons who do not speak 
English, and percentage of persons who 
are foreign-born. Additional contextual 
data were obtained from the Health 
Resources and Services Administration’s 
Area Resource File (ARF) for 2000. 
These data are used to yield estimates of 
medical providers located in the State 
and county of the sampled providers. 
Results 
Data in tables 1–7 provide details on the estimates of providers and encounters by patient 
characteristics. Tables 8–10 provide 
details on encounters by patient 
complaint and condition. Tables 11–15 
provide estimates for injury-related 
encounters, and tables 16–23 provide 
estimates for encounters that include 
medications prescribed or provided, 
including details of medications by 
therapeutic class. Below are highlights 
of information found in the tables. 
Ambulatory care providers 
+	 Office-based primary care physicians 
were equally distributed per population in MSAs and non-MSAs, 
with about 53 physicians per 
100,000 persons. However, the rate 
of office-based medical specialists in 
non-MSAs was less than half the 
rate in MSAs (13 vs. 31 physicians 
per 100,000 persons). The number 
of OPDs and EDs per population in 
non-MSAs was more than double 
the rate in MSAs (table 1). 
+	 In MSAs, there were, on average, 
about three hospital EDs per county, 
and in non-MSAs, there was about 
one hospital ED per county. OPDs 
with physician-supervised evaluation 
and management clinics were 
operated less frequently: about 3.5 
OPDs for every two MSA counties 
and one OPD for every two 
non-MSA counties (table 1). 
+	 The visit load was equivalent for 
physicians in MSAs and non-MSAs 
regardless of whether the physician 
was engaged in primary care, 
surgical specialties, or medical 
specialties. However, hospital OPDs 
and EDs in MSAs had, on average, 
three times the volume of annual 
visits compared with non-MSAs 
(table 1). 
Overall utilization 
+	 There was an average of 979.5 
million ambulatory care visits per 
year in 1999 and 2000. Nearly half 
were to primary care physicians, 
17.0 and 16.3 percent were to 
office-based medical and surgical 
specialists respectively, 10.8 percent 
were to hospital EDs, and 
8.6 percent were to hospital OPDs 
with physician-supervised evaluation 
and management clinics (table 2). 
+	 The distribution of visits by setting 
type varied according to patient and 
provider location characteristics. 
Patients under the age of 45 had a 
higher percentage of their 
ambulatory care visits to the ED 
compared with older patients. 
Similarly, male, black, and 
uninsured patients had a higher 
percentage of their visits to the ED. 
Compared to MSAs, visits in 
non-MSAs were more likely to be to 
office-based primary care physicians 
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Figure 1. Annual rate of ambulatory care visits by patient and visit characteristics and 
setting type: United States, 1999–2000 
Figure 2. Age-adjusted ambulatory care visit rates by type of setting and year: 
United States, 1993–94 and 1999–2000 and EDs but less likely to be to 
medical specialists (table 2). 
+ Visit rates were also significantly 
different across patient age, sex, 
race, and payment categories, as 
well as for provider region and 
MSA status categories (figure 1). 
Females had a higher visit rate than 
males overall and to primary care 
physicians, medical specialists, and 
OPDs. There were no gender 
differences in visit rates to surgical 
specialists and EDs. Compared with white persons, black persons had 
higher visit rates to hospital settings 
but lower visit rates to surgical and 
medical specialists. There was no 
race effect in overall visit rates or 
visit rates to primary care 
physicians. Visit rates for the 
uninsured were lower than for 
privately-insured persons overall, 
and for all physician office settings 
but higher in the ED. 
+	 Visit rates in MSAs and non-MSAs 
were similar for all settings except + 
+ 
+ 
medical specialties where the rate 
for non-MSAs was half the rate 
found in MSAs (29.9 visits per 100 
persons vs. 69.1) (table 3). This 
could imply that persons in 
non-MSAs are less likely to seek 
care provided by medical specialists 
or that they may travel to MSAs for 
such care because medical 
specialists are less likely to be found 
working in non-MSAs. 
Age-adjusted visit rates to hospital 
settings did not change since 
1993–94; however, visit rates to 
primary care and surgical specialists 
increased, and visit rates to medical 
specialists decreased (figure 2). This 
coincides with an increase in the 
percentage of visits by members of 
HMOs for all settings and may 
suggest that use of HMOs for health 
care has reduced utilization of care 
provided by medical specialists. 
Primary care physicians may 
substitute for medical specialists but 
are not likely to substitute for 
surgical specialists. 
Government sources (Medicare, 
Medicaid, and State Children’s 
Health Insurance Program) 
accounted for a larger amount of 
utilization in non-MSAs compared 
with MSAs (table 4, figure 3). 
Visits in non-MSAs were more 
likely to be made by patients living 
in the same ZIP Code as the 
provider, compared with visits in 
MSAs (figure 4). Distance traveled 
between the patient and provider is 
shorter for visits to primary care 
specialists and EDs compared with 
other setting types. 
+	 Although private insurance covers 
the majority of total ambulatory care 
utilization for both white and black 
or African-American patients, visits 
by black patients were more likely 
to fall into the Medicaid or no 
insurance payment categories 
compared with visits by white 
patients (table 5). 
+	 The percentage of visits to the ED 
was lower for patients living in high 
median income areas (7.1 percent) 
compared with patients living in low 
median income areas (15.0 percent) 
(table 6). 
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Figure 3. Distribution of ambulatory care visits by primary expected source of payment, 
according to provider’s metropolitan statistical area status: United States, 1999–2000 
Figure 4. Distribution of ambulatory care visits by distance traveled from patient to 
provider, according to metropolitan statistical area status and setting type: United States, 
1999–2000 + 
+ 
Ordinal analysis (high, medium, and 
low) of the Census contextual 
variables (based on the patient’s ZIP 
Code) and ED visit rates found that 
the visit rates were inversely related 
to median income, education level, 
being foreign-born, and speaking a 
language other than English 
(figure 5). 
Visit rates to surgical specialists, 
medical specialists, OPDs, and EDs 
were all linearly related to the 
median income of the patient’s 
residential area. Higher visit rates to 
hospital settings were inversely 
related to income (table 7), 
confirming population-based surveys 
that show higher use of EDs and 
OPDs by lower-income persons. 
NAMCS data show that higher 
income was associated with visits to 
office-based surgical and medical 
specialists. 
Reasons for visit and 
diagnoses 
+	 Seventy-five percent of all visits for 
preventive care were made to 
primary care physicians (figure 6). 
+	 The condition mix (i.e., types of 
conditions seen) as defined by the 
primary diagnosis at visits varied 
greatly across ambulatory care 
settings (table 9). 
+	 Top illness-related primary 
diagnoses rendered at ambulatory 
care visits included essential 
hypertension (37.4 million visits per 
year), acute upper respiratory 
infections excluding pharyngitis 
(36.0 million), arthropathies (31.2 
million), diabetes mellitus (24.7 
million), malignant neoplasms (21.3 
million), and spinal disorders (20.6 
million) (table 10). 
+	 There were 31.1 million visits per 
year for routine infant or child 
health checks, 22.1 million visits for 
normal pregnancy, 17.6 million 
visits for general medical exams, 
and 14.8 million visits for follow-up 
exams (table 10). 
+	 Between 1993–94 and 1999–2000, 
age-adjusted visit rates increased for 
any-listed diagnoses of hypertension 
and diabetes (i.e., first-, second-, or 
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Figure 5. Annual visit rates to hospital emergency departments by selected residential area 
characteristics: United States, 1999–2000 
Figure 6. Percentage of ambulatory care visits by setting type, according to major reason 
for visit: United States, 1999–2000 
Figure 7. Age-adjusted ambulatory care visit rates for selected diagnoses by year: 
United States, 1993–94 and 1999–2000 third-listed diagnoses) but decreased 
for otitis media (figure 7). 
+ Conditions accounting for most of 
the rise in overall visit rates between 
1993–94 and 1999–2000 can be 
explained by significant increases in 
visits with a primary diagnosis in 
the supplemental classification, 
ill-defined symptoms, endocrine 
system, musculoskeletal system, and 
circulatory system chapters of the 
ICD–9–CM. 
Injuries 
+	 There was an annual average of 
136.8 million visits for injuries in 
1999–2000, including visits for 
acute, chronic, and late effects of 
injuries and poisonings and adverse 
effects of medical treatment, a rate 
of 501 visits per 1,000 persons 
(table 11). 
+	 Nearly 30 percent of injury visits 
were to EDs, with a similar 
percentage to primary care 
physicians. One-quarter of the injury 
visits were to surgical specialists 
(table 11). 
+	 The injury visit rate was highest 
among persons 75 years of age and 
over and lowest for children under 
15 years of age (783 vs. 359 visits 
per 1,000 persons) (table 12). 
+	 Injuries represented a larger share of 
the case mix in EDs (37.0 percent of 
visits) compared with other settings. 
Injuries accounted for 20.6 percent 
of visits to surgical specialists and 
between 8 and 11 percent of visits to 
primary care physicians, medical 
specialists, and OPDs (table 13). 
+	 Leading causes of injury were falls 
(22.6 million visits), being struck by 
or against another object or person 
(12.8 million visits), and motor 
vehicle crashes (11.0 million visits). 
Adverse effects of medical treatment 
resulted in 6.7 million visits 
(figure 8). 
+	 Intentional injuries accounted for 
2.7 percent of all injury visits, or 3.7 
million visits. Of these, 3 million 
visits were for assaults, and 464,000 
visits were for self-inflicted injuries 
(table 14). 
+	 The most frequent injuries treated at 
ambulatory care visits were open 
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Figure 8. Percentage of ambulatory care visits by setting type, according to leading causes 
of injury: United States, 1999–2000 
Figure 9. Most frequent annual injury visits at all types of ambulatory care settings: United 
States, 1999–2000 wounds of hand, wrist, and fingers 
(4.0 million visits); back sprains and 
strains (3.6 million cervical and 2.8 
million lumbar visits); lower leg and 
ankle sprains and strains (3.2 million 
visits); fractures of hand, wrist, and 
fingers (2.9 million visits); and open 
wounds on the face (2.4 million 
visits) (figure 9). +	 Approximately 40 percent of injury 
visits had a primary diagnosis not in 
the acute injury/poisoning chapter of 
the ICD–9–CM. One-quarter of 
these diagnoses were in the 
musculoskeletal system chapter 
(table 15). Medications 
+	 Drugs were provided, prescribed, or 
continued at 66.8 percent of 
ambulatory care visits. Visits to 
surgical specialists were least likely 
to include medications compared 
with the other settings, with only 
42.7 percent of the visits listing one 
or more medications. In contrast, 
visits to medical specialists were 
most likely to include five or more 
drugs provided, prescribed, or 
continued (12.3 percent) (table 16). 
+	 In 1999 and 2000, there was an 
annual average of 153 drug 
mentions for every 100 ambulatory 
care visits (table 17), a 16% increase 
from 1993–94. The therapeutic 
classes driving the increase were 
pain relief drugs (39% increase), 
central nervous system (CNS) drugs 
(42% increase), respiratory tract 
drugs (30% increase), and hormones 
(31% increase) (data not shown). 
+	 Patients at visits in non-MSAs 
received more drug prescriptions 
than in MSAs, primarily driven by 
the higher drug mention rate at 
primary care visits (187 mentions 
per 100 visits in non-MSAs vs. 156 
mentions per 100 visits in MSAs) 
(table 17). Higher prescribing rates 
for antimicrobial agents and pain 
relief drugs in non-MSAs also 
contributed to the difference 
(figure 10). 
+	 Visits to medical specialists had the 
highest drug mention rate (189 
drugs per 100 visits), and visits to 
surgical specialists had the lowest 
rate (81 drugs per 100 visits) 
(table 17). 
+	 Compared with patients at private 
insurance visits, uninsured patients 
were more likely to receive 
prescriptions for antimicrobials, 
CNS drugs, pain relief drugs, and 
otologics; however, uninsured 
patients were less likely to receive 
prescriptions for cardiovascular-renal 
drugs, metabolics, hormones, 
immunologics, neurologics, and 
respiratory tract drugs (figure 11). 
The mean patient age at private 
insurance visits is the same as at 
visits by uninsured patients, so these 
observed differences in prescription 
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Figure 10. Variation in drug mention rates for selected therapeutic classes by metropolitan 
statistical area status: United States, 1999–2000 
Figure 11. Variation in drug mention rates for selected therapeutic classes by primary 
expected source of payment: United States, 1999–2000 
+
patterns are more likely reflective of 
the types of conditions for which 
treatment is sought. 
	 The top drugs mentioned at 
ambulatory visits were 
acetaminophen, amoxicillin, ibuprofen, albuterol, and 
hydrocodone (table 18). 
+ The top therapeutic classes included 
cardiovascular-renal drugs, pain 




antimicrobial agents, and hormones 
(table 19). 
Within the antimicrobial class, 
penicillins were still the leading 
agent prescribed, with 41.3 million 
mentions per year, followed by 
cephalosporins with 30.7 million 
mentions (table 20). Antidepressants 
were the leading CNS drug 
prescribed, with 60 million 
mentions. Non-narcotic analgesics 
and nonsteroidal anti-inflammatory 
drugs (NSAIDs) each represented 
one-third of the pain-relief mentions 
(table 20). 
The top specific therapeutic classes 
include antiarthritics, 
antidepressants, vaccines, 
non-narcotic analgesics, and narcotic 
analgesics (table 21). 
Males had a higher prescription rate 
than females for hyperlipidemia 
drugs (141 vs. 127 scripts per 1,000 
persons). Females had higher 
prescribing rates than males for all 
other classes (table 22). 
Cephalosporins were the preferred 
antimicrobial agent prescribed at 
visits by Medicare patients, and 
penicillins were recorded most 
frequently at visits by Medicaid 
patients (table 23). 
Discussion 
The results presented in this report paint a picture of variation in medical care provided across 
ambulatory care settings. They also 
provide important information on access 
to providers and health condition of 
safety-net populations (e.g., African 
Americans, poor, uninsured, and persons 
living in non-MSAs). Because 
disparities in care and access to care are 
important public health issues, 
additional analysis of the NAMCS and 
NHAMCS data was conducted in an 
attempt to explain some of the findings 
in more detail. Logistic regression 
models (see ‘‘Appendix IV’’ and 
‘‘Appendix V’’), which compared 
utilization across subgroups after 
adjusting for subgroup differences on 
selected influential factors, were used 
for this purpose. 
Page 10 [ Series 13, No. 157 Although overall and office-based 
primary care utilization rates were the 
same for black or African Americans 
and white persons, the rates varied by 
type of setting. Black persons had 
higher visit rates than white persons to 
hospital settings, while white persons 
had higher rates of visits to surgical and 
medical specialty offices (χ2=219.4, 
df = 8, p<.01). Similarly, the likelihood 
that a randomly selected ambulatory 
care visit was made to a hospital setting 
was higher for African Americans than 
for white persons (OR=2.15 for ED, and 
OR=2.19 for OPD). These odds are 
reduced to 1.83 for the ED and 1.52 for 
the OPD after adjusting for various 
patient characteristics including age, sex, 
income, education, insurance type, and 
type and number of conditions as well 
as provider MSA status (see ‘‘Appendix 
IV’’). 
In the logistic regression model, 
source of payment and type of condition 
(injury vs. illness) remain significant 
factors in modeling ED use. Compared 
with visits by patients with private 
insurance, Medicare patients (OR=1.71), 
Medicaid patients (OR=2.0), and the 
uninsured (OR=3.15) are all more likely 
to make a health care visit to the ED as 
opposed to other types of settings. 
One-quarter of care received by 
uninsured persons is provided by EDs, 
and almost one-fifth of care received by 
Medicaid recipients is obtained in the 
ED. This compares to less than 
one-tenth of privately-insured care being 
provided in the ED. This corroborates 
the population-based data from the 
NHIS that shows that, compared with 
privately-insured persons, uninsured 
persons are much less likely to make 
any health care visits but about equally 
likely to make at least one ED visit. 
One of the key differences between 
patients visiting providers in MSAs and 
non-MSAs revolves around the 
likelihood of visiting primary care and 
medical specialists. Compared to 
non-MSAs, MSAs were less likely to 
have visits to office-based primary care 
physicians (OR=0.90) and EDs (OR= 
0.91) and more likely to have visits to 
office-based medical specialists 
(OR=3.00). To investigate this further, a 
logistic regression analysis was 
performed to model likelihood of visits to these providers. After adding to the 
model the distance traveled between the 
ZIP Code of the patient and the ZIP 
Code of the provider and the amount of 
similar providers in the county of the 
sampled visit, the adjusted odds ratios 
for MSA status were no longer 
significantly different from 1.0 (see 
‘‘Appendix V’’). The model indicates 
that patients still travel farther to see 
surgical and medical specialists even 
after adjusting for MSA status and 
number of providers available. 
Therefore, it seems that the lack of 
medical specialists in non-MSAs is the 
factor most related to their lower use of 
these services. It is not that patients in 
these areas do not have conditions that 
are related to the kind of care best 
treated by medical specialties. But, 
because of the shortage of physician 
supply, such care is more often provided 
by a primary care physician in 
non-MSAs compared with MSAs. The 
results of this logistic regression 
analysis seem to support the hypothesis 
that, if more medical specialists were 
available in non-MSAs, their services 
would be used. 
Primary care providers may 
substitute for medical specialists but are 
less likely to substitute for surgical 
specialists. There were no differences in 
the observed estimates for the likelihood 
of a visit being made to a surgical 
specialist by MSA status. The estimates 
in table 1 also support the theory of 
availability affecting utilization, as the 
rate of visits per provider in MSAs and 
non-MSAs is very similar for all 
physician services; however, the rate per 
provider for hospital settings is much 
higher in MSAs compared to 
non-MSAs. 
The importance of health insurance 
in increased medical utilization has been 
demonstrated (8). Data in this report 
have clearly shown the wide variation in 
utilization rates across settings by 
various patient characteristics. The rates 
by setting for insurance type shown in 
table 2 can also be used to show 
important relative indicators of where 
care is provided. For example, the rate 
of ED use by the uninsured was 46.6 
visits per 100 persons, and the rate of 
primary care physician use was 59.7 per 
100 persons. So, for every ED visit by an uninsured person, there were 1.3 
visits to a primary care physician. But, 
for privately insured persons, there were 
6.6 primary care physician visits for 
every ED visit. The visit rate for 
uninsured persons to the ED is twice as 
high as their rate of visit to an OPD, but 
the visit rates for persons on Medicaid 
were similar for the two hospital 
settings. 
The NAMCS and NHAMCS data 
presented cannot show the relative value 
and quality of care received at 
ambulatory care encounters; however, 
when the data are presented in terms of 
population rates, observed variations 
raise questions regarding where further 
research should be performed. For 
example, table 23 shows great variation 
between privately-insured and uninsured 
persons for most of the therapeutic 
classes presented. Compared with 
uninsured persons, the rate of 
medication use for privately-insured 
persons was over three times higher for 
lipid-lowering drugs, two to three times 
higher for blood glucose regulators, 
medication for acid reflux and other 
peptic disorders, heart regulators (e.g., 
angiotensin converting enzyme (ACE) 
inhibitors, calcium channel blockers, and 
beta blockers), estrogens/progestins, and 
vitamins. Uninsured persons also have a 
lower population rate for mentions of 
antihistamines, vaccines, and electrolyte 
replenishers but have equal utilization 
rates for the various pain-relieving 
drugs, antimicrobials, and antidepressant 
medications. These results suggest that 
uninsured persons will make health care 
appointments when they are in pain, 
have an infection, or are depressed, but 
they are unlikely to make appointments 
for chronic conditions or preventive care 
for chronic conditions. This conclusion 
is reinforced by data that indicate that 
uninsured persons have the lowest rate 
of visits for preventive care than any 
other payment group (data not shown). 
The trend analyses performed in 
this study found that between 1993–94 
and 1999–2000, visit rates increased for 
primary care and surgical specialists but 
decreased for medical specialists. The 
lack of change in ED and OPD visit 
rates overall is belied by increases 
observed in these rates for 
subpopulations such as uninsured 
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Figure 12. Comparison of distribution of visits for asthma: United States, 1999–2000 persons. A study of NAMCS and 
NHAMCS data between 1996–97 and 
2000–2001 found an increase in the 
proportion of all ambulatory care visits 
to EDs by uninsured persons (from 17.0 
to 25.2 percent) (20). The study also 
found a 37% percent decrease in the use 
of physician offices by uninsured 
persons. The greater reliance on EDs by 
uninsured persons is likely related to a 
decline in the provision of charity care 
by office-based physicians (21,22). 
This report also showed increases in 
visit rates for the chronic conditions of 
hypertension and diabetes but no change 
for arthritis or major depression. Use of 
medications at ambulatory care visits 
was found to increase by 13%, driven 
by a higher rate of prescribing for pain 
relievers, CNS drugs (including 
antidepressants), respiratory tract drugs, 
and hormones. Various factors, including 
adherence to treatment guidelines and 
the availability of new and improved 
medications, help explain these increases 
(23). 
Finally, this report shed light on 
how the ED serves as a health care 
safety net for members of vulnerable 
populations. Although the observed 
percentage of ambulatory care visits 
made to the ED is double for black or 
African-American persons compared 
with white persons (18.9 vs. 
9.8 percent), about one-third of the 
observed difference can be explained by 
differences in utilization patterns by 
patients with differing demographics 
(e.g., age, sex, income, education, 
insurance type, number and type of 
conditions). Insurance status has more 
impact on where the patient will seek 
care. The uninsured and persons with 
public insurance are receiving more care 
in hospital settings than physicians’ 
offices. Evidence from the NAMCS 
induction interview indicates that, 
compared with willingness to accept 
new privately-insured patients, 
office-based physicians are less likely to 
accept new Medicare, Medicaid, or 
charity cases—especially primary care 
physicians (22). This means that patients 
who rely on these payment sources may 
need to seek care in hospital settings 
and other safety-net providers such as 
community health centers. Patients in 
these same payment groups are also more likely to make visits to OPDs 
compared with privately insured 
patients. 
The effect of no health insurance or 
under-insurance on ED utilization is also 
characterized by specific diseases. The 
overall distribution of visits with a 
primary diagnosis of asthma showed 
that 15.3 percent of visits occur in the 
ED (table 10), but that distribution is 
strikingly different when looking at 
different sources of payment. Figure 12 
shows that, among asthma visits by the 
uninsured, approximately 44 percent are 
to the ED, but among asthma visits by 
the privately insured, the percentage is 
only 10 percent. Asthma is a condition 
considered sensitive to primary care; if 
the patient is receiving good primary 
care for this disease, then there should 
be relatively few visits to the ED. 
The type of condition is also an 
important factor in selecting the ED as 
the provider of choice. The report 
indicated that diagnoses such as chest 
pain, open wounds, and contusions are 
primarily seen in the ED. Certain causes 
of injury are also predominantly seen in 
the ED (e.g., self-inflicted injuries, 
assaults, and unintentional injuries involving cutting or piercing 
instruments). Visits for adverse effects 
of medical treatment are less likely to 
be seen in the ED compared with other 
types of injuries in general. Relatively 
more of these visits actually occur in 
physician offices. 
One area of ED use that was not 
examined in this report is visits where 
the patient arrives by ambulance. 
Ambulance transport is an important 
access issue for some patients and 
especially for patients in less densely 
populated areas. Data from the 
1999–2000 NHAMCS show that 
annually there were 14.8 million 
ambulance transports to the ED, 
occurring at 14 percent of ED visits. 
Ambulance use increased with patient 
age (270 per 1,000 persons 75 years of 
age and over vs. 20 per 1,000 persons 
under 15 years of age). The rate was 
double in non-MSAs compared with 
MSAs (118 vs. 53 per 1,000 persons). 
Approximately 40 percent of the 
transports were for trauma patients, and 
33 percent resulted in a hospitalization. 
It is important to document how the use 
of ambulances is integral to emergency 
care in non-MSAs. No national 
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calls that did not result in a visit to the 
ED (i.e., where the emergency medical 
services (EMS) staff treated the patient 
on site). From the rate of transport to 
the ED we might assume that 
non-MSAs also have a higher rate of 
non-transport EMS calls. 
Interpretation of NAMCS and 
NHAMCS encounter data on medical 
care utilization is limited by the fact that 
multiple sampled visits may be made by 
the same person, but these surveys do 
not track specific patients. Therefore, we 
do not know if computed visit rates 
actually represent fewer patients making 
more visits or more patients making 
fewer visits. Data from population-based 
surveys such as the NHIS, National 
Health and Nutrition Examination 
Survey (NHANES), and the Medical 
Expenditure Panel Survey can be 
investigated to compare the amount of 
care obtained by one person. For 
example, the 1999 NHIS indicates that 
uninsured persons make fewer 
ambulatory care visits than persons with 
insurance (7). NHANES III data indicate 
that 78.3 percent of adults used 
analgesic medications during the 
sampled month (1988–94) (24), and 
6.5 percent of adults took lipid-lowering 




Ambulatory care visit and drug data from the NAMCS and NHAMCS are available in a 
variety of formats including CD-ROM 
and downloadable data files accessed 
through the Ambulatory Health Care 
Data homepage on the Internet at 
http://www.cdc.gov/nchs/about/major/ 
ahcd/ahcd1.htm. For additional 
information concerning NAMCS and 
NHAMCS data, contact the Ambulatory 
Care Statistics Branch at (301) 
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Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295,221 143,729 62,366 81,573 2,623 4,930
Geographic region
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69,040 32,635 14,363 20,811 535 697
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65,125 34,366 13,934 14,452 920 1,453
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90,475 43,016 20,001 24,812 767 1,880
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70,581 33,713 14,068 21,499 402 900
MSA1 status
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 243,276 113,131 51,497 74,334 1,560 2,755
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51,945 30,598 10,870 7,240 1,063 2,175
Number of providers per 100,000 persons2
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108.2 52.7 22.9 29.9 1.0 1.8
Geographic region
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131.8 62.3 27.4 39.7 1.0 1.3
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96.9 51.1 20.7 21.5 1.4 2.2
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93.6 44.5 20.7 25.7 0.8 1.9
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124.8 59.6 24.9 38.0 0.7 1.6
MSA1 status
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112.0 52.1 23.7 31.2 0.7 1.3
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93.6 55.1 19.6 13.1 1.9 3.9
Number of providers per county3
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91.7 44.6 19.4 25.3 0.8 1.5
MSA1 status
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 284.5 132.3 60.2 86.9 1.8 3.2
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22.0 12.9 4.6 3.1 0.4 0.9
Number of annual visits per provider
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,318 3,226 2,561 2,044 32,008 21,377
Geographic region
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,174 2,991 2,916 1,814 41,781 28,030
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,541 3,339 2,514 2,119 25,339 18,525
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,514 3,502 2,332 2,201 33,069 21,637
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,001 2,987 2,572 2,034 32,240 20,288
MSA1 status
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,260 3,188 2,593 2,020 43,969 29,049
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,590 3,368 2,412 2,282 14,454 11,660
1MSA is metropolitan statistical area.
2Regional and metropolitan area estimates were provided by the Division of Health Interview Statistics (DHIS), National Center for Health Statistics, and are based on U.S. Census Bureau estimates of
the civilian noninstitutionalized population of the United States as of July 1, 1999, and July 1, 2000. DHIS estimates differ slightly from Census Bureau monthly postcensal estimates because of
differences in the adjustment process.
3Based on 3,220 counties: 855 MSA counties and 2,365 non-MSA counties.
NOTE: Numbers may not add to totals because of rounding. Figures are annual averages.
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Table 2. Annual number and percent distribution of ambulatory care visits by setting type, according to selected patient and provider 
characteristics: United States, 1999–2000 
Primary Surgical Medical 
Combined care specialty speciality Outpatient Emergency 
Characteristic setting offices offices offices departments departments 
Number of visits in thousands 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  979,485 463,692 159,740 166,706 83,956 105,391 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  170,719 105,358 11,251 13,076 18,397 22,636 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  89,730 41,517 9,438 12,484 9,692 16,600 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  245,083 114,485 33,396 43,547 21,558 32,097 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  248,291 107,644 48,422 53,281 20,831 18,112 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  111,285 46,857 26,678 24,010 7,242 6,499 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  114,377 47,832 30,555 20,308 6,236 9,447 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  572,896 285,258 85,793 95,832 50,339 55,674 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  406,588 178,434 73,947 70,875 33,617 49,717 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  826,886 391,210 143,717 147,806 63,289 80,864 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  114,050 50,822 11,165 13,007 17,487 21,568 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  38,550 21,660 4,858 5,893 3,179 2,959 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  516,508 275,313 80,134 86,880 32,482 41,699 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  188,693 76,575 44,463 38,575 13,307 15,773 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100,946 46,720 6,695 10,395 19,151 17,984 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  76,305 23,279 12,452 13,546 8,858 18,169 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  97,034 41,804 15,996 17,309 10,158 11,766 
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  219,117 97,596 41,881 37,749 22,353 19,537 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  230,619 114,741 35,030 30,619 23,311 26,917 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  317,944 150,660 46,647 54,612 25,347 40,677 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  211,805 100,694 36,181 43,726 12,944 18,259 
MSA1 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  792,977 360,653 133,517 150,184 68,591 80,031 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  186,508 103,039 26,222 16,522 15,365 25,360 
Percent distribution 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 47.3 16.3 17.0 8.6 10.8 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 61.7 6.6 7.7 10.8 13.3 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 46.3 10.5 13.9 10.8 18.5 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 46.7 13.6 17.8 8.8 13.1 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 43.4 19.5 21.5 8.4 7.3 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 42.1 24.0 21.6 6.5 5.8 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 41.8 26.7 17.8 5.5 8.3 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 49.8 15.0 16.7 8.8 9.7 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 43.9 18.2 17.4 8.3 12.2 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 47.3 17.4 17.9 7.7 9.8 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 44.6 9.8 11.4 15.3 18.9 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 56.2 12.6 15.3 8.2 7.7 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 53.3 15.5 16.8 6.3 8.1 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 40.6 23.6 20.4 7.1 8.4 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 46.3 6.6 10.3 19.0 17.8 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 30.5 16.3 17.8 11.6 23.8 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 43.1 16.5 17.8 10.5 12.1 
See footnotes at end of table. 
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Table 2. Annual number and percent distribution of ambulatory care visits by setting type, according to selected patient and provider 
characteristics: United States, 1999–2000—Con. 
Primary Surgical Medical 
Combined care specialty speciality Outpatient Emergency 
Characteristic setting offices offices offices departments departments 
Geographic region of provider Percent distribution 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 44.5 19.1 17.2 10.2 8.9 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 49.8 15.2 13.3 10.1 11.7 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 47.4 14.7 17.2 8.0 12.8 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 47.5 17.1 20.6 6.1 8.6 
MSA1 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 45.5 16.8 18.9 8.6 10.1 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 55.2 14.1 8.9 8.2 13.6 
1MSA is metropolitan statistical area. 
NOTE: Numbers may not add to totals because of rounding. Figures are annual averages. 
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Table 3. Annual ambulatory care visit rates by setting type and selected patient and provider characteristics: United States, 
1999–2000 
Primary Surgical Medical 
Combined care specialty speciality Outpatient Emergency 
Characteristic setting offices offices offices departments departments 
Number of visits per 100 persons1–3 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  358.9 169.9 58.5 61.1 30.8 38.6 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  283.2 174.8 18.7 21.7 30.5 37.6 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  234.6 108.5 24.7 32.7 25.4 43.4 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  297.9 139.2 40.6 52.9 26.2 39.0 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  416.5 180.5 81.3 89.3 35.0 30.4 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  626.2 263.7 150.1 135.1 40.8 36.6 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  772.6 323.2 206.5 137.1 42.1 63.8 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  409.5 203.9 61.4 68.4 36.0 39.8 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  305.5 134.1 55.6 53.3 25.3 37.4 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  369.0 174.6 64.1 66.0 28.3 36.1 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  322.8 143.8 31.6 36.8 49.5 61.0 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  284.0 159.4 35.8 43.4 23.5 21.8 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  259.8 138.5 40.3 43.7 16.3 21.0 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  516.1 209.4 121.6 105.5 36.4 43.1 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  355.0 164.3 23.5 36.6 67.4 63.2 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  195.6 59.7 31.9 34.7 22.7 46.6 
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  418.5 186.4 80.0 72.1 42.7 37.3 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  343.0 170.6 52.1 45.5 34.7 40.1 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  328.7 155.8 48.2 56.5 26.2 42.1 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  374.5 178.0 64.1 77.2 23.0 32.3 
MSA4 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  365.0 166.0 61.5 69.1 31.6 36.9 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  336.4 185.9 47.3 29.9 27.7 45.7 
Standard error of rate 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11.4 7.9 2.6 3.3 2.2 1.4 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13.2 11.3 1.8 2.9 2.7 2.0 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9.9 7.3 2.2 2.7 1.8 1.9 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10.8 7.9 2.2 4.1 1.9 1.4 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14.2 9.5 3.9 5.5 2.7 1.1 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  23.9 1.7 7.6 8.6 3.9 1.8 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  29.4 21.5 11.4 8.8 5.2 2.9 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13.6 9.6 3.0 4.1 2.5 1.5 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9.9 6.7 2.3 3.1 1.9 1.4 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12.3 8.0 2.9 3.7 2.3 1.6 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  20.6 17.0 2.2 3.8 3.5 2.8 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  52.6 43.7 5.6 6.6 3.1 2.8 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  9.2 7.1 1.9 3.1 1.6 0.8 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21.8 15.0 6.7 6.9 3.5 1.8 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  19.4 14.3 2.4 5.7 4.5 2.9 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10.8 5.6 5.5 3.6 2.0 2.2 
See footnotes at end of table. 
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Table 3. Annual ambulatory care visit rates by setting type and selected patient and provider characteristics: United States, 
1999–2000—Con. 
Primary Surgical Medical 
Combined care specialty speciality Outpatient Emergency 
Characteristic setting offices offices offices departments departments 
Geographic region of provider Standard error of rate 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21.8 14.7 6.3 6.6 6.2 2.9 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  27.4 18.2 5.0 5.9 5.0 2.8 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  20.1 14.1 4.5 6.2 3.3 2.7 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21.2 15.8 5.1 7.9 3.5 2.6 
MSA4 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11.6 7.9 2.9 3.9 2.4 1.4 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  37.2 23.9 7.7 7.7 5.4 4.4 
1Based on U.S. Census Bureau monthly postcensal estimates of the civilian noninstitutionalized population of the United States as of July 1, 1999, and July 1, 2000. Figures are consistent with the 
downloadable series, ‘‘U.S. Population Estimates by Age, Sex, Race, and Hispanic Origin: 1980–99 (with short-term projection to dates in 2000)’’ and are available at the U.S. Census Bureau Internet 
site: http://www.census.gov/popest/archives/1990s/nat_detail.html. Figures have been adjusted for underenumeration using the 1990 National Population Adjustment Matrix. 
2Regional and metropolitan area estimates were provided by the Division of Health Interview Statistics (DHIS), NCHS, and are based on U.S. Census Bureau estimates of the civilian 
noninstitutionalized population of the United States as of July 1, 1999, and July 1, 2000. DHIS estimates differ slightly from Census Bureau monthly postcensal estimates because of differences in the 
adjustment process. 
3Denominators for primary expected source of payment rates are from the 1999 and 2000 estimates of heatlh insurance coverage from the Current Population Survey. 
4MSA is metropolitan statistical area. 
NOTE: Figures are annual averages. 
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Table 4. Percent distribution of ambulatory care visits by selected patient and provider characteristics, according to metropolitan statistical 
area status: United States, 1999–2000 
Characteristic Total MSA1 Non-MSA1 Total MSA1 Non-MSA1 
Percent distribution Standard error of percent 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 100.0 100.0 . . . . . . . . . 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  17.4 17.3 18.1 0.6 0.6 1.5 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9.2 9.1 9.5 0.2 0.2 0.5 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  25.0 25.7 22.0 0.4 0.4 1.0 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  25.3 25.6 24.2 0.3 0.4 0.9 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11.4 11.2 12.0 0.2 0.3 0.5 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  11.7 11.1 14.2 0.3 0.3 0.7 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  58.5 58.5 58.4 0.4 0.4 0.6 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  41.5 41.5 41.6 0.4 0.4 0.6 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  84.4 82.9 90.9 0.9 1.0 2.3 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11.6 12.5 *7.9 0.6 0.5 2.4 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3.9 4.6 1.2 0.7 0.9 0.3 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  52.7 53.8 48.3 0.8 0.9 1.5 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  19.3 17.9 24.9 0.5 0.5 1.4 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10.3 9.7 12.9 0.5 0.5 1.0 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  7.8 7.9 7.4 0.3 0.4 0.7 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9.9 10.7 6.5 0.5 0.6 0.7 
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  22.4 22.9 20.1 1.1 1.2 2.9 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  23.5 21.6 31.9 1.6 1.5 5.0 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  32.5 31.6 36.3 1.6 1.6 5.4 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21.6 24.0 *11.6 1.2 1.3 5.3 
. . . Category not applicable. 
* Figure does not meet standard of reliability or precision. 
1MSA is metropolitan statistical area. 
NOTE: Numbers may not add to totals because of rounding. Figures are annual averages. 
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Table 5. Percent distribution of ambulatory care visits by expected source of payment, according to selected patient and provider 
characteristics: United States, 1999–2000 
Private 
Characteristic Total insurance Medicare Medicaid Uninsured Other 
Percent distribution 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 52.7 19.3 10.3 7.8 9.9 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 61.2 1.2 23.8 6.6 7.2 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 58.3 1.1 16.6 13.2 10.8 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 63.2 2.7 8.6 11.1 14.3 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 66.3 7.6 6.3 8.4 11.3 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 21.8 65.6 4.4 2.5 5.7 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 13.8 76.2 3.1 1.9 4.9 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 53.3 19.4 11.0 7.5 8.7 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 51.9 19.0 9.3 8.2 11.6 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 54.3 20.2 8.4 7.5 9.7 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 41.3 15.2 22.1 10.3 11.1 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 53.1 12.2 17.0 7.0 10.6 
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 51.3 18.7 10.4 8.9 10.7 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 55.6 20.3 9.9 6.0 8.3 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 51.0 20.8 11.2 9.4 7.6 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 53.7 16.5 9.3 6.2 14.3 
Standard error of percent 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 0.8 0.5 0.5 0.3 0.5 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.5 0.3 1.4 0.5 0.8 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.1 0.2 0.9 0.6 0.6 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.0 0.2 0.4 0.5 0.9 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.0 0.4 0.4 0.5 0.7 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 0.9 1.1 0.5 0.4 0.6 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 0.9 1.2 0.3 0.3 0.8 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 0.9 0.6 0.5 0.4 0.5 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 0.8 0.5 0.5 0.3 0.7 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 0.8 0.6 0.4 0.4 0.5 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.4 0.8 1.3 0.7 1.0 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 3.4 1.1 3.3 0.8 1.8 
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.6 0.8 0.8 0.9 1.2 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.1 0.8 0.6 0.5 0.8 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.6 1.1 1.0 0.6 0.9 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.7 1.3 1.0 0.6 1.5 
. . . Category not applicable. 
NOTE: Numbers may not add to totals because of rounding. Figures are annual averages. 
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Table 6. Annual number of visits and percent distribution of ambulatory care visits by setting type, according to selected contextual 
variables based on residential ZIP Code: United States, 1999–2000 
Surgical 
Combined Primary specialty Medical Outpatient Emergency Total percent 
Contextual variable1 settings care offices offices specialty offices departments departments distribution2 
Number of visits in thousands 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  979,485 463,692 159,740 166,706 83,956 105,391 100.0 
Percent distribution 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 47.3 16.3 17.0 8.6 10.8 . . . 
Median household income3 
Low (less than $33,000) . . . . . . . . . . . . . . . . . . . . . . .  100.0 43.5 15.4 13.4 12.8 15.0 23.4 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 49.4 15.8 16.9 7.7 10.2 53.6 
High (greater than $60,000) . . . . . . . . . . . . . . . . . . . . .  100.0 46.2 19.7 21.6 5.4 7.1 17.6 
Education level3 
Low (less than 15% with bachelor’s degree) . . . . . . . . . .  100.0 48.8 14.1 13.2 10.6 13.4 32.6 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 48.0 17.1 16.6 8.0 10.4 41.2 
High (greater than 35% with bachelor’s degree) . . . . . . . .  100.0 43.8 18.9 23.4 6.4 7.4 20.9 
Foreign born3 
Low (less than 5%) . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 48.5 17.1 13.5 9.3 11.6 44.3 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 45.8 17.1 19.8 6.8 10.4 32.4 
High (greater than 20%) . . . . . . . . . . . . . . . . . . . . . . .  100.0 47.2 13.7 20.1 9.6 9.4 18.0 
Language other than English3 
Low (less than 1%) . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 47.7 18.1 14.1 9.2 11.0 36.0 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 46.5 16.3 18.8 7.6 10.7 46.7 
High (greater than 10%) . . . . . . . . . . . . . . . . . . . . . . .  100.0 49.7 11.9 18.2 10.2 10.1 11.9 
Standard error of percent 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.1 0.7 0.8 0.6 0.4 . . . 
Median household income3 
Low (less than $33,000) . . . . . . . . . . . . . . . . . . . . . . .  . . . 2.3 1.3 1.1 1.1 0.9 1.5 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.3 0.7 0.9 0.7 0.4 1.4 
High (greater than $60,000) . . . . . . . . . . . . . . . . . . . . .  . . . 2.1 1.5 1.5 0.6 0.6 0.9 
Education level3 
Low (less than 15% with Bachelor’s degree) . . . . . . . . . .  . . . 1.7 1.0 1.0 0.8 0.6 1.3 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.6 0.8 1.0 0.7 0.5 1.0 
High (greater than 35% with Bachelor’s degree) . . . . . . . .  . . . 1.6 1.2 1.4 0.6 0.5 0.9 
Foreign born3 
Low (less than 5%) . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.7 1.1 0.9 0.9 0.6 1.9 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.5 1.1 1.1 0.6 0.5 1.6 
High (greater than 20%) . . . . . . . . . . . . . . . . . . . . . . .  . . . 2.3 1.2 1.7 0.9 0.7 1.1 
Language other than English3 
Low (less than 1%) . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.7 1.2 1.0 0.9 0.6 1.7 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . 1.4 0.8 1.0 0.6 0.5 1.7 
High (greater than 10%) . . . . . . . . . . . . . . . . . . . . . . .  . . . 2.7 1.2 2.0 1.0 0.9 0.9 
. . . Category not applicable.

1Based on patient’s residential ZIP Code matched to Census 2000 data.

2Total percent distributions will not sum to 100.0 because ZIP Code information was missing on 5.3% of records.

3For each contextual variable, categories reflect the percentage of persons in the low, medium, and high ranges as defined in the table based on their residential ZIP Code.

NOTE: Figures are annual averages.
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Table 7. Annual rate of visits of ambulatory care visits by setting type, according to selected contextual variables based on residential ZIP 
Code: United States, 1999–2000 
Combined Primary Surgical Medical Outpatient Emergency 
Contextual variable1 settings care offices specialty offices specialty offices departments departments 
Number of visits per 100 persons2 
Median household income3 
Low (less than $33,000) . . . . . . . . . . . . . . . . . . . . . . .  305.4 132.9 47.1 40.8 39.0 45.7 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  323.3 159.7 51.1 54.8 24.8 33.0 
High (greater than $60,000) . . . . . . . . . . . . . . . . . . . . .  364.4 168.3 71.9 78.8 19.7 25.7 
Education level3 
Low (less than 15% with bachelor’s degree) . . . . . . . . . .  328.2 160.2 46.2 43.2 34.6 44.0 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  312.6 150.0 53.4 51.9 24.9 32.6 
High (greater than 35% with Bachelor’s Degree) . . . . . . . .  349.1 152.9 66.0 81.7 22.5 26.0 
Foreign born3 
Low (less than 5%) . . . . . . . . . . . . . . . . . . . . . . . . . .  332.7 161.3 56.8 44.9 31.0 38.6 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  310.9 142.5 53.1 61.7 21.1 32.5 
High (greater than 20%) . . . . . . . . . . . . . . . . . . . . . . .  335.6 158.5 45.9 67.4 32.3 31.6 
Language other than English3 
Low (less than 1%) . . . . . . . . . . . . . . . . . . . . . . . . . .  332.4 158.4 60.1 46.8 30.5 36.6 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  329.0 153.0 53.7 61.8 25.0 35.5 
High (greater than 10%) . . . . . . . . . . . . . . . . . . . . . . .  294.3 146.2 35.0 53.5 30.0 29.7 
Standard error of rate 
Median household income3 
Low (less than $33,000) . . . . . . . . . . . . . . . . . . . . . . .  23.8 14.6 5.2 4.2 4.0 3.1 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13.1 9.0 2.4 3.7 2.2 1.5 
High (greater than $60,000) . . . . . . . . . . . . . . . . . . . . .  18.6 13.5 6.3 6.1 2.2 2.1 
Education level3 
Low (less than 15% with Bachelor’s degree) . . . . . . . . . .  17.8 11.9 3.6 4.0 3.1 2.1 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13.0 9.6 2.9 3.3 2.3 1.6 
High (greater than 35% with Bachelor’s Degree) . . . . . . . .  16.7 10.6 4.7 6.1 2.2 1.9 
Foreign born3 
Low (less than 5%) . . . . . . . . . . . . . . . . . . . . . . . . . .  19.8 12.0 4.5 4.0 3.5 2.2 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  18.2 10.9 3.6 5.0 2.0 2.3 
High (greater than 20%) . . . . . . . . . . . . . . . . . . . . . . .  19.9 14.9 4.4 5.9 3.4 2.2 
Language other than English3 
Low (less than 1%) . . . . . . . . . . . . . . . . . . . . . . . . . .  19.1 11.1 5.1 4.3 3.7 2.4 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  16.3 10.4 3.2 4.1 2.0 2.0 
High (greater than 10%) . . . . . . . . . . . . . . . . . . . . . . .  23.1 16.4 4.3 6.4 3.6 2.4 
1Based on patient’s residential ZIP Code matched to Census 2000 data. 
2Cases with missing ZIP Code information ( 5.3% of records) were assigned to the medium group for rate calculation. Denominators are based on the Census 2000 civilian noninstitutionalized 
population. 
3 For each contextual variable, categories reflect the rate of visits by persons in the low, medium, and high ranges as defined in the table based on their residential ZIP Code. 
NOTE: Figures are annual averages. 
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Table 8. Annual number and percent distribution of ambulatory care visits by the 35 principal reasons for visit most frequently mentioned 
by patients, with percent distribution by setting type: United States, 1999–2000 
Number of Surgical Medical 
visits in Percent Primary specialty specialty Outpatient Emergency 
Principal reason for visit1 and RVC code thousands distribution Total care offices offices offices departments departments 
Percent distribution 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  979,485 100.0 100.0 47.3 16.3 17.0 8.6 10.8 
General medical examination . . . . . . . . . . . . . . . . . .  X100 60,401 6.2 100.0 77.2 2.9 11.0 8.8 *0.1 
Progress visit, not otherwise specified . . . . . . . . . . . .  T800 39,608 4.0 100.0 37.1 16.1 31.0 15.4 *0.3 
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S440 26,403 2.7 100.0 73.5 1.4 6.6 8.7 9.8 
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . .  T205 23,690 2.4 100.0 12.1 73.4 6.7 6.8 1.0 
Prenatal examination, routine . . . . . . . . . . . . . . . . . .  X205 22,679 2.3 100.0 87.9 * * 11.7 * 
Symptoms referable to throat . . . . . . . . . . . . . . . . . .  S455 20,340 2.1 100.0 71.4 4.7 *4.6 9.5 9.8 
Stomach pain, cramps and spasms . . . . . . . . . . . . . .  S545 19,302 2.0 100.0 41.7 5.4 10.8 7.5 34.6 
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S010 15,255 1.6 100.0 59.5 * * 8.8 29.7 
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . .  S905 15,245 1.6 100.0 46.8 18.7 9.7 8.2 16.5 
Skin rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S860 14,613 1.5 100.0 55.8 * 25.1 8.4 10.1 
Earache, or ear infection . . . . . . . . . . . . . . . . . . . . .  S355 14,251 1.5 100.0 65.8 10.3 * 9.3 12.3 
Well baby examination . . . . . . . . . . . . . . . . . . . . . .  X105 14,205 1.5 100.0 87.9 * * 9.9 * 
Knee symptoms . . . . . . . . . . . . . . . . . . . . . . . . . .  S925 14,050 1.4 100.0 28.7 49.8 *8.0 5.8 7.6 
Chest pain and related symptoms (not referable to body 
system) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S050 13,985 1.4 100.0 34.7 * 17.8 5.5 40.8 
Vision dysfunctions . . . . . . . . . . . . . . . . . . . . . . . .  S305 13,117 1.3 100.0 * 88.9 *2.8 2.7 1.2 
Headache, pain in head . . . . . . . . . . . . . . . . . . . . .  S210 12,699 1.3 100.0 48.8 6.6 15.2 6.7 22.7 
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . .  D510 12,209 1.2 100.0 74.4 * 12.2 9.1 2.7 
Medication, other and unspecified kinds . . . . . . . . . . .  T115 11,858 1.2 100.0 62.3 3.3 21.8 10.5 2.2 
Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S110 11,238 1.1 100.0 25.1 * 62.4 9.1 3.2 
Nasal congestion . . . . . . . . . . . . . . . . . . . . . . . . .  S400 10,391 1.1 100.0 61.6 9.9 14.8 7.7 6.1 
Shoulder symptoms . . . . . . . . . . . . . . . . . . . . . . . .  S940 9,493 1.0 100.0 30.6 41.3 10.4 6.7 11.0 
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . .  D205 9,324 1.0 100.0 53.6 12.5 *23.6 9.6 * 
Low back symptoms . . . . . . . . . . . . . . . . . . . . . . .  S910 9,151 0.9 100.0 35.9 17.8 23.9 7.0 15.4 
Head cold, upper respiratory infection (coryza) . . . . . . .  S445 8,726 0.9 100.0 77.6 *2.6 * 7.7 6.2 
For other and unspecified test results . . . . . . . . . . . . .  R700 8,670 0.9 100.0 56.1 18.2 14.9 10.1 * 
Leg symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . .  S920 8,549 0.9 100.0 45.2 19.9 11.8 8.1 15.0 
Gynecological examination . . . . . . . . . . . . . . . . . . .  X225 8,065 0.8 100.0 90.1 * * 6.1 * 
Counseling, not otherwise specified . . . . . . . . . . . . . .  T605 7,888 0.8 100.0 42.8 22.1 20.7 11.6 2.8 
Blood pressure test . . . . . . . . . . . . . . . . . . . . . . . .  X320 7,886 0.8 100.0 75.9 * 13.4 8.7 * 
Anxiety and nervousness . . . . . . . . . . . . . . . . . . . .  S100 7,886 0.8 100.0 37.2 * 51.1 6.0 4.9 
Neck symptoms . . . . . . . . . . . . . . . . . . . . . . . . . .  S900 7,762 0.8 100.0 37.7 22.9 16.5 5.5 17.3 
Sinus problems . . . . . . . . . . . . . . . . . . . . . . . . . .  S410 7,666 0.8 100.0 67.8 9.7 * 8.2 2.8 
Vertigo–dizziness . . . . . . . . . . . . . . . . . . . . . . . . .  S225 7,443 0.8 100.0 54.2 8.5 12.7 6.7 17.9 
Shortness of breath . . . . . . . . . . . . . . . . . . . . . . . .  S415 7,443 0.8 100.0 37.1 * 21.6 5.5 35.4 
Eye examination . . . . . . . . . . . . . . . . . . . . . . . . . .  X230 7,145 0.7 100.0 * 93.9 * 4.4 * 
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  470,848 48.1 100.0 40.1 17.8 20.6 8.5 13.0 
Standard 
error in 
thousands Standard error of percent 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  31,235 . . . . . . 1.1 0.7 0.8 0.6 0.4 
General medical examination . . . . . . . . . . . . . . . . . .  X100 4,622 0.4 . . . 2.2 0.4 1.9 1.1 0.0 
Progress visit, not otherwise specified . . . . . . . . . . . .  T800 2,722 0.2 . . . 3.4 2.1 3.4 1.8 0.1 
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S440 1,343 0.1 . . . 1.8 0.2 1.4 1.0 0.7 
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . .  T205 1,754 0.2 . . . 1.5 2.2 1.2 1.0 0.1 
Prenatal examination, routine . . . . . . . . . . . . . . . . . .  X205 2,013 0.2 . . . 1.4 . . . . . . 1.4 . . . 
Symptoms referable to throat . . . . . . . . . . . . . . . . . .  S455 1,385 0.1 . . . 2.0 0.7 1.5 1.1 0.8 
Stomach pain, cramps and spasms . . . . . . . . . . . . . .  S545 1,044 0.1 . . . 2.3 0.7 2.6 0.8 1.9 
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S010 880 0.1 . . . 2.3 . . . . . . 1.0 1.8 
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . .  S905 900 0.1 . . . 2.8 2.6 1.4 1.1 1.0 
Skin rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S860 916 0.1 . . . 2.7 . . . 2.4 1.0 0.8 
Earache, or ear infection . . . . . . . . . . . . . . . . . . . . .  S355 916 0.1 . . . 2.4 1.4 . . . 1.1 1.0 
Well baby examination . . . . . . . . . . . . . . . . . . . . . .  X105 1,252 0.1 . . . 1.8 . . . . . . 1.3 . . . 
Knee symptoms . . . . . . . . . . . . . . . . . . . . . . . . . .  S925 1,007 0.1 . . . 2.7 3.3 2.6 0.7 0.7 
Chest pain and related symptoms (not referable to body 
system) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S050 697 0.1 . . . 2.4 . . . 2.1 0.6 2.1 
Vision dysfunctions . . . . . . . . . . . . . . . . . . . . . . . .  S305 1,185 0.1 . . . . . . 1.9 1.3 0.8 0.2 
Headache, pain in head . . . . . . . . . . . . . . . . . . . . .  S210 720 0.1 . . . 2.7 1.1 1.6 0.8 1.4 
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . .  D510 1,274 0.1 . . . 2.9 . . . 2.1 1.5 0.4 
Medication, other and unspecified kinds . . . . . . . . . . .  T115 921 0.1 . . . 3.1 0.7 2.9 1.4 0.3 
Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  S110 1,020 0.1 . . . 2.8 . . . 3.2 1.7 0.4 
Nasal congestion . . . . . . . . . . . . . . . . . . . . . . . . .  S400 929 0.1 . . . 4.3 1.5 4.1 1.0 0.7 
See footnotes at end of table. 
Page 24 [ Series 13, No. 157 
Table 8. Annual number and percent distribution of ambulatory care visits by the 35 principal reasons for visit most frequently mentioned 
by patients, with percent distribution by setting type: United States, 1999–2000—Con. 
Number of Surgical Medical 
visits in Percent Primary specialty specialty Outpatient Emergency 
Principal reason for visit1 and RVC code thousands distribution Total care offices offices offices departments departments 
Standard 
error in 
thousands Standard error of percent 
Shoulder symptoms . . . . . . . . . . . . . . . . . . . . . . . .  S940 654 0.1 . . . 3.2 3.3 2.4 1.0 1.0 
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . .  D205 1,100 0.1 . . . 6.0 2.3 7.4 1.6 . . . 
Low back symptoms . . . . . . . . . . . . . . . . . . . . . . .  S910 829 0.1 . . . 3.8 2.9 5.8 1.0 1.5 
Head cold, upper respiratory infection (coryza) . . . . . . .  S445 801 0.1 . . . 2.7 0.9 . . . 1.2 0.9 
For other and unspecified test results . . . . . . . . . . . . .  R700 995 0.1 . . . 5.2 2.9 2.7 2.0 . . . 
Leg symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . .  S920 573 0.1 . . . 3.2 3.4 1.9 1.1 1.2 
Gynecological examination . . . . . . . . . . . . . . . . . . .  X225 990 0.1 . . . 3.0 . . . . . . 1.2 . . . 
Counseling, not otherwise specified . . . . . . . . . . . . . .  T605 558 0.1 . . . 3.5 3.3 3.0 1.5 0.4 
Blood pressure test . . . . . . . . . . . . . . . . . . . . . . . .  X320 836 0.1 . . . 3.7 . . . 3.2 1.6 . . . 
Anxiety and nervousness . . . . . . . . . . . . . . . . . . . .  S100 609 0.1 . . . 4.0 . . . 4.2 0.9 0.6 
Neck symptoms . . . . . . . . . . . . . . . . . . . . . . . . . .  S900 679 0.1 . . . 3.7 3.8 4.2 0.8 1.6 
Sinus problems . . . . . . . . . . . . . . . . . . . . . . . . . .  S410 755 0.1 . . . 3.7 1.8 . . . 1.3 0.6 
Vertigo–dizziness . . . . . . . . . . . . . . . . . . . . . . . . .  S225 495 0.0 . . . 2.9 1.5 1.7 0.8 1.3 
Shortness of breath . . . . . . . . . . . . . . . . . . . . . . . .  S415 555 0.1 . . . 3.9 . . . 3.2 0.8 2.7 
Eye examination . . . . . . . . . . . . . . . . . . . . . . . . . .  X230 1,189 0.1 . . . . . . 1.7 . . . 1.3 . . . 
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14,553 0.5 . . . 1.1 0.7 1.0 0.6 0.4 
* Figure does not meet standard of reliability or precision.

... Category not applicable.

1Based on A Reason for Visit Classification (RVC) (16).

NOTE: Numbers may not add to totals because of rounding. Figures are annual averages. 
Table 9. Annual number and percent distribution of ambulatory care visits by diagnosis group, according to setting type: United States, 1999–2000 
Surgical Medical Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency Combined Primary specialty specialty Outpatient Emergency 
Diagnosis group1 settings care offices offices offices departments departments settings care offices offices offices departments departments 
Number of visits in thousands Percent distribution 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  979,485 463,692 159,740 166,706 83,956 105,391 100.0 100.0 100.0 100.0 100.0 100.0 
Infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . .  29,590 17,754 976 4,933 2,882 3,045 3.0 3.8 0.6 3.0 3.4 2.9 
Streptococcal sore throat . . . . . . . . . . . . . . . . . . . . . . .  2,425 1,725 * * 293 301 0.2 0.4 * * 0.3 0.3 
HIV infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  951 *458 * * 324 * *0.1 *0.1 * * 0.4 * 
Viral warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,443 2,061 * 1,981 257 * 0.5 0.4 * 1.2 0.3 * 
Unspecified viral and chlamydial infections . . . . . . . . . . . .  6,640 4,708 * * 464 1,281 0.7 1.0 * * 0.6 1.2 
Dermatophytosis . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,149 1,763 * 912 264 156 0.3 0.4 * 0.5 0.3 0.1 
Candidiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,998 1,503 * * 200 143 0.2 0.3 * * 0.2 0.1 
Other infectious and parasitic diseases . . . . . . . . . . . . . .  9,983 5,536 637 1,623 1,080 1,107 1.0 1.2 0.4 1.0 1.3 1.1 
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  31,262 5,065 7,653 14,981 3,250 312 3.2 1.1 4.8 9.0 3.9 0.3 
Malignant neoplasm of colon and rectum . . . . . . . . . . . . .  1,347 * 224 * 177 * 0.1 * 0.1 * 0.2 * 
Malignant neoplasm of skin . . . . . . . . . . . . . . . . . . . . .  3,532 * *839 2,101 217 * 0.4 * *0.5 1.3 0.3 * 
Malignant neoplasm of breast . . . . . . . . . . . . . . . . . . . .  5,686 * 749 *4,224 462 * 0.6 * 0.5 *2.5 0.6 * 
Malignant neoplasm of prostate . . . . . . . . . . . . . . . . . . .  2,755 * 1,916 * 129 * 0.3 * 1.2 * 0.2 * 
Malignant neoplasm of lymphatic and hematopoietic tissue . . 2,087 * * *1,186 487 * 0.2 * * *0.7 0.6 * 
Other malignant neoplasms . . . . . . . . . . . . . . . . . . . . .  5,870 * 1,522 2,486 982 136 0.6 * 1.0 1.5 1.2 0.1 
Benign neoplasm of skin . . . . . . . . . . . . . . . . . . . . . . .  3,869 1,066 524 2,130 142 * 0.4 0.2 0.3 1.3 0.2 * 
Other benign neoplasm . . . . . . . . . . . . . . . . . . . . . . . .  4,306 1,576 1,102 1,120 452 55 0.4 0.3 0.7 0.7 0.5 0.1 
Neoplasm of uncertain behavior and unspecified nature . . . .  1,809 * 680 624 202 * 0.2 * 0.4 0.4 0.2 * 
Endocrine, nutritional and metabolic diseases and immunity 
disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  45,777 28,442 3,878 7,380 4,402 1,676 4.7 6.1 2.4 4.4 5.2 1.6 
Acquired hypothyroidism . . . . . . . . . . . . . . . . . . . . . . .  2,811 1,654 * * 298 * 0.3 0.4 * * 0.4 * 
Other disorders of the thyroid gland . . . . . . . . . . . . . . . .  2,435 1,124 268 *831 197 * 0.2 0.2 0.2 *0.5 0.2 * 
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . .  24,695 14,858 3,044 3,704 2,592 497 2.5 3.2 1.9 2.2 3.1 0.5 
Disorders of lipid metabolism . . . . . . . . . . . . . . . . . . . .  7,875 6,582 * 675 491 * 0.8 1.4 * 0.4 0.6 * 
Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,144 2,301 * * 300 * 0.3 0.5 * * 0.4 * 
Other endocrine, nutritional and metabolic diseases and 
immunity disorders . . . . . . . . . . . . . . . . . . . . . . . . . .  4,816 1,922 358 *890 523 1,124 0.5 0.4 0.2 *0.5 0.6 1.1 
Diseases of the blood and blood-forming organs . . . . . . . . . .  5,105 2,759 * 1,057 632 461 0.5 0.6 * 0.6 0.8 0.4 
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,580 2,217 * * 370 322 0.4 0.5 * * 0.4 0.3 
Other diseases of the blood and blood-forming organs . . . . .  1,524 * * * 262 * 0.2 * * * 0.3 * 
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  48,739 13,878 480 25,641 5,758 2,982 5.0 3.0 0.3 15.4 6.9 2.8 
Schizophrenic disorders . . . . . . . . . . . . . . . . . . . . . . . .  2,735 * – 1,934 607 145 0.3 * – 1.2 0.7 0.1 
Major depressive disorder . . . . . . . . . . . . . . . . . . . . . .  7,228 * – 6,257 769 105 0.7 * – 3.8 0.9 0.1 
Other psychoses . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5,168 * – 3,301 602 446 0.5 * – 2.0 0.7 0.4 
Anxiety states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5,272 1,865 * 2,500 386 492 0.5 0.4 * 1.5 0.5 0.5 
Neurotic depression . . . . . . . . . . . . . . . . . . . . . . . . . .  3,720 1,107 * 2,200 319 88 0.4 0.2 * 1.3 0.4 0.1 
Alcohol dependence syndrome . . . . . . . . . . . . . . . . . . .  564 * – * *251 147 0.1 * – * *0.3 0.1 
Drug dependence and nondependent use of drugs . . . . . . .  2,162 * * 215 485 703 0.2 * * 0.1 0.6 0.7 
Acute reaction to stress and adjustment reaction . . . . . . . .  3,790 1,009 * 2,257 415 94 0.4 0.2 * 1.4 0.5 0.1 
Depressive disorder, not elsewhere classified . . . . . . . . . .  7,491 3,798 * 2,520 736 372 0.8 0.8 * 1.5 0.9 0.4 
Attention deficit disorder . . . . . . . . . . . . . . . . . . . . . . .  4,949 2,463 – 1,921 554 * 0.5 0.5 – 1.2 0.7 * 
Other mental disorders . . . . . . . . . . . . . . . . . . . . . . . .  5,660 1,844 356 2,448 634 377 0.6 0.4 0.2 1.5 0.8 0.4 
Diseases of the nervous system and sense organs . . . . . . . .  83,906 26,329 40,652 5,376 5,725 5,826 8.6 5.7 25.4 3.2 6.8 5.5 
Migraine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,142 1,995 * 787 253 947 0.4 0.4 * 0.5 0.3 0.9 
Other disorders of the central nervous system . . . . . . . . . .  4,018 974 * 2,029 526 220 0.4 0.2 * 1.2 0.6 0.2 
Carpal tunnel syndrome . . . . . . . . . . . . . . . . . . . . . . . .  2,604 * 1,363 377 161 * 0.3 * 0.9 0.2 0.2 * 
Other disorders of the nervous system . . . . . . . . . . . . . . .  3,009 1,182 667 808 223 130 0.3 0.3 0.4 0.5 0.3 0.1 
Retinal detachment and other retinal disorders . . . . . . . . . .  3,600 * 3,249 * 97 * 0.4 * 2.0 * 0.1 * 
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Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  7,522 * 7,208 * 237 * 0.8 * 4.5 * 0.3 * 
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9,478 * 8,889 101 *211 * 1.0 * 5.6 0.1 *0.3 * 
Disorders of refraction and accommodation . . . . . . . . . . . .  4,707 * 4,433 – 138 * 0.5 * 2.8 – 0.2 * 
Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,359 2,077 1,073 * 468 594 0.4 0.4 0.7 * 0.6 0.6 
Disorders of eyelids . . . . . . . . . . . . . . . . . . . . . . . . . .  2,143 * 1,388 * 162 89 0.2 * 0.9 * 0.2 0.1 
Other disorders of the eye and adnexa . . . . . . . . . . . . . .  8,240 * 6,425 *209 489 380 0.8 * 4.0 *0.1 0.6 0.4 
Disorders of external ear . . . . . . . . . . . . . . . . . . . . . . .  5,090 2,573 1,594 * 360 408 0.5 0.6 1.0 * 0.4 0.4 
Otitis media and Eustachian tube disorders . . . . . . . . . . . .  19,965 13,184 1,891 * 1,968 2,580 2.0 2.8 1.2 * 2.3 2.4 
Other diseases of the ear and mastoid process . . . . . . . . .  5,029 1,903 2,042 * 432 404 0.5 0.4 1.3 * 0.5 0.4 
Diseases of the circulatory system . . . . . . . . . . . . . . . . . .  73,475 44,141 2,619 16,144 6,175 4,397 7.5 9.5 1.6 9.7 7.4 4.2 
Angina pectoris . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,767 * * 794 87 268 0.2 * * 0.5 0.1 0.3 
Coronary atherosclerosis . . . . . . . . . . . . . . . . . . . . . . .  8,284 3,798 * 3,708 555 * 0.8 0.8 * 2.2 0.7 * 
Other ischemic heart disease . . . . . . . . . . . . . . . . . . . .  2,132 * * 824 107 648 0.2 * * 0.5 0.1 0.6 
Cardiac dysrhythmias . . . . . . . . . . . . . . . . . . . . . . . . .  5,234 2,314 * 1,672 432 782 0.5 0.5 * 1.0 0.5 0.7 
Congestive heart failure . . . . . . . . . . . . . . . . . . . . . . . .  3,374 1,735 – 753 264 622 0.3 0.4 – 0.5 0.3 0.6 
Other heart disease . . . . . . . . . . . . . . . . . . . . . . . . . .  4,362 1,979 * 1,751 372 160 0.4 0.4 * 1.1 0.4 0.2 
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . .  37,451 28,591 489 4,449 3,322 600 3.8 6.2 0.3 2.7 4.0 0.6 
Cerebrovascular disease . . . . . . . . . . . . . . . . . . . . . . .  2,993 1,281 * 552 125 763 0.3 0.3 * 0.3 0.1 0.7 
Diseases of the arteries, arterioles, and capillaries . . . . . . .  2,107 * 432 738 224 87 0.2 * 0.3 0.4 0.3 0.1 
Hemorrhoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,868 943 354 * 173 132 0.2 0.2 0.2 * 0.2 0.1 
Other diseases of the circulatory system . . . . . . . . . . . . .  3,903 1,771 693 637 514 288 0.4 0.4 0.4 0.4 0.6 0.3 
Diseases of the respiratory system . . . . . . . . . . . . . . . . . .  117,247 73,344 6,075 15,232 9,751 12,844 12.0 15.8 3.8 9.1 11.6 12.2 
Acute sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,654 2,788 213 * 309 184 0.4 0.6 0.1 * 0.4 0.2 
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,294 7,746 196 * 1,178 1,584 1.2 1.7 0.1 * 1.4 1.5 
Acute tonsillitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,041 2,074 263 * 274 344 0.3 0.4 0.2 * 0.3 0.3 
Acute bronchitis and bronchiolitis . . . . . . . . . . . . . . . . . .  4,623 3,245 * * 321 911 0.5 0.7 * * 0.4 0.9 
Other acute respiratory infections . . . . . . . . . . . . . . . . . .  25,577 19,447 440 751 2,369 2,569 2.6 4.2 0.3 0.5 2.8 2.4 
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13,195 9,179 1,088 951 1,285 693 1.3 2.0 0.7 0.6 1.5 0.7 
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13,565 5,032 1,596 *6,233 610 94 1.4 1.1 *1.0 *3.7 0.7 0.1 
Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,188 2,268 * * 345 1,371 0.4 0.5 * * 0.4 1.3 
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . .  10,559 7,321 * 501 832 1,791 1.1 1.6 * 0.3 1.0 1.7 
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12,504 5,906 * *3,383 1,173 1,916 1.3 1.3 * *2.0 1.4 1.8 
Other chronic obstructive pulmonary disease and allied 
conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,916 2,624 * *620 353 253 0.4 0.6 * *0.4 0.4 0.2 
Other diseases of the respiratory system . . . . . . . . . . . . .  11,131 5,714 1,935 *1,645 703 1,134 1.1 1.2 1.2 *1.0 0.8 1.1 
Diseases of the digestive system . . . . . . . . . . . . . . . . . . .  35,569 14,556 5,883 5,904 3,106 6,121 3.6 3.1 3.7 3.5 3.7 5.8 
Diseases of the teeth and supporting structures . . . . . . . . .  3,157 716 *1,178 * 201 919 0.3 0.2 *0.7 * 0.2 0.9 
Gastritis and duodenitis . . . . . . . . . . . . . . . . . . . . . . . .  2,907 1,740 * * 216 578 0.3 0.4 * * 0.3 0.5 
Esophagitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  709 * * * *47 * 0.1 * * * *0.1 * 
Ulcer of stomach and small intestine . . . . . . . . . . . . . . . .  876 * * * 77 108 0.1 * * * *0.1 0.1 
Hernia of abdominal cavity . . . . . . . . . . . . . . . . . . . . . .  3,291 * 2,018 * 246 160 0.3 * 1.3 * 0.3 0.2 
Noninfectious enteritis and colitis . . . . . . . . . . . . . . . . . .  5,912 2,918 * *965 531 1,428 0.6 0.6 * *0.6 0.6 1.4 
Diverticula of intestine . . . . . . . . . . . . . . . . . . . . . . . . .  1,232 * * * 103 142 0.1 * * * 0.1 0.1 
Constipation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,439 * * * 218 403 0.1 * * * 0.3 0.4 
Irritable colon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,336 * * * 105 * 0.1 * * * 0.1 * 
Anal and rectal diseases . . . . . . . . . . . . . . . . . . . . . . .  1,577 * 377 * 159 227 0.2 * 0.2 * 0.2 0.2 
Disorders of the gallbladder and biliary tract . . . . . . . . . . .  1,767 * 728 * 109 407 0.2 * 0.5 * 0.1 0.4 
Gastrointestinal hemorrhage . . . . . . . . . . . . . . . . . . . . .  1,091 * * * 69 365 0.1 * * * 0.1 0.3 
Other diseases of the digestive system . . . . . . . . . . . . . .  10,276 4,751 1,168 2,032 1,025 1,299 1.0 1.0 0.7 1.2 1.2 1.2 
See footnotes at end of table. 
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Diseases of the genitourinary system . . . . . . . . . . . . . . . . .  49,336 26,080 11,443 *3,184 3,948 4,681 5.0 5.6 7.2 *1.9 4.7 4.4 
Calculus of kidney and ureter . . . . . . . . . . . . . . . . . . . .  2,256 * 988 * 121 550 0.2 * 0.6 * 0.1 0.5 
Cystitis and other disorders of the bladder . . . . . . . . . . . .  2,596 1,005 1,105 * 148 179 0.3 0.2 0.7 * 0.2 0.2 
Urinary tract infection, site not specified . . . . . . . . . . . . . .  8,316 5,070 914 * 607 1,568 0.8 1.1 0.6 * 0.7 1.5 
Other diseases of the urinary system . . . . . . . . . . . . . . .  5,143 1,242 1,764 *766 625 745 0.5 0.3 1.1 *0.5 0.7 0.7 
Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . . . . . .  3,154 * 2,202 * 104 * 0.3 * 1.4 * 0.1 * 
Other disorders of male genital organs . . . . . . . . . . . . . .  3,774 1,083 2,108 * 231 299 0.4 0.2 1.3 * 0.3 0.3 
Disorders of breast . . . . . . . . . . . . . . . . . . . . . . . . . . .  5,600 2,062 1,860 * 489 88 0.6 0.4 1.2 * 0.6 0.1 
Inflammatory disorders of female pelvic organs . . . . . . . . .  2,805 1,968 * * 306 396 0.3 0.4 * * 0.4 0.4 
Noninflammatory disorders of female genital organs . . . . . .  2,922 2,197 * * 317 319 0.3 0.5 * * 0.4 0.3 
Disorders of menstruation and abnormal bleeding . . . . . . . .  3,250 2,717 * * 270 203 0.3 0.6 * * 0.3 0.2 
Menopausal and postmenopausal disorders . . . . . . . . . . .  4,019 3,748 * * 177 * 0.4 0.8 * * 0.2 * 
Other disorders of the female genital tract . . . . . . . . . . . .  5,502 3,700 361 *563 554 324 0.6 0.8 0.2 *0.3 0.7 0.3 
Complications of pregnancy, childbirth, and the puerperium . . . 6,426 3,901 * * 1,032 1,206 0.7 0.8 * * 1.2 1.1 
Diseases of the skin and subcutaneous tissue . . . . . . . . . . .  50,159 16,789 3,829 23,186 3,429 2,926 5.1 3.6 2.4 13.9 4.1 2.8 
Cellulitis and abscess . . . . . . . . . . . . . . . . . . . . . . . . .  4,635 2,307 399 * 450 1,137 0.5 0.5 0.3 * 0.5 1.1 
Other infection of the skin and subcutaneous tissue . . . . . .  1,980 1,039 295 * 187 245 0.2 0.2 0.2 * 0.2 0.2 
Contact dermatitis and other eczema . . . . . . . . . . . . . . .  8,700 4,498 * 2,833 680 656 0.9 1.0 * 1.7 0.8 0.6 
Psoriasis and similar disorders . . . . . . . . . . . . . . . . . . .  1,538 * – 1,244 164 * 0.2 * – 0.7 0.2 * 
Other inflammatory conditions of skin and subcutaneous 
tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,009 1,749 * 3,582 456 197 0.6 0.4 * 2.1 0.5 0.2 
Corns, callosities and other hypertrophic and atrophic skin 
conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,481 * *746 1,062 131 * 0.3 * *0.5 0.6 0.2 * 
Actinic and seborrheic keratosis . . . . . . . . . . . . . . . . . . .  5,662 * * 4,645 119 * 0.6 * * 2.8 0.1 * 
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,728 1,257 * 5,206 232 * 0.7 0.3 * 3.1 0.3 * 
Sebaceous cyst . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,134 1,109 843 956 150 75 0.3 0.2 0.5 0.6 0.2 0.1 
Urticaria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,700 * * * 131 357 0.2 * * * 0.2 0.3 
Other disorders of the skin and subcutaneous tissue . . . . . .  7,592 2,980 1,185 2,462 729 236 0.8 0.6 0.7 1.5 0.9 0.2 
Diseases of the musculoskeletal system and connective 
tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  71,645 27,889 19,897 12,707 5,461 5,691 7.3 6.0 12.5 7.6 6.5 5.4 
Rheumatoid arthritis . . . . . . . . . . . . . . . . . . . . . . . . . .  3,223 * * *2,261 199 * 0.3 * * *1.4 0.2 * 
Osteoarthrosis and allied disorders . . . . . . . . . . . . . . . . .  7,485 2,944 2,861 1,100 500 81 0.8 0.6 1.8 0.7 0.6 0.1 
Other arthropathies and related disorders . . . . . . . . . . . . .  5,855 2,334 978 1,929 443 172 0.6 0.5 0.6 1.2 0.5 0.2 
Derangements and other and unspecified joint disorders . . . 9,814 3,636 3,487 933 744 1,013 1.0 0.8 2.2 0.6 0.9 1.0 
Intervertebral disc disorders . . . . . . . . . . . . . . . . . . . . .  4,433 962 2,026 *1,157 191 97 0.5 0.2 1.3 *0.7 0.2 0.1 
Lumbago . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,452 1,967 351 *839 514 781 0.5 0.4 0.2 *0.5 0.6 0.7 
Other dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,756 4,774 2,743 1,681 978 1,581 1.2 1.0 1.7 1.0 1.2 1.5 
Peripheral enthesopathies and allied disorders . . . . . . . . . .  6,749 2,594 2,988 485 414 268 0.7 0.6 1.9 0.3 0.5 0.3 
Synovitis and tenosynovitis . . . . . . . . . . . . . . . . . . . . . .  1,953 * 1,069 * 100 82 0.2 * 0.7 * 0.1 0.1 
Myalgia and myositis, unspecified . . . . . . . . . . . . . . . . . .  3,053 1,399 * *843 233 468 0.3 0.3 * *0.5 0.3 0.4 
Other rheumatism, excluding back . . . . . . . . . . . . . . . . .  7,819 3,670 1,812 781 622 934 0.8 0.8 1.1 0.5 0.7 0.9 
Disorders of bone and cartilage . . . . . . . . . . . . . . . . . . .  3,599 1,777 886 * 308 160 0.4 0.4 0.6 * 0.4 0.2 
Other diseases of the musculoskeletal system and connective 
tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,454 *668 464 * 216 * 0.1 0.1 0.3 * 0.3 * 
Congenital anomalies . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,251 1,030 956 462 773 * 0.3 0.2 0.6 0.3 0.9 * 
Certain conditions originating in the perinatal period . . . . . . . .  555 * * * 86 * 0.1 * * * 0.1 * 







Table 9. Annual number and percent distribution of ambulatory care visits by diagnosis group, according to setting type: United States, 1999–2000—Con. 
Surgical Medical Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency Combined Primary specialty specialty Outpatient Emergency 







Number of visits in thousands Percent distribution 
Symptoms, signs, and ill-defined conditions . . . . . . . . . . . . .  68,723 30,655 5,825 9,932 5,262 17,049 7.0 6.6 3.6 6.0 6.3 16.2 
Syncope and collapse . . . . . . . . . . . . . . . . . . . . . . . . .  1,568 * – 246 67 779 0.2 * – 0.1 0.1 0.7 
Convulsions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,191 * – 559 325 691 0.2 * – 0.3 0.4 0.7 
Dizziness and giddiness . . . . . . . . . . . . . . . . . . . . . . .  2,460 1,150 322 269 189 530 0.3 0.2 0.2 0.2 0.2 0.5 
Pyrexia of unknown origin . . . . . . . . . . . . . . . . . . . . . .  2,222 900 – * 139 1,152 0.2 0.2 – * 0.2 1.1 
Symptoms involving skin and other integumentary tissue . . . 5,659 3,561 449 640 409 601 0.6 0.8 0.3 0.4 0.5 0.6 
Headache . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,949 1,483 * 663 299 1,217 0.4 0.3 * 0.4 0.4 1.2 
Epistaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,167 * 355 – * 422 0.1 * 0.2 – * 0.4 
Abnormal heart sounds . . . . . . . . . . . . . . . . . . . . . . . .  1,715 * – 296 157 361 0.2 * – 0.2 0.2 0.3 
Dyspnea and respiratory abnormalities . . . . . . . . . . . . . .  2,252 892 * 369 149 784 0.2 0.2 * 0.2 0.2 0.7 
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,030 1,270 * * 174 214 0.2 0.3 * * 0.2 0.2 
Chest pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,955 2,084 * 880 432 3,517 0.7 0.4 * 0.5 0.5 3.3 
Symptoms involving urinary system . . . . . . . . . . . . . . . .  3,297 882 1,375 * 210 587 0.3 0.2 0.9 * 0.2 0.6 
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9,159 3,349 434 *1,150 706 3,521 0.9 0.7 0.3 *0.7 0.8 3.3 
Other symptoms, signs, and ill-defined conditions . . . . . . . .  24,098 12,747 2,428 4,291 1,960 2,672 2.5 2.7 1.5 2.6 2.3 2.5 
Injury and poisoning . . . . . . . . . . . . . . . . . . . . . . . . . . .  80,291 21,083 18,607 4,974 5,303 30,325 8.2 4.5 11.6 3.0 6.3 28.8 
Fracture of radius and ulna . . . . . . . . . . . . . . . . . . . . . .  2,268 * 1,454 – 183 563 0.2 * 0.9 – 0.2 0.5 
Fracture of hand and fingers . . . . . . . . . . . . . . . . . . . . .  2,938 * 1,512 – 268 858 0.3 * 0.9 – 0.3 0.8 
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . .  4,935 * 2,858 * 426 1,255 0.5 * 1.8 * 0.5 1.2 
Other fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,740 * 1,743 * 210 1,069 0.4 * 1.1 * 0.3 1.0 
Sprains and strains of wrist and hand . . . . . . . . . . . . . . .  1,837 * * * 125 539 0.2 * * * 0.1 0.5 
Sprains and strains of knee and leg . . . . . . . . . . . . . . . .  2,540 805 847 * 176 594 0.3 0.2 0.5 * 0.2 0.6 
Sprains and strains of ankle . . . . . . . . . . . . . . . . . . . . .  3,167 * 652 * 182 1,392 0.3 * 0.4 * 0.2 1.3 
Sprains and strains of neck . . . . . . . . . . . . . . . . . . . . .  3,597 1,232 * *550 146 1,294 0.4 0.3 * *0.3 0.2 1.2 
Other sprains and strains of back . . . . . . . . . . . . . . . . . .  6,354 2,883 860 *963 328 1,320 0.6 0.6 0.5 *0.6 0.4 1.3 
Other sprains and strains . . . . . . . . . . . . . . . . . . . . . . .  5,756 2,362 1,438 * 349 1,312 0.6 0.5 0.9 * 0.4 1.2 
Intracranial injury, excluding those with skull fracture . . . . . .  661 * * * * 333 0.1 * * * * 0.3 
Open wound of head . . . . . . . . . . . . . . . . . . . . . . . . .  3,361 * * * 178 2,595 0.3 * * * 0.2 2.5 
Open wound of hand and fingers . . . . . . . . . . . . . . . . . .  3,834 867 * * 232 2,139 0.4 0.2 * * 0.3 2.0 
Other open wound . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,837 1,057 613 * 445 2,598 0.5 0.2 0.4 * 0.5 2.5 
Superficial injury of cornea . . . . . . . . . . . . . . . . . . . . . .  937 * * – 76 388 0.1 * * – 0.1 0.4 
Other superficial injury . . . . . . . . . . . . . . . . . . . . . . . . .  3,015 1,161 * * 202 1,304 0.3 0.3 * * 0.2 1.2 
Contusions with intact skin surfaces . . . . . . . . . . . . . . . .  8,914 2,092 1,113 * 517 4,756 0.9 0.5 0.7 * 0.6 4.5 
Other injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9,683 1,993 2,785 *622 702 3,581 1.0 0.4 1.7 *0.4 0.8 3.4 
Poisonings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,681 * * * 65 973 0.2 * * * 0.1 0.9 
Other and unspecified effects of external causes . . . . . . . .  4,188 2,108 * * 314 1,041 0.4 0.5 * * 0.4 1.0 
Complications of surgical and medical care, not elsewhere 
classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,048 * 889 * 138 423 0.2 * 0.6 * 0.2 0.4 
Supplementary classification of factors influencing health status 
and contact with health services . . . . . . . . . . . . . . . . . . .  154,519 97,979 27,951 10,651 14,850 3,087 15.8 21.1 17.5 6.4 17.7 2.9 
Potential health hazards related to communicable diseases . . 3,045 2,162 * * 536 94 0.3 0.5 * * 0.6 0.1 
Potential health hazards relating to personal and family 
history . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10,300 4,313 2,917 1,841 956 273 1.1 0.9 1.8 1.1 1.1 0.3 
Routine infant or child health check . . . . . . . . . . . . . . . .  31,175 27,479 * *754 2,860 * 3.2 5.9 * *0.5 3.4 * 
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . .  22,098 19,287 – * 2,520 186 2.3 4.2 – * 3.0 0.2 
Postpartum care and examination . . . . . . . . . . . . . . . . .  2,178 1,958 – – 220 * 0.2 0.4 * – 0.3 * 
Encounter for contraceptive management . . . . . . . . . . . . .  2,066 1,159 439 * 425 * 0.2 0.3 0.3 * 0.5 * 
Other encounter related to reproduction . . . . . . . . . . . . . .  1,208 785 * * 244 * 0.1 0.2 – * 0.3 * 
Lens replaced by pseudophakos . . . . . . . . . . . . . . . . . .  1,997 – 1,979 – * – 0.2 – – – * – 
See footnotes at end of table. 
Table 9. Annual number and percent distribution of ambulatory care visits by diagnosis group, according to setting type: United States, 1999–2000—Con. 
Surgical Medical Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency Combined Primary specialty specialty Outpatient Emergency 
Diagnosis group1 settings care offices offices offices departments departments settings care offices offices offices departments departments 
Number of visits in thousands Percent distribution 
Artificial opening status and other postsurgical states . . . . . .  7,776 679 5,910 *506 620 61 0.8 0.1 3.7 *0.3 0.7 0.1 
Attention to surgical dressing and sutures . . . . . . . . . . . . .  1,922 747 * * 196 557 0.2 0.2 * * 0.2 0.5 
Follow-up examination . . . . . . . . . . . . . . . . . . . . . . . . .  14,846 4,498 6,638 *2,354 1,153 202 1.5 1.0 4.2 *1.4 1.4 0.2 
General medical examination . . . . . . . . . . . . . . . . . . . .  17,583 14,121 404 *1,345 1,531 183 1.8 3.0 0.3 *0.8 1.8 0.2 
Observation and evaluation for suspected conditions not 
found . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,932 2,454 912 514 543 508 0.5 0.5 0.6 0.3 0.6 0.5 
Gynecological examination . . . . . . . . . . . . . . . . . . . . . .  9,155 8,458 * * 515 * 0.9 1.8 * * 0.6 * 
Other factors influencing health status and contact with health 
services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  24,240 9,877 8,190 2,701 2,515 956 2.5 2.1 5.1 1.6 3.0 0.9 
Blank and illegible . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  23,910 11,622 2,778 4,702 2,133 2,675 2.4 2.5 1.7 2.8 2.5 2.5 












Table 10. Annual number and percent distribution of ambulatory care visits by setting type, according to selected primary diagnosis groups: United States, 1999–2000 
Number of Surgical Medical 
visits in Percent Primary specialty specialty Outpatient Emergency 








All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  979,485 100.0 100.0 47.3 16.3 17.0 8.6 10.8 
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  401 37,451 3.8 100.0 76.3 1.3 11.9 8.9 1.6 
Acute URI, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . .  460–461, 463–466 36,895 3.8 100.0 74.7 2.5 3.1 8.9 10.9 
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V20.2 31,175 3.2 100.0 88.1 * *2.4 9.2 * 
Arthropathies and related disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  710–719 26,377 2.7 100.0 36.2 28.2 23.6 7.1 4.9 
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  250 24,695 2.5 100.0 60.2 12.3 15.0 10.5 2.0 
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V22 22,098 2.3 100.0 87.3 * * 11.4 0.8 
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  140–208, 230–234 21,278 2.2 100.0 10.1 25.1 52.2 11.5 1.1 
Spinal disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  720–724 20,642 2.1 100.0 37.3 24.8 17.8 8.2 11.9 
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . .  381–382 19,965 2.0 100.0 66.0 9.5 * 9.9 12.9 
Rheumatisms, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  725–729 19,573 2.0 100.0 41.9 30.5 11.6 7.0 9.0 
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V70 17,583 1.8 100.0 80.3 2.3 *7.6 8.7 1.0 
Follow-up examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V67 14,846 1.5 100.0 30.3 44.7 15.9 7.8 1.4 
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  477 13,565 1.4 100.0 37.1 *11.8 45.9 4.5 0.7 
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  473 13,195 1.3 100.0 69.6 8.2 7.2 9.7 5.3 
Heart disease, excluding ischemic . . . . .  391–392, 393–398, 402, 404, 415–416, 420–429 12,970 1.3 100.0 46.5 * 32.2 8.2 12.1 
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  493 12,504 1.3 100.0 47.2 * 27.1 9.4 15.3 
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  410–414.9 12,183 1.2 100.0 40.2 * 43.7 6.1 7.9 
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  462 11,294 1.2 100.0 68.6 1.7 * 10.4 14.0 
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  490–491 10,559 1.1 100.0 69.3 * 4.7 7.9 17.0 
Potential health hazards relating to personal and family history . . . . . . . . . . .  V10–V19 10,300 1.1 100.0 41.9 28.3 17.9 9.3 2.6 
Sprains and strains, excluding ankles and back . . . . . . . . . . . . .  840–844, 845.4, 848 10,133 1.0 100.0 39.1 25.0 *5.4 6.4 24.1 
Benign neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  210–229, 235–239 9,984 1.0 100.0 29.3 23.1 38.8 8.0 0.9 
Sprains and strains of neck and back . . . . . . . . . . . . . . . . . . . . . . . . . . . .  846, 847 9,951 1.0 100.0 41.3 12.4 15.2 4.8 26.3 
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  366 9,478 1.0 100.0 * 93.8 * *2.2 * 
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  789 9,159 0.9 100.0 36.6 4.7 12.6 7.7 38.4 
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V72.3 9,155 0.9 100.0 92.4 * * 5.6 * 
Fractures, excluding lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  800–819 8,946 0.9 100.0 10.4 52.6 * 7.4 27.8 
Contusions with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  920–924 8,914 0.9 100.0 23.5 12.5 * 5.8 53.4 
Contact dermatitis and other eczema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  692 8,700 0.9 100.0 51.7 * 32.6 7.8 7.5 
Open wound, excluding head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  874–897 8,670 0.9 100.0 22.2 10.3 * 7.8 54.6 
Urinary tract infection, site not specified . . . . . . . . . . . . . . . . . . . . . . . . . . . .  599.0 8,316 0.8 100.0 61.0 11.0 * 7.3 18.9 
Psychoses, excluding major depressive disorder . . . . .  290–295, 296.0–296.1, 296.4–299 7,902 0.8 100.0 11.0 * 66.2 15.3 7.5 
Disorder of lipoid metabolism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  272 7,875 0.8 100.0 83.6 * 8.6 6.2 * 
Artificial opening and other postsurgical status . . . . . . . . . . . . . . . . . . . . .  V44–V45 7,776 0.8 100.0 8.7 76.0 *6.5 8.0 * 
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  365 7,522 0.8 100.0 * 95.8 * 3.1 * 
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  457,855 46.7 100.0 41.6 17.4 19.3 8.8 12.9 
See footnotes at end of table. 
Table 10. Annual number and percent distribution of ambulatory care visits by setting type, according to selected primary diagnosis groups: United States, 1999–2000—Con. 
Number of Surgical Medical 
visits in Percent Primary specialty specialty Outpatient Emergency 
Primary diagnosis group1 and ICD–9–CM codes thousands distribution Total care offices offices offices departments departments 
Standard 
error in 
thousands Standard error of percent 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  31,235 . . . . . . 1.1 0.7 0.8 0.6 0.4 
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  401 2,825 0.2 . . . 2.2 0.4 1.8 1.0 0.2 
Acute URI, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . .  460–461, 463–466 2,268 0.2 . . . 1.7 0.4 0.8 1.0 0.7 
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V20.2 2,332 0.2 . . . 1.6 . . . 1.3 1.1 . . . 
Arthropathies and related disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  710–719 2,335 0.2 . . . 3.7 2.8 5.5 1.0 0.5 
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  250 1,886 0.2 . . . 3.5 1.8 3.7 1.2 0.3 
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V22 1,926 0.2 . . . 1.4 . . . . . . 1.3 0.1 
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  140–208, 230–234 2,466 0.3 . . . 1.7 3.3 5.6 2.1 0.2 
Spinal disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  720–724 1,806 0.2 . . . 3.6 4.7 4.1 1.2 1.1 
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . .  381–382 1,330 0.1 . . . 2.3 1.3 . . . 1.1 1.0 
Rheumatisms, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  725–729 1,117 0.1 . . . 2.6 2.3 2.4 0.8 0.6 
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V70 1,604 0.1 . . . 2.5 0.6 2.4 1.3 0.2 
Follow-up examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V67 1,534 0.2 . . . 5.0 5.1 4.6 1.2 0.4 
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  477 2,776 0.3 . . . 8.7 3.8 10.8 1.2 0.2 
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  473 925 0.1 . . . 2.6 1.3 1.9 1.4 0.6 
Heart disease, excluding ischemic . . . . .  391–392, 393–398, 402, 404, 415–416, 420–429 836 0.1 . . . 3.0 . . . 2.7 1.6 0.9 
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  493 1,292 0.1 . . . 4.6 . . . 6.5 1.3 1.6 
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  410–414.9 914 0.1 . . . 3.8 . . . 4.0 1.0 0.8 
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  462 1,010 0.1 . . . 3.3 0.4 . . . 1.4 1.6 
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  490–491 769 0.1 . . . 2.5 . . . 1.3 1.2 1.5 
Potential health hazards relating to personal and family history . . . . . . . . . . .  V10–V19 753 0.1 . . . 3.5 3.1 2.9 1.2 0.4 
Sprains and strains, excluding ankles and back . . . . . . . . . . . . .  840–844, 845.4, 848 626 0.1 . . . 2.8 2.5 1.7 0.9 1.6 
Benign neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  210–229, 235–239 715 0.1 . . . 2.8 2.6 3.1 1.0 0.2 
Sprains and strains of neck and back . . . . . . . . . . . . . . . . . . . . . . . . . . . .  846, 847 801 0.1 . . . 4.2 2.4 3.9 0.9 2.3 
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  366 1,083 0.1 . . . . . . 1.7 . . . 0.8 . . . 
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  789 693 0.1 . . . 3.2 0.8 4.8 1.1 3.2 
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  V72.3 1,062 0.1 . . . 2.3 . . . . . . 1.0 . . . 
Fractures, excluding lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  810–819 638 0.1 . . . 1.9 3.4 . . . 1.2 2.2 
Contusions with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  920–924 679 0.1 . . . 5.2 2.0 . . . 1.0 4.2 
Contact dermatitis and other eczema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  692 709 0.1 . . . 3.9 . . . 3.7 1.0 0.8 
Open wound, excluding head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  874–897 490 0.0 . . . 2.9 1.9 . . . 1.0 2.8 
Urinary tract infection, site not specified . . . . . . . . . . . . . . . . . . . . . . . . . . . .  599.0 570 0.0 . . . 2.5 1.3 . . . 1.1 1.4 
Psychoses, excluding major depressive disorder . . . . .  290–295, 296.0–296.1, 296.4–299 730 0.1 . . . 2.6 . . . 3.8 2.6 0.9 
Disorder of lipoid metabolism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  272 736 0.1 . . . 2.4 . . . 1.7 1.2 . . . 
Artificial opening and other postsurgical status . . . . . . . . . . . . . . . . . . . . .  V44–V45 795 0.1 . . . 2.2 3.2 2.1 1.3 . . . 
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  365 866 0.1 . . . . . . 1.1 . . . 0.9 . . . 
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14,395 0.5 . . . 1.1 0.7 0.9 0.6 0.4 
. . . Category not applicable. 
* Figure does not meet standard of reliability or precision. 
1These groups are based on the principal diagnosis coded according to the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (17). A complete list of the ICD–9–CM codes used to formulate the groupings in this table is 
shown in Appendix I. The intent of this table is to provide a more detailed breakdown of the diagnostic content of ambulatory care visits than would be possible using only the major disease categories or chapter heading used in the ICD–9–CM. 
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Table 11. Annual number and percent distribution of injury-related ambulatory care visits by setting type, according to selected patient and 
provider characteristics: United States, 1999–2000 
Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency 
Characteristic settings care offices offices offices departments departments 
Number of visits in thousands 
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . .  136,815 37,850 32,948 17,571 9,417 39,029 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21,630 6,778 3,661 852 1,742 8,597 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  18,056 3,960 4,056 1,226 1,288 7,526 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  43,527 11,507 10,362 5,713 3,109 12,835 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  32,084 9,540 8,998 5,425 2,216 5,904 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9,929 3,016 2,715 1,997 501 1,700 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,588 3,049 3,154 2,357 561 2,467 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  66,724 19,969 15,717 8,615 4,679 17,743 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  70,091 17,881 17,230 8,956 4,738 21,286 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  115,970 32,464 29,357 15,529 7,597 31,023 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  17,085 4,082 2,855 1,753 1,524 6,872 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,760 1,304 735 289 296 1,135 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  64,100 20,779 16,656 6,253 3,873 16,540 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  18,639 5,274 4,683 3,718 1,035 3,928 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,342 3,006 1,263 536 1,470 5,067 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12,942 1,633 2,051 957 1,165 7,136 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  29,791 7,158 8,295 6,107 1,874 6,357 
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  28,724 6,558 8,858 3,822 1,860 7,625 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  32,560 11,050 6,074 2,414 3,188 9,833 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  43,973 11,589 9,095 6,327 2,666 14,296 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  31,558 8,653 8,920 5,008 1,703 7,276 
MSA1 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  110,269 29,514 27,487 16,360 7,482 29,425 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  26,546 8,337 5,460 1,211 1,935 9,604 
Percent distribution 
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . .  100.0 27.7 24.1 12.8 6.9 28.5 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 31.3 16.9 3.9 8.1 39.7 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 21.9 22.5 6.8 7.1 41.7 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 26.4 23.8 13.1 7.1 29.5 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 29.7 28.0 16.9 6.9 18.4 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 30.4 27.3 20.1 5.0 17.1 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 26.3 27.2 20.3 4.8 21.3 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 29.9 23.6 12.9 7.0 26.6 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 25.5 24.6 12.8 6.8 30.4 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 28.0 25.3 13.4 6.6 26.8 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 23.9 16.7 10.3 8.9 40.2 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 34.7 19.6 7.7 7.9 30.2 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 32.4 26.0 9.8 6.0 25.8 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 28.3 25.1 19.9 5.6 21.1 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 26.5 11.1 4.7 13.0 44.7 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 12.6 15.8 7.4 9.0 55.1 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 24.0 27.8 20.5 6.3 21.3 
See footnotes at end of table. 
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Table 11. Annual number and percent distribution of injury-related ambulatory care visits by setting type, according to selected patient and 
provider characteristics: United States, 1999–2000—Con. 
Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency 
Characteristic settings care offices offices offices departments departments 
Geographic region of provider Percent distribution 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 22.8 30.8 13.3 6.5 26.5 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 33.9 18.7 7.4 9.8 30.2 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 26.4 20.7 14.4 6.1 32.5 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 27.4 28.3 15.9 5.4 23.1 
MSA1 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 26.8 24.9 14.8 6.8 26.7 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 31.4 20.6 4.6 7.3 36.2 
1MSA is metropolitan statistical area. 
NOTE: Numbers may not add to totals because of rounding. Figures are annual averages. 
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Table 12. Annual rate of injury-related ambulatory care visits by setting type and selected patient and provider characteristics: 
United States, 1999–2000 
Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency 
Characteristic settings care offices offices offices departments departments 
Number of visits per 1,000 persons1–3 
All injury-related visits . . . . . . . . . . . . . . . . . . . . .  501.2 138.6 120.7 64.4 34.5 143.0 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . .  358.8 112.4 60.7 14.1 28.9 142.6 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . .  472.2 103.5 106.1 32.2 33.7 196.8 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . .  529.2 139.9 126.0 69.4 37.8 156.0 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . .  538.4 159.9 151.0 91.3 37.2 99.1 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . .  558.7 169.7 152.8 112.4 28.2 95.7 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . .  782.8 206.0 213.3 159.2 37.8 166.5 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  477.0 142.7 112.4 61.7 33.5 126.9 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  526.6 134.3 129.4 67.4 35.6 159.9 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  517.5 144.8 131.0 69.4 33.9 138.4 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  483.8 115.5 80.9 49.8 43.1 194.5 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  277.4 *96.2 54.2 21.4 21.9 83.8 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . .  322.4 104.5 83.8 31.5 19.5 83.2 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  509.8 144.3 128.1 101.7 28.3 107.5 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  398.9 105.7 44.4 *18.9 51.7 178.2 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  331.8 41.9 52.6 24.5 29.9 183.0 
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  548.4 125.3 169.0 72.9 35.5 145.6 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  484.1 164.3 90.2 35.9 47.5 146.3 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  454.7 119.8 94.0 65.5 27.6 147.8 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  557.7 152.8 157.6 88.7 30.1 128.5 
MSA4 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  507.5 135.8 126.5 75.5 34.4 135.4 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  478.9 150.6 98.5 *22.0 34.9 173.0 
Standard error of rate 
All injury-related visits . . . . . . . . . . . . . . . . . . . . .  19.9 10.1 8.3 7.5 3.5 5.4 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . .  17.4 11.0 9.5 3.7 3.4 6.9 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . .  25.0 14.0 12.1 5.8 3.9 9.1 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . .  26.2 13.6 9.8 14.9 4.2 6.4 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . .  30.2 15.8 12.7 11.4 4.2 3.9 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . .  30.2 20.8 12.7 11.6 3.9 6.5 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . .  40.0 24.0 21.2 15.8 7.1 10.1 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  19.0 10.3 8.1 7.1 3.4 5.0 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  23.1 11.4 9.3 10.1 3.9 6.2 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21.8 10.5 9.2 7.5 3.8 6.1 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  29.8 17.6 10.5 14.3 4.5 9.3 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  45.5 31.1 10.2 5.4 4.6 11.3 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . .  13.7 7.5 7.0 3.1 2.4 3.8 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  24.5 14.5 10.8 10.2 3.9 6.0 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  23.7 13.2 8.6 6.9 5.1 9.3 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  18.5 6.3 8.3 5.1 3.6 9.4 
See footnotes at end of table. 
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Table 12. Annual rate of injury-related ambulatory care visits by setting type and selected patient and provider characteristics: 
United States, 1999–2000—Con. 
Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency 
Characteristic settings care offices offices offices departments departments 
Geographic region of provider Standard error of rate 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  48.3 13.9 21.5 18.3 7.2 12.0 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  44.4 32.5 11.6 5.8 9.1 11.6 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  28.1 11.3 14.5 14.1 5.4 9.3 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  47.0 18.3 19.4 19.5 6.5 11.9 
MSA4 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21.5 10.6 9.1 9.2 3.9 5.5 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  55.6 20.5 23.5 6.7 8.1 17.2 
* Figure does not meet standard of reliability or precision. 
1Based on U.S. Census Bureau monthly postcensal estimates of the civilian noninstitutionalized population of the United States as of July 1, 1999, and July 1, 2000. Figures are consistent with the 
downloadable series, ‘‘U.S. Population Estimates by Age, Sex, Race, and Hispanic Origin: 1980–1999 (with short-term projection to dates in 2000)’’ and are available at the U.S. Census Bureau 
Internet site: http://www.census.gov/popest/archives/1990s/nat_detail.html. Figures have been adjusted for underenumeration using the 1990 National Population Adjustment Matrix. 
2Regional and metropolitan area estimates were provided by the Division of Health Interview Statistics (DHIS), NCHS, and are based on Census Bureau estimates of the civilian noninstitutionalized 
population of the United States as of July 1, 1999, and July 1, 2000. DHIS estimates differ slightly from Census Bureau monthly postcensal estimates because of differences in the adjustment process. 
3Denominators for primary expected source of payment rates are from the 1999 and 2000 estimates of heatlh insurance coverage from the Current Population Survey. 
4MSA is metropolitan statistical area. 
NOTE: Figures are annual averages. 
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Table 13. Percentage of injury-related ambulatory care visits to each setting, by selected patient and provider characteristics: United States, 
1999–2000 
Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency 
Characteristic settings care offices offices offices departments departments 
Percent of visits that are for injuries 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14.0 8.2 20.6 10.5 11.2 37.0 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12.7 6.4 32.5 6.5 9.5 38.0 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  20.1 9.5 43.0 9.8 13.3 45.3 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  17.8 10.1 31.0 13.1 14.4 40.0 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12.9 8.9 18.6 10.2 10.6 32.6 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  8.9 6.4 10.2 8.3 6.9 26.2 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  10.1 6.4 10.3 11.6 9.0 26.1 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11.7 7.0 18.3 9.0 9.3 31.9 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  17.2 10.0 23.3 12.6 14.1 42.8 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14.0 8.3 20.4 10.5 12.0 38.4 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  15.0 8.0 25.6 13.5 8.7 31.9 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9.8 6.0 15.1 4.9 9.3 38.4 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  12.4 7.6 20.8 7.2 11.9 39.7 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9.9 6.9 10.5 9.6 7.8 24.9 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11.2 6.4 18.9 *5.2 7.7 28.2 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  17.0 7.0 16.5 7.1 13.2 39.3 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  30.7 17.1 51.9 35.3 18.5 54.0 
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13.1 6.7 21.2 10.1 8.3 39.0 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14.1 9.6 17.3 7.9 13.7 36.5 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13.8 7.7 19.5 11.6 10.5 35.1 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14.9 8.6 24.7 11.5 13.2 39.9 
MSA1 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13.9 8.2 20.6 10.9 10.9 36.8 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14.2 8.1 20.8 7.3 12.6 37.9 
Standard error of percent 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.4 1.1 1.1 0.7 0.4 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.6 0.5 3.6 1.5 0.7 0.9 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.9 1.2 4.0 1.7 1.0 0.8 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.7 0.7 1.8 2.4 1.0 0.6 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.5 0.7 1.3 1.1 0.8 0.7 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.7 0.8 0.8 0.7 1.2 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.6 0.9 1.1 1.2 0.9 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.4 1.1 0.9 0.6 0.5 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.5 0.6 1.2 1.6 0.9 0.6 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.4 1.1 1.0 0.8 0.5 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.8 0.9 2.8 3.3 0.6 0.7 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.7 0.7 2.5 1.4 1.6 1.7 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.4 1.4 0.6 0.8 0.6 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.5 0.8 0.9 0.7 0.7 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.5 0.7 2.9 1.6 0.5 0.8 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.7 0.9 2.3 1.1 1.0 0.7 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.7 2.2 3.3 5.9 2.5 1.4 
See footnotes at end of table. 
Series 13, No. 157 [ Page 37 
Table 13. Percentage of injury-related ambulatory care visits to each setting, by selected patient and provider characteristics: United States, 
1999–2000—Con. 
Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency 
Characteristic settings care offices offices offices departments departments 
Geographic region of provider Standard error of percent 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.9 0.5 2.2 2.2 1.0 1.1 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.6 1.2 1.6 1.2 1.4 0.7 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.8 0.6 2.2 2.2 1.3 0.6 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.8 0.7 2.5 2.2 1.5 1.1 
MSA1 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.5 1.2 1.2 0.8 0.4 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.8 0.6 3.1 1.1 1.4 1.1 
* Figure does not meet standard of reliability or precision. 
1MSA is metropolitan statistical area. 
NOTE: Figures are annual averages. 
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Table 14. Annual number, percent distribution, and rate of injury-related ambulatory care visits, by intent and mechanism: United States, 
1999–2000 
Percent 
Number of Standard Standard Rate of Standard seen in 
visits in error in Percent error of visits per error emergency 
Intent and mechanism thousands thousands distribution percent 1,000 persons of rate departments 
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . .  136,815 5,428 100.0 . . . 501 20 28.5 
Unintentional injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  94,115 4,091 68.8 0.8 345 15 32.3 
Falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  22,505 1,118 16.5 0.5 82 4 34.6 
Struck against or struck accidentally by objects or persons . . . .  11,134 667 8.1 0.3 41 2 40.3 
Motor vehicle traffic . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,010 687 8.1 0.4 40 3 39.3 
Overexertion and strenuous movements . . . . . . . . . . . . . . . .  8,796 878 6.4 0.5 32 3 20.5 
Natural and environmental factors . . . . . . . . . . . . . . . . . . .  5,716 480 4.2 0.3 21 2 30.5 
Cutting and piercing instruments or objects . . . . . . . . . . . . . .  5,499 375 4.0 0.2 20 1 56.0 
Foreign body accidentally entering eye or other orifice . . . . . . .  1,930 193 1.4 0.1 7 1 45.4 
Poisoning by drugs, medicinal substances, biologicals, other solid 
and liquid substances, gases, and vapors . . . . . . . . . . . . . .  1,713 164 1.3 0.1 6 1 44.7 
Motor vehicle, nontraffic . . . . . . . . . . . . . . . . . . . . . . . . . .  1,167 181 0.9 0.1 4 1 33.0 
Fire and flames, hot substance or object, caustic or corrosive 
material, and steam . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,131 149 0.8 0.1 4 1 42.0 
Pedal cycle, nontraffic, and other . . . . . . . . . . . . . . . . . . . .  1,073 123 0.8 0.1 4 <1 49.9 
Machinery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,063 144 0.8 0.1 4 1 34.8 
Other transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . .  602 106 0.4 0.1 2 <1 26.0 
Drowning/submersion and suffocation . . . . . . . . . . . . . . . . .  *188 56 0.1 <1 1 <1 *63.2 
Firearm missile . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  176 43 0.1 <1 1 <1 30.2 
Other and not elsewhere classified . . . . . . . . . . . . . . . . . . .  10,766 723 7.9 0.4 39 3 13.1 
Mechanism unspecified . . . . . . . . . . . . . . . . . . . . . . . . . .  9,644 615 7.1 0.4 35 2 21.1 
Intentional injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,744 326 2.7 0.2 14 1 57.5 
Self-inflicted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  464 56 0.3 <1 2 <1 87.9 
Poisoning by solid or liquid substances, gases, and vapors . . 294 41 0.2 <1 1 <1 97.2 
Cutting and piercing instrument . . . . . . . . . . . . . . . . . . . .  95 23 0.1 <1 0 <1 74.4 
Other mechanism . . . . . . . . . . . . . . . . . . . . . . . . . . . .  * . . . * . . . * . . . * 
Mechanism unspecified . . . . . . . . . . . . . . . . . . . . . . . . .  * . . . * . . . * . . . * 
Assault . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,074 226 2.3 0.2 11 1 55.8 
Firearms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  *49 17 <1 <1 *<1 <1 * 
Cutting and piercing instrument . . . . . . . . . . . . . . . . . . . .  187 39 0.1 <1 1 <1 71.9 
Unarmed fight or brawl, striking by blunt or thrown object . . . .  1,581 132 1.2 0.1 6 <1 60.2 
Other mechanism . . . . . . . . . . . . . . . . . . . . . . . . . . . .  516 88 0.4 0.1 2 <1 46.8 
Mechanism unspecified . . . . . . . . . . . . . . . . . . . . . . . . .  741 115 0.5 0.1 3 <1 50.0 
Other causes of violence . . . . . . . . . . . . . . . . . . . . . . . . .  *205 152 0.2 0.1 *1 1 * 
Injuries of undetermined intent . . . . . . . . . . . . . . . . . . . . . . .  373 67 0.3 0.1 1 <1 45.7 
Adverse effects of medical treatment . . . . . . . . . . . . . . . . . . .  6,686 476 4.9 0.3 24 2 19.2 
Missing cause1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  31,898 1,481 23.3 0.8 117 5 15.7 
. . . Category not applicable. 
* Figure does not meet standard of reliability or precision. 
1Includes illegible and blank entries. 
NOTE: Numbers may not add to totals because of rounding. Figures are annual averages. 
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Table 15. Annual number and percent distribution of injury-related ambulatory care visits, by region of body and nature of injury: 
United States, 1999–2000 
Percent of 
Number of Standard Standard visits seen Standard 
visits in error in Percent error of in emergency error of 
Region of body and nature of injury1 thousands thousands distribution percent departments percent 
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . .  136,815 5,434 100.0 . . . 28.5 1.1 
Head, face, and neck . . . . . . . . . . . . . . . . . . . . . . . . .  9,337 462 6.8 0.3 64.6 2.6 
Fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  490 85 0.4 0.1 45.1 8.0 
Internal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  672 120 0.5 0.1 49.5 8.7 
Open wound . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,448 247 2.5 0.2 76.2 4.5 
Contusions/superficial . . . . . . . . . . . . . . . . . . . . . . .  3,342 287 2.4 0.2 57.0 4.9 
Burns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  117 25 0.1 0.0 68.7 13.2 
Unspecified . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,197 124 0.9 0.1 71.5 5.5 
Spine and back . . . . . . . . . . . . . . . . . . . . . . . . . . . .  8,059 651 5.9 0.4 26.3 2.4 
Fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  725 133 0.5 0.1 12.2 3.2 
Sprains and strains . . . . . . . . . . . . . . . . . . . . . . . . .  7,247 639 5.3 0.4 27.6 2.7 
Torso . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5,522 437 4.0 0.3 36.4 3.0 
Fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  735 128 0.5 0.1 38.4 7.2 
Sprains and strains . . . . . . . . . . . . . . . . . . . . . . . . .  2,800 321 2.0 0.2 23.5 3.2 
Internal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  107 28 0.1 0.0 * . . . 
Open wound . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  237 66 0.2 0.0 49.6 13.6 
Contusions/superficial . . . . . . . . . . . . . . . . . . . . . . .  1,325 154 1.0 0.1 57.0 5.9 
Unspecified . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  259 63 0.2 0.0 41.8 10.5 
Upper extremities . . . . . . . . . . . . . . . . . . . . . . . . . . .  21,494 1,193 15.7 0.6 38.2 2.2 
Fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,995 565 5.1 0.4 27.1 2.4 
Dislocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  867 118 0.6 0.1 35.4 5.1 
Sprains and strains . . . . . . . . . . . . . . . . . . . . . . . . .  4,369 392 3.2 0.2 23.7 2.4 
Open wound . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,753 373 3.5 0.2 56.3 4.1 
Amputations . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  122 27 0.1 0.0 55.3 11.5 
Contusions/superficial . . . . . . . . . . . . . . . . . . . . . . .  2,842 266 2.1 0.2 55.8 5.2 
Crushing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  165 47 0.1 0.0 56.1 14.6 
Burns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  420 73 0.3 0.1 56.0 8.6 
Unspecified . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  876 121 0.6 0.1 34.7 5.2 
Lower extremities . . . . . . . . . . . . . . . . . . . . . . . . . . .  18,335 923 13.4 0.5 33.6 1.8 
Fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,522 380 3.3 0.3 26.1 2.6 
Dislocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,842 223 1.3 0.2 7.1 1.5 
Sprains and strains . . . . . . . . . . . . . . . . . . . . . . . . .  6,530 422 4.8 0.3 34.7 2.2 
Open wound . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,621 133 1.2 0.1 62.7 4.3 
Contusion/superficial . . . . . . . . . . . . . . . . . . . . . . . .  2,875 307 2.1 0.2 44.0 4.9 
Burns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  139 38 0.1 0.0 * . . . 
Unspecified . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  719 120 0.5 0.1 30.6 6.0 
Other and unspecified body sites . . . . . . . . . . . . . . . . .  7,965 509 5.8 0.3 33.8 2.3 
Fracture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  413 84 0.3 0.1 * . . . 
Sprains and strains . . . . . . . . . . . . . . . . . . . . . . . . .  2,295 268 1.7 0.2 21.2 2.7 
Open wound . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,838 166 1.3 0.1 44.9 4.2 
Contusion/superficial . . . . . . . . . . . . . . . . . . . . . . . .  2,482 229 1.8 0.2 37.7 3.6 
Burns . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  316 69 0.2 0.1 33.0 8.8 
Unspecified . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  367 52 0.3 0.0 64.0 7.1 
System wide and late effects . . . . . . . . . . . . . . . . . . . .  3,691 278 2.7 0.2 47.9 3.6 
Foreign bodies . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,237 153 0.9 0.1 47.6 5.8 
Poisoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,681 172 1.2 0.1 57.9 5.7 
Other and unspecified effects of external causes . . . . . .  239 75 *0.2 0.1 *45.3 14.6 
Late effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  232 84 *0.2 0.1 * . . . 
Early complications of trauma . . . . . . . . . . . . . . . . . .  205 80 *0.1 0.1 * . . . 
Adverse effects . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5,889 469 4.3 0.3 22.6 1.9 
Anaphylactic shock . . . . . . . . . . . . . . . . . . . . . . . . .  3,840 346 2.8 0.2 23.6 2.4 
Surgical and medical complications . . . . . . . . . . . . . . .  2,048 279 1.5 0.2 20.6 3.0 
All other body sites . . . . . . . . . . . . . . . . . . . . . . . . . .  54,798 2,827 40.1 1.0 14.8 0.8 
Musculoskeletal . . . . . . . . . . . . . . . . . . . . . . . . . . .  15,817 1,234 11.6 0.7 13.6 1.1 
Ill-defined symptoms . . . . . . . . . . . . . . . . . . . . . . . .  3,876 371 2.8 0.2 32.7 2.8 
Skin and subcutaneous tissue . . . . . . . . . . . . . . . . . .  9,151 629 6.7 0.4 9.2 0.9 
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . .  3,138 448 2.3 0.3 23.2 3.3 
Nervous system . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,641 321 2.7 0.2 14.2 1.5 
Other illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10,361 668 7.6 0.4 14.3 1.1 
Supplementary classification . . . . . . . . . . . . . . . . . . .  8,814 740 6.4 0.5 12.7 1.2 
Unknown2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,726 245 1.3 0.2 34.9 5.5 
. . . Category not applicable.

*Figure does not meet standard of reliability or precision.

0.0 Quantity greater than zero but less than 0.05.

1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (17). A description of the codes used to define each category is shown in Appendix I, table IV.

2Includes blank diagnoses, uncodable diagnoses, and illegible diagnoses.

NOTE: Numbers may not add to totals because of rounding and because subcategories having fewer than 30 records have been omitted. Figures are annual averages.
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Table 16. Annual number and percent distribution of ambulatory care visits by medication therapy, according to setting type: United States, 
1999–2000 
Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency 
Medication therapy settings care offices offices offices departments departments 
Number of visits in thousands 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  979,485 463,692 159,740 166,706 83,956 105,391 
Was medication therapy provided or prescribed? 
Yes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  654,429 331,486 68,196 123,028 54,610 77,109 
No . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  325,056 132,206 91,544 43,678 29,346 28,282 
Number of medications provided or prescribed 
0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  325,056 132,206 91,544 43,678 29,346 28,282 
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  272,898 139,210 36,922 44,138 21,767 30,862 
2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  166,572 83,260 16,669 29,923 13,803 22,919 
3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  90,211 45,161 7,096 18,697 7,459 11,798 
4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  48,437 26,405 2,894 9,725 3,933 5,480 
5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  30,026 15,124 1,692 7,687 2,643 2,879 
6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  46,285 22,326 2,924 12,859 5,005 3,172 
Percent distribution 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  100.0 100.0 100.0 100.0 100.0 100.0 
Was medication therapy provided or prescribed? 
Yes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  66.8 71.5 42.7 73.8 65.0 73.2 
No . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  33.2 28.5 57.3 26.2 35.0 26.8 
Number of medications provided or prescribed 
0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  33.2 28.5 57.3 26.2 35.0 26.8 
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  27.9 30.0 23.1 26.5 25.9 29.3 
2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  17.0 18.0 10.4 17.9 16.4 21.7 
3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9.2 9.7 4.4 11.2 8.9 11.2 
4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.9 5.7 1.8 5.8 4.7 5.2 
5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3.1 3.3 1.1 4.6 3.1 2.7 
6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.7 4.8 1.8 7.7 6.0 3.0 
Standard error of percent 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . . . . . . . . . . 
Was medication therapy provided or prescribed? 
Yes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.7 1.0 1.5 1.6 1.3 0.8 
No . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.7 1.0 1.5 1.6 1.3 0.8 
Number of medications provided or prescribed 
0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.7 1.0 1.5 1.6 1.3 0.8 
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.7 0.9 1.3 0.7 0.5 
2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.3 0.5 0.5 0.8 0.5 0.3 
3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.2 0.4 0.4 0.6 0.3 0.3 
4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.2 0.3 0.2 0.5 0.2 0.2 
5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.1 0.2 0.2 0.5 0.2 0.2 
6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.3 0.4 0.4 0.7 0.6 0.3 
. . . Category not applicable. 
NOTE: Numbers may not add to totals because of rounding. Figures are annual averages. 
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Table 17. Annual rate of drug mentions at ambulatory care visits by setting type and selected patient and provider characteristics: 
United States, 1999–2000 
Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency 
Characteristic settings care offices offices offices departments departments 
Number of mentions per 100 visits1 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  153.0 163.1 80.8 188.7 155.7 158.9 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  117.4 119.4 36.8 158.7 117.7 123.5 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  110.7 97.6 69.2 154.3 106.2 136.7 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  127.4 123.4 65.5 155.3 134.9 163.3 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  169.2 193.9 76.8 189.5 189.0 185.8 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  203.2 247.2 99.1 227.3 227.2 198.4 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  210.1 259.6 107.9 253.1 222.9 188.9 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  156.0 162.6 85.8 193.5 156.2 165.5 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  148.7 164.0 75.1 182.2 154.9 151.4 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  152.5 163.1 80.1 188.1 157.0 160.6 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  158.9 167.8 84.6 201.6 154.7 153.8 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  146.1 151.9 91.8 174.5 135.1 148.1 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  141.1 144.4 75.5 179.6 147.9 159.9 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  211.0 259.9 101.2 245.6 219.5 191.8 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  159.0 163.5 83.1 221.0 147.2 151.7 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  131.8 142.0 69.4 150.5 127.6 149.7 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  113.7 120.7 58.9 117.9 137.9 136.2 
Geographic region of provider 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  152.7 161.9 86.3 191.6 172.0 151.3 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  148.9 159.0 78.9 188.4 156.0 145.5 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  155.3 169.4 72.6 187.5 144.1 161.8 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  154.3 159.6 87.1 188.0 149.9 180.2 
MSA2 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  149.0 156.3 82.6 188.7 150.7 156.0 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  169.8 187.1 71.9 212.8 178.2 168.0 
Standard error of rate 
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2.7 4.3 4.5 6.8 4.6 3.4 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3.3 4.3 4.4 14.3 3.9 3.2 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3.0 4.3 18.6 7.0 3.3 3.0 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2.9 4.5 3.7 7.3 4.0 3.2 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3.6 6.1 4.6 8.3 6.5 5.1 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5.8 9.5 6.8 11.7 10.3 7.0 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  5.8 10.3 8.3 11.6 17.8 8.3 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3.1 4.9 5.0 8.0 5.0 3.7 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2.7 4.3 4.5 6.9 4.9 3.3 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2.9 4.5 4.6 6.9 5.1 3.8 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.3 7.9 7.7 13.8 6.0 3.6 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6.2 9.6 10.7 12.8 9.4 7.3 
Primary expected source of payment 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  2.7 4.0 4.8 6.7 5.2 3.5 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5.6 9.7 7.4 10.9 13.3 7.3 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.2 7.5 9.4 12.1 4.4 4.3 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.3 7.8 10.1 8.4 6.8 3.5 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.1 6.6 5.0 14.5 6.5 4.4 
See footnotes at end of table. 
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Table 17. Annual rate of drug mentions at ambulatory care visits by setting type and selected patient and provider characteristics: 
United States, 1999–2000—Con. 
Surgical Medical 
Combined Primary specialty specialty Outpatient Emergency 
Characteristic settings care offices offices offices departments departments 
Geographic region of provider Standard error of rate 
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5.9 8.6 9.1 17.7 9.6 7.4 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.8 7.8 8.1 14.4 7.3 3.4 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5.9 9.4 8.2 11.9 7.6 6.1 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.3 6.3 11.1 10.5 11.0 10.0 
MSA2 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2.7 4.3 4.5 6.8 4.4 3.3 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  7.4 10.4 6.9 24.7 17.8 9.8 
1Number of drug mentions divided by total number of visits multiplied by 100. 
2MSA is metropolitan statistical area. 
NOTE: Figures are annual averages. 
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Table 18. Annual number and rate per 100 drug mentions of the 35 most frequently occurring generic substances at ambulatory care visits, 
with percent distribution by setting: United States, 1999–2000 
Number of 
Number of occurrences Primary Surgical Medical 
occurrences per 100 drug care specialty specialty Outpatient Emergency 
Generic substance in thousands1 mentions2 Total offices offices offices departments departments 
Percent distribution 
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . .  67,284 4.5 100.0 37.7 9.6 9.4 8.7 34.7 
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . .  36,761 2.5 100.0 68.8 3.2 4.9 10.1 13.0 
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  32,784 2.2 100.0 39.7 4.9 8.0 10.8 36.5 
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  26,002 1.7 100.0 53.3 2.6 15.7 9.9 18.6 
Hydrocodone . . . . . . . . . . . . . . . . . . . . . . . . . . .  24,437 1.6 100.0 43.5 12.5 7.7 5.2 31.1 
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . .  23,156 1.5 100.0 69.6 4.5 14.5 9.5 2.0 
Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21,884 1.5 100.0 70.1 5.5 13.9 8.2 2.3 
Levothyroxine . . . . . . . . . . . . . . . . . . . . . . . . . .  19,095 1.3 100.0 57.1 5.0 26.7 8.1 3.1 
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  18,960 1.3 100.0 45.3 6.9 27.6 10.1 10.2 
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . .  18,432 1.2 100.0 52.3 5.4 25.1 8.3 9.0 
Guaifenesin . . . . . . . . . . . . . . . . . . . . . . . . . . . .  18,430 1.2 100.0 69.8 5.7 8.0 9.7 6.9 
Loratadine . . . . . . . . . . . . . . . . . . . . . . . . . . . .  18,268 1.2 100.0 63.8 6.6 20.2 7.1 2.3 
Lisinopril . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  16,262 1.1 100.0 67.3 4.4 17.5 8.3 2.5 
Atorvastatin calcium . . . . . . . . . . . . . . . . . . . . . .  15,857 1.1 100.0 61.0 4.8 25.5 6.7 2.1 
Prednisone . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14,943 1.0 100.0 33.9 5.7 38.1 9.1 13.2 
Atenolol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  14,590 1.0 100.0 58.8 5.6 23.8 8.6 3.1 
Omeprazole . . . . . . . . . . . . . . . . . . . . . . . . . . .  13,330 0.9 100.0 55.6 4.1 25.3 10.1 5.0 
Amlodipine . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13,082 0.9 100.0 61.3 3.7 22.8 9.4 2.9 
Cephalexin . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12,763 0.9 100.0 52.9 9.9 5.7 8.5 23.0 
Naproxen . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12,570 0.8 100.0 54.3 11.9 12.2 9.4 12.3 
Multiple vitamins . . . . . . . . . . . . . . . . . . . . . . . . .  12,539 0.8 100.0 64.1 4.0 14.9 14.1 3.0 
Metoprolol . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12,120 0.8 100.0 54.8 4.9 27.2 8.3 5.0 
Digoxin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,862 0.8 100.0 52.7 4.0 32.4 5.7 5.1 
Triamcinolone . . . . . . . . . . . . . . . . . . . . . . . . . .  11,610 0.8 100.0 47.4 9.0 33.0 8.1 2.6 
Pseudoephedrine . . . . . . . . . . . . . . . . . . . . . . . .  11,603 0.8 100.0 65.7 5.2 13.0 10.2 5.9 
Insulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,426 0.8 100.0 50.4 5.8 21.7 13.3 8.8 
Influenza virus vaccine . . . . . . . . . . . . . . . . . . . . .  11,187 0.7 100.0 81.4 0.1 6.6 11.7 0.2 
Metformin . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,098 0.7 100.0 64.7 4.0 19.8 9.1 2.4 
Fluticasone propionate . . . . . . . . . . . . . . . . . . . . .  10,915 0.7 100.0 50.3 7.8 30.6 8.8 2.6 
Promethazine . . . . . . . . . . . . . . . . . . . . . . . . . .  10,303 0.7 100.0 38.7 1.6 0.6 5.6 53.5 
Sertraline . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10,095 0.7 100.0 47.2 2.8 37.8 9.1 3.1 
Clavulanate potassium . . . . . . . . . . . . . . . . . . . . .  10,018 0.7 100.0 70.5 5.4 2.4 9.7 12.0 
Warfarin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9,739 0.6 100.0 51.4 6.3 27.7 9.5 5.2 
Medroxyprogesterone . . . . . . . . . . . . . . . . . . . . .  9,716 0.6 100.0 71.3 3.6 10.8 12.2 2.1 
Trimethoprim . . . . . . . . . . . . . . . . . . . . . . . . . . .  9,639 0.6 100.0 55.3 9.3 5.2 13.3 16.9 
1Frequency of mention combines single-ingredient agents with mentions of the agent as an ingredient in a combination drug. 
2Based on an estimated annual average of 1,498,266,000 drug mentions at ambulatory care visits in 1999–2000. 
NOTE: Figures are annual averages. 
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Table 19. Annual rate of drug mentions at ambulatory care visits by setting type and therapeutic classification: United States, 1999–2000

Primary Surgical Medical 
Combined care specialty specialty Outpatient Emergency 
Therapeutic classification1 settings offices offices offices departments departments 
Number of mentions per 100 visits2 
All drug mentions . . . . . . . . . . . . . . . . . . . . . . . . . . .  153.0 163.1 80.8 188.7 155.7 158.9 
Anesthetic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.5 0.5 2.7 1.4 1.9 4.3 
Antidotes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.1 *0.0 *0.0 *0.2 *0.1 0.3 
Antimicrobial agents . . . . . . . . . . . . . . . . . . . . . . . . .  15.3 18.3 6.8 9.2 16.6 23.5 
Hematologic agents . . . . . . . . . . . . . . . . . . . . . . . . . .  2.6 2.8 0.7 3.7 3.2 2.4 
Cardiovascular-renal drugs . . . . . . . . . . . . . . . . . . . . .  21.7 26.3 8.5 29.1 20.7 10.6 
Central nervous system . . . . . . . . . . . . . . . . . . . . . . .  12.5 10.8 2.2 29.1 12.9 8.5 
Contrast media/radiopharmaceuticals . . . . . . . . . . . . . . .  0.5 0.8 *0.6 *0.1 0.6 0.1 
Gastrointestinal agents . . . . . . . . . . . . . . . . . . . . . . . .  6.7 7.1 1.9 8.9 7.9 8.0 
Metabolic/nutrients . . . . . . . . . . . . . . . . . . . . . . . . . .  10.3 12.8 3.2 13.2 11.2 5.3 
Hormones and agents related to hormonal mechanisms . . . 14.8 18.5 5.8 17.9 15.0 7.7 
Immunologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6.2 9.4 *0.6 4.0 7.7 3.4 
Skin/mucous membrane . . . . . . . . . . . . . . . . . . . . . . .  7.1 6.2 3.1 16.1 5.9 3.5 
Neurologic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.0 3.4 1.2 7.8 4.8 4.7 
Oncolytics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.2 0.4 0.7 4.5 1.6 0.1 
Ophthalmics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.3 1.1 20.8 0.7 1.8 1.3 
Otologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.8 0.9 0.4 0.7 0.9 1.3 
Relief of pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21.0 18.1 12.4 18.2 21.4 50.9 
Antiparasitics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.6 0.6 *0.1 *1.2 0.9 0.2 
Respiratory tract . . . . . . . . . . . . . . . . . . . . . . . . . . . .  16.9 19.9 6.3 17.8 16.6 19.0 
Unclassified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4.3 5.2 2.6 4.4 3.7 3.7 
Homeopathic products . . . . . . . . . . . . . . . . . . . . . . . .  0.2 0.2 0.2 *0.4 0.2 *0.0 
Standard error of rate 
All drug mentions . . . . . . . . . . . . . . . . . . . . . . . . . . .  2.7 4.3 4.5 6.8 4.7 3.4 
Anesthetic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.1 0.1 0.6 0.2 0.3 0.2 
Antidotes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.0 0.0 0.0 0.1 0.0 0.0 
Antimicrobial agents . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.6 0.5 0.7 0.8 0.6 
Hematologic agents . . . . . . . . . . . . . . . . . . . . . . . . . .  0.1 0.2 0.1 0.4 0.2 0.1 
Cardiovascular-renal drugs . . . . . . . . . . . . . . . . . . . . .  0.8 1.4 1.0 2.1 1.4 0.6 
Central nervous system . . . . . . . . . . . . . . . . . . . . . . .  0.5 0.6 0.4 2.0 0.8 0.4 
Contrast media/radiopharmaceuticals . . . . . . . . . . . . . . .  0.1 0.1 0.5 0.1 0.1 0.0 
Gastrointestinal agents . . . . . . . . . . . . . . . . . . . . . . . .  0.2 0.4 0.2 0.9 0.5 0.3 
Metabolic/nutrients . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.7 0.4 1.1 0.7 0.3 
Hormones and agents related to hormonal mechanisms . . . 0.5 0.7 0.7 2.1 0.8 0.3 
Immunologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.7 0.3 1.2 0.5 0.1 
Skin/mucous membrane . . . . . . . . . . . . . . . . . . . . . . .  0.3 0.3 0.3 1.3 0.4 0.2 
Neurologic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.2 0.2 0.1 0.6 0.3 0.2 
Oncolytics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.2 0.1 0.1 1.1 0.2 0.0 
Ophthalmics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.4 0.1 2.1 0.1 0.2 0.1 
Otologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.1 0.1 0.1 0.2 0.1 0.1 
Relief of pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.5 0.8 0.8 1.8 0.9 1.0 
Antiparasitics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.1 0.1 0.0 0.4 0.1 0.0 
Respiratory tract . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.7 0.8 0.6 3.4 1.1 0.5 
Unclassified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.2 0.4 0.3 0.5 0.2 0.2 
Homeopathic products . . . . . . . . . . . . . . . . . . . . . . . .  0.0 0.1 0.1 0.2 0.0 0.0 
* Figure does not meet standard of reliability or precision.

0.0 Quantity is greater than zero but less than 0.05.

1Based on the standard drug classification used in the National Drug Code Directory, 1995 edition (NDC) (19).

2Number of drug mentions divided by total number of visits multiplied by 100.

NOTE: Figures are annual averages. 
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Table 20. Annual number and percent distribution of drug mentions at ambulatory care visits by therapeutic classification, with percent 
distribution by setting type: United States, 1999–2000 
Number of Primary Surgical Medical 
mentions in Percent care specialty specialty Outpatient Emergency 
Therapeutic classification1 thousands distribution Total offices offices offices departments departments 
Percent distribution 
All drug mentions . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,498,266 100.0 100.0 50.5 8.6 21.0 8.7 11.2 
Anesthetic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . .  15,025 1.0 100.0 15.0 28.9 15.1 10.7 30.3 
Anesthetics, local (Injectable) . . . . . . . . . . . . . . . . . .  10,089 0.7 100.0 14.1 38.4 14.4 10.2 22.9 
Anesthetics, general . . . . . . . . . . . . . . . . . . . . . . . .  737 0.0 100.0 * * * *37.9 49.9 
Adjuncts to anesthesia/analeptics . . . . . . . . . . . . . . . .  2,430 0.2 100.0 * * * 5.0 69.2 
Medicinal gases . . . . . . . . . . . . . . . . . . . . . . . . . . .  662 0.0 100.0 * * 76.4 * * 
Anesthetics, topical . . . . . . . . . . . . . . . . . . . . . . . . .  389 0.0 100.0 * * * *27.1 28.1 
Anesthetics, rectal . . . . . . . . . . . . . . . . . . . . . . . . .  416 0.0 100.0 * * * * * 
Antidotes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  960 0.1 100.0 * * 35.5 *7.5 28.1 
Antidotes, specific . . . . . . . . . . . . . . . . . . . . . . . . .  582 0.0 100.0 * * * * 32.3 
Antidotes, general . . . . . . . . . . . . . . . . . . . . . . . . .  155 0.0 100.0 * * * * *52.6 
Antitoxins/antivenins . . . . . . . . . . . . . . . . . . . . . . . .  223 0.0 100.0 * * * * * 
Antimicrobial agents . . . . . . . . . . . . . . . . . . . . . . . . .  149,999 10.0 100.0 56.7 7.2 10.3 9.3 16.5 
Penicillins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  41,294 2.8 100.0 66.5 3.4 4.7 10.2 15.2 
Cephalosporins . . . . . . . . . . . . . . . . . . . . . . . . . . .  30,693 2.0 100.0 55.6 6.8 5.5 7.5 24.6 
Erythromycins/lincosamides/macrolides . . . . . . . . . . . .  22,526 1.5 100.0 62.3 4.6 10.6 8.4 14.2 
Tetracyclines . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  7,428 0.5 100.0 41.2 5.0 39.8 7.0 7.0 
Aminoglycosides . . . . . . . . . . . . . . . . . . . . . . . . . .  3,012 0.2 100.0 40.8 11.7 * 7.3 33.6 
Sulfonamides and trimethoprim . . . . . . . . . . . . . . . . .  10,051 0.7 100.0 52.8 8.7 *8.0 13.3 17.1 
Urinary tract antiseptics . . . . . . . . . . . . . . . . . . . . . .  4,324 0.3 100.0 56.2 25.8 * 6.4 4.0 
Miscellaneous antibacterial agents . . . . . . . . . . . . . . .  7,174 0.5 100.0 40.1 4.7 29.0 9.0 17.2 
Antimycobacterial/anti-leprosy agents . . . . . . . . . . . . .  457 0.0 100.0 * * * *19.5 * 
Quinolones/derivatives . . . . . . . . . . . . . . . . . . . . . .  14,201 0.9 100.0 50.9 18.4 7.6 6.7 16.4 
Antifungals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  673 0.0 100.0 * * * *28.6 * 
Antiviral agents . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,825 0.5 100.0 48.2 4.9 21.9 18.2 6.9 
Hematologic agents . . . . . . . . . . . . . . . . . . . . . . . . . .  25,536 1.7 100.0 51.1 4.6 23.9 10.6 9.8 
Deficiency anemias . . . . . . . . . . . . . . . . . . . . . . . .  10,261 0.7 100.0 57.5 * 22.7 14.5 3.1 
Anticoagulants/thrombolytics . . . . . . . . . . . . . . . . . . .  14,999 1.0 100.0 47.5 6.1 24.6 8.0 13.8 
Blood components/substitutes . . . . . . . . . . . . . . . . . .  59 0.0 100.0 * * * * * 
Hemostatics/antihemophilics . . . . . . . . . . . . . . . . . . .  211 0.0 100.0 * * * * *37.5 
Cardiovascular-renal drugs . . . . . . . . . . . . . . . . . . . . .  212,630 14.2 100.0 57.4 6.4 22.9 8.2 5.3 
Cardiac glycosides . . . . . . . . . . . . . . . . . . . . . . . . .  11,870 0.8 100.0 52.7 4.0 32.4 5.8 5.2 
Antiarrhythmic agents . . . . . . . . . . . . . . . . . . . . . . .  2,351 0.2 100.0 38.8 * 36.3 6.4 9.6 
Antianginal agents . . . . . . . . . . . . . . . . . . . . . . . . .  12,519 0.8 100.0 44.9 2.8 25.6 6.5 20.2 
Vascular disorders, cerebral/peripheral . . . . . . . . . . . . .  4,108 0.3 100.0 55.7 21.1 15.6 7.0 * 
Agents used to treat shock/hypotension . . . . . . . . . . . .  467 0.0 100.0 * * * * 34.0 
Antihypertensive agents . . . . . . . . . . . . . . . . . . . . . .  19,184 1.3 100.0 58.6 8.5 22.2 7.9 2.8 
Diuretics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  32,561 2.2 100.0 57.0 4.8 22.5 9.3 6.4 
Coronary vasodilators . . . . . . . . . . . . . . . . . . . . . . .  264 0.0 100.0 * * * * * 
Relaxants/stimulants, urinary tract . . . . . . . . . . . . . . .  2,326 0.2 100.0 47.8 29.7 * 7.1 4.3 
Calcium channel blockers . . . . . . . . . . . . . . . . . . . . .  35,719 2.4 100.0 59.8 5.2 22.4 8.6 4.0 
Carbonic anhydrase inhibitors . . . . . . . . . . . . . . . . . .  530 0.0 100.0 * * * * * 
Beta blockers . . . . . . . . . . . . . . . . . . . . . . . . . . . .  33,452 2.2 100.0 58.3 6.3 24.2 8.1 3.1 
Alpha agonists/alpha blockers . . . . . . . . . . . . . . . . . .  16,860 1.1 100.0 54.0 9.5 21.7 8.5 6.3 
ACE2 inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . .  40,353 2.7 100.0 63.6 4.4 20.2 8.5 3.3 
Central nervous system . . . . . . . . . . . . . . . . . . . . . . .  122,151 8.2 100.0 41.1 2.9 39.7 8.9 7.3 
Sedatives and hypnotics . . . . . . . . . . . . . . . . . . . . .  13,768 0.9 100.0 44.0 *4.9 27.7 8.9 14.5 
Antianxiety agents . . . . . . . . . . . . . . . . . . . . . . . . .  23,388 1.6 100.0 47.5 3.7 31.5 7.2 10.0 
Antipsychotic/antimanics . . . . . . . . . . . . . . . . . . . . .  11,099 0.7 100.0 17.7 * 58.7 14.5 8.2 
Antidepressants . . . . . . . . . . . . . . . . . . . . . . . . . . .  59,984 4.0 100.0 42.2 3.0 43.2 8.7 3.0 
Anorexiants/CNS3 stimulants . . . . . . . . . . . . . . . . . . .  8,657 0.6 100.0 51.0 * 37.6 8.6 1.3 
CNS3 , miscellaneous . . . . . . . . . . . . . . . . . . . . . . .  713 0.0 100.0 * * 49.2 *7.2 * 
Alzheimer-type dementia . . . . . . . . . . . . . . . . . . . . .  987 0.1 100.0 * * 40.1 10.3 * 
Antiemetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,448 0.2 100.0 * * * 6.3 50.7 
Contrast media/radiopharmaceutical . . . . . . . . . . . . . . .  5,328 0.4 100.0 67.9 *17.2 * 8.8 2.3 
Diagnostics, radiopaque and nonradioactive . . . . . . . . .  5,251 0.4 100.0 68.9 *17.4 * 8.9 2.3 
Gastrointestinal agents . . . . . . . . . . . . . . . . . . . . . . . .  65,573 4.4 100.0 49.9 4.6 22.5 10.2 12.8 
Disorders, acid/peptic . . . . . . . . . . . . . . . . . . . . . . .  45,407 3.0 100.0 53.3 4.8 23.6 9.6 8.7 
Antidiarrheals . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,503 0.3 100.0 57.3 * 18.0 7.7 13.7 
Laxatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,004 0.4 100.0 42.9 5.2 16.8 18.2 16.9 
Miscellaneous gastrointestinals . . . . . . . . . . . . . . . . .  3,853 0.3 100.0 34.4 * 42.2 10.8 9.1 
Antispasmodics/anticholinergics . . . . . . . . . . . . . . . . .  2,639 0.2 100.0 46.7 * * 8.3 23.0 
Antacids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,468 0.2 100.0 31.9 * * 8.7 48.9 
See footnotes at end of table. 
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Table 20. Annual number and percent distribution of drug mentions at ambulatory care visits by therapeutic classification, with percent 
distribution by setting type: United States, 1999–2000—Con. 
Number of Primary Surgical Medical 
mentions in Percent care specialty specialty Outpatient Emergency 
Therapeutic classification1 thousands distribution Total offices offices offices departments departments 
Percent distribution 
Metabolic/nutrients . . . . . . . . . . . . . . . . . . . . . . . . . .  101,353 6.8 100.0 58.4 5.1 21.7 9.3 5.6 
Hyperlipidemia . . . . . . . . . . . . . . . . . . . . . . . . . . .  36,490 2.4 100.0 61.5 4.5 24.9 7.2 1.8 
Vitamins/minerals . . . . . . . . . . . . . . . . . . . . . . . . . .  29,878 2.0 100.0 61.0 5.5 18.3 12.2 3.0 
Nutrition, enteral/parenteral . . . . . . . . . . . . . . . . . . . .  1,755 0.1 100.0 * * * 7.2 27.1 
Replenishers/regulators of electrolytes/water . . . . . . . . .  24,065 1.6 100.0 54.5 5.4 17.0 8.8 14.3 
Calcium metabolism . . . . . . . . . . . . . . . . . . . . . . . .  7,744 0.5 100.0 57.1 6.7 27.0 8.1 1.2 
Hematopoietic growth factor . . . . . . . . . . . . . . . . . . .  1,421 0.1 100.0 * * * *17.4 * 
Hormones/hormonal mechanisms . . . . . . . . . . . . . . . . .  145,284 9.7 100.0 58.9 6.3 20.5 8.7 5.6 
Adrenal corticosteroids . . . . . . . . . . . . . . . . . . . . . .  31,628 2.1 100.0 39.7 10.3 27.5 8.2 14.3 
Androgens/anabolic steroids . . . . . . . . . . . . . . . . . . .  2,641 0.2 100.0 63.2 20.7 * 4.6 * 
Estrogens/progestins . . . . . . . . . . . . . . . . . . . . . . .  32,380 2.2 100.0 70.1 5.2 13.5 8.8 2.4 
Anterior pituitary/hypothalmic function . . . . . . . . . . . . .  464 0.0 100.0 * * * * * 
Blood glucose regulators . . . . . . . . . . . . . . . . . . . . .  45,933 3.1 100.0 60.9 4.9 20.7 9.6 4.0 
Thyroid/antithyroid . . . . . . . . . . . . . . . . . . . . . . . . .  21,369 1.4 100.0 56.1 5.3 27.4 8.0 3.2 
Antidiuretics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  210 0.0 100.0 * * * * * 
Relaxants/stimulants uterine . . . . . . . . . . . . . . . . . . .  294 0.0 100.0 * * * * * 
Contraceptives . . . . . . . . . . . . . . . . . . . . . . . . . . .  8,923 0.6 100.0 82.1 * *4.7 8.4 2.4 
Infertility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  376 0.0 100.0 * * * * * 
Immunologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  61,201 4.1 100.0 70.9 *1.7 11.0 10.6 5.8 
Vaccines/antisera . . . . . . . . . . . . . . . . . . . . . . . . . .  53,645 3.6 100.0 77.6 * *5.0 10.5 6.6 
Immunomodulators . . . . . . . . . . . . . . . . . . . . . . . . .  1,871 0.1 100.0 * * 45.7 29.8 * 
Allergenic extracts . . . . . . . . . . . . . . . . . . . . . . . . .  3,808 0.3 100.0 *37.1 *19.4 *36.6 *6.9 * 
Skin/mucous membrane . . . . . . . . . . . . . . . . . . . . . . .  69,159 4.6 100.0 41.6 7.1 38.8 7.1 5.4 
Antiseptics/disinfectants . . . . . . . . . . . . . . . . . . . . . .  3,988 0.3 100.0 35.4 *7.7 37.7 6.9 12.2 
Dermatologics, miscellaneous . . . . . . . . . . . . . . . . . .  14,230 0.9 100.0 41.2 4.0 44.7 7.3 2.8 
Keratolytics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  878 0.1 100.0 * * 39.9 * * 
Topical steroids . . . . . . . . . . . . . . . . . . . . . . . . . . .  23,088 1.5 100.0 38.2 9.5 41.1 6.5 4.6 
Burn/sunburn, sunscreen/suntan products . . . . . . . . . . .  454 0.0 100.0 * * * * * 
Acne products . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,791 0.3 100.0 * * 86.2 2.7 * 
Topical anti-infectives . . . . . . . . . . . . . . . . . . . . . . .  18,165 1.2 100.0 56.4 4.3 23.5 9.1 6.6 
Dermatitis/antipruritics . . . . . . . . . . . . . . . . . . . . . . .  691 0.0 100.0 * * * 12.3 * 
Topical analgesics . . . . . . . . . . . . . . . . . . . . . . . . .  3,340 0.2 100.0 29.8 29.0 23.4 4.3 13.5 
Neurologic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . .  39,558 2.6 100.0 39.8 4.7 32.8 10.2 12.6 
Extrapyramidal movement disorders . . . . . . . . . . . . . .  3,213 0.2 100.0 31.0 * 48.3 12.0 5.3 
Skeletal muscle hyperactivity . . . . . . . . . . . . . . . . . . .  15,765 1.1 100.0 49.1 7.3 15.5 7.9 20.2 
Anticonvulsants . . . . . . . . . . . . . . . . . . . . . . . . . . .  20,488 1.4 100.0 34.1 2.8 43.5 11.7 7.9 
Oncolytics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,831 0.8 100.0 14.2 9.7 63.7 11.2 1.3 
Antineoplastics, miscellaneous . . . . . . . . . . . . . . . . . .  3,399 0.2 100.0 * * 73.8 *13.9 * 
Hormonal/biological response modulators . . . . . . . . . . .  3,476 0.2 100.0 24.6 27.5 39.1 7.8 * 
Antimetabolites . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,538 0.2 100.0 * * 73.4 *8.7 * 
Antibiotics, alkaloids, enzymes . . . . . . . . . . . . . . . . . .  578 0.0 100.0 * * * *14.9 * 
DNA damaging drugs . . . . . . . . . . . . . . . . . . . . . . .  818 0.1 100.0 * * * 22.6 * 
Ophthalmics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  42,331 2.8 100.0 11.8 78.5 2.8 3.7 3.2 
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12,923 0.9 100.0 10.3 83.4 * 2.9 0.8 
Cycloplegics/mydriatics . . . . . . . . . . . . . . . . . . . . . .  4,237 0.3 100.0 * 90.1 * *3.4 *1.4 
Ocular anti-infective/anti-inflammatory . . . . . . . . . . . . .  15,915 1.1 100.0 18.1 69.4 * 4.5 4.9 
Miscellaneous ophthalmics . . . . . . . . . . . . . . . . . . . .  6,421 0.4 100.0 * 88.8 * *2.7 4.6 
Decongestants/antiallergy agents . . . . . . . . . . . . . . . .  1,689 0.1 100.0 * 72.3 * *2.8 * 
Contact lens products . . . . . . . . . . . . . . . . . . . . . . .  109 0.0 100.0 * * * *11.2 * 
Otologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  8,042 0.5 100.0 51.5 7.2 15.2 9.6 16.5 
Otic, topical (Misc) . . . . . . . . . . . . . . . . . . . . . . . . .  3,188 0.2 100.0 63.0 12.2 * 8.9 12.2 
Vertigo/motion sickness/vomiting . . . . . . . . . . . . . . . .  4,854 0.3 100.0 43.9 3.9 22.8 10.1 19.3 
Relief of pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  205,804 13.7 100.0 40.8 9.6 14.8 8.7 26.1 
Analgesics/general . . . . . . . . . . . . . . . . . . . . . . . . .  7,382 0.5 100.0 46.1 5.5 29.9 8.2 10.4 
Analgesics, narcotic . . . . . . . . . . . . . . . . . . . . . . . .  29,962 2.0 100.0 30.2 10.5 11.9 8.0 39.4 
Analgesics, non-narcotic . . . . . . . . . . . . . . . . . . . . .  72,152 4.8 100.0 38.2 8.2 14.7 9.5 29.4 
Antimigraine/other headaches . . . . . . . . . . . . . . . . . .  3,238 0.2 100.0 53.0 * 29.2 7.9 6.6 
Antiarthritics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9,296 0.6 100.0 43.4 20.3 27.0 6.4 2.9 
Antigout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,122 0.3 100.0 55.3 * 28.5 7.5 3.1 
NSAID4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  79,638 5.3 100.0 45.2 10.2 11.8 8.7 24.1 
See footnotes at end of table. 
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Table 20. Annual number and percent distribution of drug mentions at ambulatory care visits by therapeutic classification, with percent 
distribution by setting type: United States, 1999–2000—Con. 
Number of Primary Surgical Medical 
mentions in Percent care specialty specialty Outpatient Emergency 
Therapeutic classification1 thousands distribution Total offices offices offices departments departments 
Percent distribution 
Antiparasitics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5,818 0.4 100.0 44.7 * 34.7 12.7 4.2 
Antiprotozoals . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,640 0.2 100.0 63.3 * * 16.4 4.9 
Scabicides/pediculicides . . . . . . . . . . . . . . . . . . . . .  461 0.0 100.0 * * * *10.0 * 
Antimalarials . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,646 0.2 100.0 * * 63.7 *9.2 * 
Respiratory tract . . . . . . . . . . . . . . . . . . . . . . . . . . . .  165,860 11.1 100.0 55.6 6.0 17.9 8.4 12.1 
Antiasthmatics/bronchodilators . . . . . . . . . . . . . . . . . .  46,811 3.1 100.0 49.9 4.0 20.7 9.2 16.2 
Nasal decongestants . . . . . . . . . . . . . . . . . . . . . . .  17,724 1.2 100.0 60.5 11.9 *11.6 9.7 6.4 
Antitussives/expectorants/mucolytics . . . . . . . . . . . . . .  21,955 1.5 100.0 71.5 4.8 7.5 8.7 7.6 
Antihistamines . . . . . . . . . . . . . . . . . . . . . . . . . . . .  54,390 3.6 100.0 52.8 4.8 18.3 7.4 16.6 
Cold remedies . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,165 0.1 100.0 * * * *7.0 * 
Corticosteroid-inhalation/nasal . . . . . . . . . . . . . . . . . .  22,950 1.5 100.0 53.5 9.9 26.8 7.8 2.1 
Unclassified/miscellaneous . . . . . . . . . . . . . . . . . . . . .  42,446 2.8 100.0 56.7 9.6 17.2 7.4 9.1 
Unclassified . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  37,265 2.5 100.0 56.5 8.8 17.8 7.7 9.3 
Pharmaceutical aids . . . . . . . . . . . . . . . . . . . . . . . .  1,621 0.1 100.0 63.7 * * 5.6 5.3 
Homeopathic products . . . . . . . . . . . . . . . . . . . . . . . .  2,377 0.2 100.0 45.8 *15.6 *30.7 5.9 * 
Standard 
error in 
thousands Standard error of percent 
All drug mentions . . . . . . . . . . . . . . . . . . . . . . . . . . .  62,436 . . . . . . 1.4 0.6 1.1 0.7 0.5 
Anesthetic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,270 0.1 . . . 2.1 5.1 2.3 1.8 2.6 
Anesthetics, local (injectable) . . . . . . . . . . . . . . . . . .  1,115 0.1 . . . 2.5 6.5 3.1 1.9 2.8 
Anesthetics, general . . . . . . . . . . . . . . . . . . . . . . . .  151 0.0 . . . . . . . . . . . . 11.5 10.3 
Adjuncts to anesthesia/analeptics . . . . . . . . . . . . . . . .  219 0.0 . . . . . . . . . . . . 1.4 5.1 
Medicinal gases . . . . . . . . . . . . . . . . . . . . . . . . . . .  169 0.0 . . . . . . . . . 13.1 . . . . . . 
Anesthetics, topical . . . . . . . . . . . . . . . . . . . . . . . . .  92 0.0 . . . . . . . . . . . . 8.5 7.6 
Anesthetics, rectal . . . . . . . . . . . . . . . . . . . . . . . . .  114 0.0 . . . . . . . . . . . . . . . . . . 
Antidotes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  170 0.0 . . . . . . . . . 8.8 2.7 5.2 
Antidotes, specific . . . . . . . . . . . . . . . . . . . . . . . . .  134 0.0 . . . . . . . . . . . . . . . 7.5 
Antidotes, general . . . . . . . . . . . . . . . . . . . . . . . . .  62 0.0 . . . . . . . . . . . . . . . 21.0 
Antitoxins/antivenins . . . . . . . . . . . . . . . . . . . . . . . .  82 0.0 . . . . . . . . . . . . . . . . . . 
Antimicrobial agents . . . . . . . . . . . . . . . . . . . . . . . . .  6,382 0.3 . . . 1.5 0.6 0.8 0.8 0.8 
Penicillins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,303 0.1 . . . 1.9 0.6 1.1 1.0 0.9 
Cephalosporins . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,790 0.1 . . . 2.2 0.9 1.0 0.9 1.5 
Erythromycins/lincosamides/macrolides . . . . . . . . . . . .  1,337 0.1 . . . 2.4 0.6 1.7 1.0 1.1 
Tetracyclines . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  580 0.0 . . . 3.8 1.0 3.5 1.1 0.8 
Aminoglycosides . . . . . . . . . . . . . . . . . . . . . . . . . .  283 0.0 . . . 5.3 3.3 . . . 1.1 3.5 
Sulfonamides and trimethoprim . . . . . . . . . . . . . . . . .  833 0.0 . . . 3.3 1.3 2.7 1.5 1.4 
Urinary tract antiseptics . . . . . . . . . . . . . . . . . . . . . .  377 0.0 . . . 3.9 2.7 . . . 0.9 0.7 
Miscellaneous antibacterial agents . . . . . . . . . . . . . . .  567 0.0 . . . 3.7 1.0 4.1 1.0 1.5 
Antimycobacterial/anti-leprosy agents . . . . . . . . . . . . .  203 0.0 . . . . . . . . . . . . 11.3 . . . 
Quinolones/derivatives . . . . . . . . . . . . . . . . . . . . . .  878 0.1 . . . 3.0 1.9 1.7 0.9 1.2 
Antifungals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  175 0.0 . . . . . . . . . . . . 12.2 . . . 
Antiviral agents . . . . . . . . . . . . . . . . . . . . . . . . . . .  603 0.0 . . . 4.5 1.3 4.5 2.7 1.0 
Hematologic agents . . . . . . . . . . . . . . . . . . . . . . . . . .  1,335 0.1 . . . 2.4 0.7 2.3 1.0 0.7 
Deficiency anemias . . . . . . . . . . . . . . . . . . . . . . . .  876 0.1 . . . 3.9 . . . 4.1 1.7 0.4 
Anticoagulants/thrombolytics . . . . . . . . . . . . . . . . . . .  907 0.0 . . . 2.9 0.9 2.3 1.0 1.1 
Blood components/substitutes . . . . . . . . . . . . . . . . . .  24 0.0 . . . . . . . . . . . . . . . . . . 
Hemostatics/antihemophilics . . . . . . . . . . . . . . . . . . .  64 0.0 . . . . . . . . . . . . . . . 12.2 
Cardiovascular-renal drugs . . . . . . . . . . . . . . . . . . . . .  11,169 0.4 . . . 1.9 0.8 1.6 0.8 0.4 
Cardiac glycosides . . . . . . . . . . . . . . . . . . . . . . . . .  985 0.1 . . . 3.6 0.9 3.3 0.8 0.7 
Antiarrhythmic agents . . . . . . . . . . . . . . . . . . . . . . .  266 0.0 . . . 5.8 . . . 5.1 1.5 1.7 
Antianginal agents . . . . . . . . . . . . . . . . . . . . . . . . .  945 0.0 . . . 3.4 0.8 2.9 1.0 1.7 
Vascular disorders, cerebral/peripheral . . . . . . . . . . . . .  425 0.0 . . . 4.6 3.3 3.0 1.4 . . . 
Agents used to treat shock/hypotension . . . . . . . . . . . .  107 0.0 . . . . . . . . . . . . . . . 8.2 
Antihypertensive agents . . . . . . . . . . . . . . . . . . . . . .  1,281 0.1 . . . 2.6 1.1 2.0 1.1 0.4 
Diuretics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,800 0.1 . . . 2.4 0.9 2.0 1.0 0.6 
Coronary vasodilators . . . . . . . . . . . . . . . . . . . . . . .  76 0.0 . . . . . . . . . . . . . . . . . . 
Relaxants/stimulants, urinary tract . . . . . . . . . . . . . . .  346 0.0 . . . 7.2 7.0 . . . 1.8 1.0 
Calcium channel blockers . . . . . . . . . . . . . . . . . . . . .  2,265 0.1 . . . 2.5 0.9 2.1 0.9 0.4 
See footnotes at end of table. 
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Table 20. Annual number and percent distribution of drug mentions at ambulatory care visits by therapeutic classification, with percent 
distribution by setting type: United States, 1999–2000—Con. 
Number of Primary Surgical Medical 
mentions in Percent care specialty specialty Outpatient Emergency 
Therapeutic classification1 thousands distribution Total offices offices offices departments departments 
Standard 
error in 
thousands Standard error of percent 
Carbonic anhydrase inhibitors . . . . . . . . . . . . . . . . . .  125 0.0 . . . . . . . . . . . . . . . . . . 
Beta blockers . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,980 0.1 . . . 2.2 1.0 1.9 1.0 0.3 
Alpha agonist/alpha blockers . . . . . . . . . . . . . . . . . . .  1,177 0.1 . . . 2.6 1.3 2.1 1.1 0.5 
ACE2 inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,259 0.1 . . . 2.1 0.9 1.8 0.9 0.4 
Central nervous system . . . . . . . . . . . . . . . . . . . . . . .  6,782 0.3 . . . 2.1 0.5 2.1 0.8 0.4 
Sedatives and hypnotics . . . . . . . . . . . . . . . . . . . . .  1,065 0.1 . . . 3.9 1.9 3.9 1.2 1.4 
Antianxiety agents . . . . . . . . . . . . . . . . . . . . . . . . .  1,583 0.1 . . . 2.6 1.0 2.3 0.8 0.7 
Antipsychotics/antimanics . . . . . . . . . . . . . . . . . . . . .  1,158 0.1 . . . 4.0 . . . 4.6 2.3 1.0 
Antidepressants . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,710 0.2 . . . 2.4 0.5 2.5 0.9 0.3 
Anorexiants/CNS3 stimulants . . . . . . . . . . . . . . . . . . .  813 0.1 . . . 4.4 . . . 4.6 1.4 0.3 
CNS3 , miscellaneous . . . . . . . . . . . . . . . . . . . . . . .  133 0.0 . . . . . . . . . 9.8 2.4 . . . 
Alzheimer-type dementia . . . . . . . . . . . . . . . . . . . . .  155 0.0 . . . . . . . . . 7.7 2.4 . . . 
Antiemetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  406 0.0 . . . . . . . . . . . . 1.4 5.6 
Contrast media/radiopharmaceutical . . . . . . . . . . . . . . .  918 0.1 . . . 10.1 11.7 . . . 1.8 0.6 
Diagnostics, radiopaque and nonradioactive . . . . . . . . .  915 0.1 . . . 10.4 11.8 . . . 1.8 0.6 
Gastrointestinal agents . . . . . . . . . . . . . . . . . . . . . . . .  3,535 0.1 . . . 2.3 0.5 2.4 1.0 0.8 
Disorders, acid/peptic . . . . . . . . . . . . . . . . . . . . . . .  2,727 0.1 . . . 2.4 0.6 2.4 1.0 0.6 
Antidiarrheals . . . . . . . . . . . . . . . . . . . . . . . . . . . .  476 0.0 . . . 4.9 . . . 4.3 1.3 1.7 
Laxatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  492 0.0 . . . 4.4 1.2 4.2 1.9 1.6 
Miscellaneous gastrointestinals . . . . . . . . . . . . . . . . .  556 0.0 . . . 5.0 . . . 7.5 2.1 1.7 
Antispasmodics/anticholinergics . . . . . . . . . . . . . . . . .  275 0.0 . . . 5.7 . . . . . . 1.5 3.2 
Antacids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  224 0.0 . . . 4.7 . . . . . . 1.3 4.1 
Metabolic/nutrients . . . . . . . . . . . . . . . . . . . . . . . . . .  5,317 0.2 . . . 2.0 0.7 1.8 0.9 0.4 
Hyperlipidemia . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,164 0.1 . . . 2.5 0.8 2.3 0.9 0.3 
Vitamins/minerals . . . . . . . . . . . . . . . . . . . . . . . . . .  2,173 0.1 . . . 2.5 0.8 2.2 1.3 0.4 
Nutrition, enteral/parenteral . . . . . . . . . . . . . . . . . . . .  321 0.0 . . . . . . . . . . . . 1.7 5.2 
Replenishers/regulators of electrolytes/water . . . . . . . . .  1,582 0.1 . . . 3.0 1.0 2.3 1.0 1.2 
Calcium metabolism . . . . . . . . . . . . . . . . . . . . . . . .  810 0.1 . . . 5.2 1.7 5.1 1.6 0.3 
Hematopoietic growth factor . . . . . . . . . . . . . . . . . . .  386 0.0 . . . . . . . . . . . . 5.5 . . . 
Hormones/hormonal mechanisms . . . . . . . . . . . . . . . . .  8,317 0.3 . . . 2.3 0.8 2.2 0.8 0.4 
Adrenal corticosteroids . . . . . . . . . . . . . . . . . . . . . .  2,227 0.1 . . . 2.9 1.2 2.8 1.0 1.0 
Androgens/anabolic steroids . . . . . . . . . . . . . . . . . . .  329 0.0 . . . 4.7 3.5 . . . 1.0 . . . 
Estrogens/progestins . . . . . . . . . . . . . . . . . . . . . . .  2,188 0.1 . . . 2.2 1.1 1.9 0.9 0.3 
Anterior pituitary/hypothalmic function . . . . . . . . . . . . .  118 0.0 . . . . . . . . . . . . . . . . . . 
Blood glucose regulators . . . . . . . . . . . . . . . . . . . . .  3,331 0.2 . . . 3.3 1.1 3.4 1.0 0.4 
Thyroid/antithyroid . . . . . . . . . . . . . . . . . . . . . . . . .  2,142 0.1 . . . 5.1 1.1 6.0 1.2 0.5 
Antidiuretics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  55 0.0 . . . . . . . . . . . . . . . . . . 
Relaxants/stimulants uterine . . . . . . . . . . . . . . . . . . .  140 0.0 . . . . . . . . . . . . . . . . . . 
Contraceptives . . . . . . . . . . . . . . . . . . . . . . . . . . .  875 0.1 . . . 2.6 . . . 1.6 1.3 0.5 
Infertility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  142 0.0 . . . . . . . . . . . . . . . . . . 
Immunologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,193 0.3 . . . 3.2 0.6 3.2 1.1 0.5 
Vaccines/antisera . . . . . . . . . . . . . . . . . . . . . . . . . .  3,832 0.2 . . . 2.4 . . . 2.1 1.2 0.6 
Immunomodulators . . . . . . . . . . . . . . . . . . . . . . . . .  292 0.0 . . . . . . . . . 8.2 6.8 . . . 
Allergenic extracts . . . . . . . . . . . . . . . . . . . . . . . . .  1,252 0.1 . . . 17.4 9.9 17.8 3.2 . . . 
Skin/mucous membrane . . . . . . . . . . . . . . . . . . . . . . .  3,547 0.2 . . . 2.3 0.7 2.3 0.7 0.4 
Antiseptics/disinfectants . . . . . . . . . . . . . . . . . . . . . .  493 0.0 . . . 6.2 3.3 6.2 1.5 2.2 
Dermatologics, miscellaneous . . . . . . . . . . . . . . . . . .  843 0.0 . . . 3.3 0.9 3.1 0.7 0.3 
Keratolytics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  158 0.0 . . . . . . . . . 8.5 . . . . . . 
Topical steroids . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,559 0.1 . . . 2.9 1.3 3.0 1.1 0.4 
Burn/sunburn, sunscreen/suntan products . . . . . . . . . . .  111 0.0 . . . . . . . . . . . . . . . . . . 
Acne products . . . . . . . . . . . . . . . . . . . . . . . . . . . .  491 0.0 . . . . . . . . . 3.5 0.7 . . . 
Topical anti-infectives . . . . . . . . . . . . . . . . . . . . . . .  1,149 0.1 . . . 2.7 0.7 2.3 0.9 0.6 
Dermatitis/antipruritics . . . . . . . . . . . . . . . . . . . . . . .  126 0.0 . . . . . . . . . . . . 3.0 . . . 
Topical analgesics . . . . . . . . . . . . . . . . . . . . . . . . .  459 0.0 . . . 7.0 5.6 6.1 1.0 2.3 
Neurologic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,123 0.1 . . . 2.2 0.7 2.1 0.9 0.7 
Extrapyramidal movement disorders . . . . . . . . . . . . . .  368 0.0 . . . 5.7 . . . 6.0 2.5 1.1 
Skeletal muscle hyperactivity . . . . . . . . . . . . . . . . . . .  953 0.0 . . . 2.8 1.2 2.0 0.8 1.3 
Anticonvulsants . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,376 0.1 . . . 2.9 0.7 2.8 1.4 0.6 
See footnotes at end of table. 
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Table 20. Annual number and percent distribution of drug mentions at ambulatory care visits by therapeutic classification, with percent 
distribution by setting type: United States, 1999–2000—Con. 
Number of Primary Surgical Medical 
mentions in Percent care specialty specialty Outpatient Emergency 
Therapeutic classification1 thousands distribution Total offices offices offices departments departments 
Standard 
error in 
thousands Standard error of percent 
Oncolytics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,832 0.1 . . . 3.1 1.9 6.0 2.3 0.3 
Antineoplastics, miscellaneous . . . . . . . . . . . . . . . . . .  790 0.1 . . . . . . . . . 7.1 4.2 . . . 
Hormonal/biological response modulators . . . . . . . . . . .  565 0.0 . . . 5.6 5.2 9.1 1.5 . . . 
Antimetabolites . . . . . . . . . . . . . . . . . . . . . . . . . . .  875 0.1 . . . . . . . . . 7.2 2.7 . . . 
Antibiotics, alkaloids, enzymes . . . . . . . . . . . . . . . . . .  241 0.0 . . . . . . . . . . . . 6.8 . . . 
DNA damaging drugs . . . . . . . . . . . . . . . . . . . . . . .  205 0.0 . . . . . . . . . . . . 6.6 . . . 
Ophthalmics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,891 0.3 . . . 1.5 2.2 0.6 0.6 0.4 
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,456 0.1 . . . 2.7 3.0 . . . 0.7 0.2 
Cycloplegics/mydriatics . . . . . . . . . . . . . . . . . . . . . .  1,043 0.1 . . . . . . 3.5 . . . 1.6 0.5 
Ocular anti-infective/anti-inflammatory . . . . . . . . . . . . .  1,554 0.1 . . . 2.3 3.0 . . . 0.8 0.6 
Miscellaneous ophthalmics . . . . . . . . . . . . . . . . . . . .  1,182 0.1 . . . . . . 2.8 . . . 0.9 1.1 
Decongestants/antiallergy agents . . . . . . . . . . . . . . . .  704 0.0 . . . . . . 12.4 . . . 1.4 . . . 
Contact lens products . . . . . . . . . . . . . . . . . . . . . . .  65 0.0 . . . . . . . . . . . . 9.2 . . . 
Otologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  635 0.0 . . . 3.6 1.3 3.2 1.2 1.5 
Otic, topical (Misc) . . . . . . . . . . . . . . . . . . . . . . . . .  376 0.0 . . . 4.4 2.8 . . . 1.7 1.9 
Vertigo/motion sickness/vomiting . . . . . . . . . . . . . . . .  460 0.0 . . . 4.9 0.9 4.9 1.5 2.2 
Relief of pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  9,227 0.3 . . . 1.8 0.7 1.4 0.7 1.1 
Analgesics/general . . . . . . . . . . . . . . . . . . . . . . . . .  822 0.0 . . . 4.7 1.6 4.4 1.6 1.5 
Analgesics, narcotic . . . . . . . . . . . . . . . . . . . . . . . .  1,777 0.1 . . . 2.8 1.4 2.3 0.9 2.2 
Analgesics, non-narcotic . . . . . . . . . . . . . . . . . . . . .  3,254 0.1 . . . 1.7 0.8 1.2 0.8 1.2 
Antimigraine/other headaches . . . . . . . . . . . . . . . . . .  397 0.0 . . . 5.0 . . . 4.7 1.6 1.1 
Antiarthritics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,017 0.1 . . . 4.9 3.3 6.1 1.1 0.5 
Antigout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  463 0.0 . . . 5.0 . . . 4.7 1.5 0.7 
NSAID4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,785 0.1 . . . 2.2 0.9 1.7 0.8 1.1 
Antiparasitics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  814 0.1 . . . 5.9 . . . 7.3 2.3 0.7 
Antiprotozoals . . . . . . . . . . . . . . . . . . . . . . . . . . . .  266 0.0 . . . 4.8 . . . . . . 2.6 0.9 
Scabicides/pediculicides . . . . . . . . . . . . . . . . . . . . .  118 0.0 . . . . . . . . . . . . 3.7 . . . 
Antimalarials . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  676 0.0 . . . . . . . . . 9.9 3.1 . . . 
Respiratory tract . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10,051 0.4 . . . 2.5 0.6 3.0 0.8 0.7 
Antiasthmatics/bronchodilators . . . . . . . . . . . . . . . . . .  2,999 0.1 . . . 3.0 0.7 3.7 0.9 1.1 
Nasal decongestants . . . . . . . . . . . . . . . . . . . . . . .  1,451 0.1 . . . 3.9 2.6 3.6 1.3 0.7 
Antitussives/expectorants/mucolytics . . . . . . . . . . . . . .  1,620 0.1 . . . 2.4 0.8 1.7 1.1 0.7 
Antihistamines . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,522 0.1 . . . 2.6 0.6 3.0 0.8 1.1 
Cold remedies . . . . . . . . . . . . . . . . . . . . . . . . . . . .  305 0.0 . . . . . . . . . . . . 2.9 . . . 
Corticosteroid-inhalation/nasal . . . . . . . . . . . . . . . . . .  2,152 0.1 . . . 4.2 1.5 5.0 1.2 0.3 
Unclassified/miscellaneous . . . . . . . . . . . . . . . . . . . . .  2,400 0.1 . . . 2.8 1.0 2.1 0.7 0.7 
Unclassified . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,147 0.1 . . . 2.9 1.0 2.3 0.7 0.7 
Pharmaceutical aids . . . . . . . . . . . . . . . . . . . . . . . .  254 0.0 . . . 7.7 . . . . . . 1.4 1.4 
Homeopathic products . . . . . . . . . . . . . . . . . . . . . . . .  448 0.0 . . . 9.0 4.8 11.0 1.6 . . . 
* Figure does not meet standard of reliability or precision.

. . . Category not applicable.

0.0 Quantity is greater than zero but less than 0.05.

1Based on the standard drug classification used in the National Drug Code Directory, 1995 edition (NDC) (19).

2ACE is angiotensin converting enzyme.

3CNS is central nervous system.

4NSAID is non-steroidal anti-inflammatory drug.

NOTE: Numbers may not add to totals because of rounding and because subcategories with fewer than 30 records were omitted. Figures are annual averages. 
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Table 21. Annual number and rate of the top 35 specific therapeutic classes of drug mentions at ambulatory care visits, with percentage 
change since 1993–94 and percentage of change accounted for by each class: United States, 1999–2000 
Percent Percent 
1999–2000 Drug mention difference contributed to 
Therapeutic classification1 drug mentions rate2 since 1993–94 total increase 
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,498,266 153.0 15.8 100.0 
Antiarthritics . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  68,629 7.0 10.0 2.9 
Antidepressants . . . . . . . . . . . . . . . . . . . . . . . . . . .  59,476 6.1 43.1 10.8 
Vaccines/antisera . . . . . . . . . . . . . . . . . . . . . . . . . .  54,430 5.6 –0.4 –0.1 
Analgesics, non-narcotic . . . . . . . . . . . . . . . . . . . . .  53,849 5.5 4.2 0.9 
Analgesics, narcotic . . . . . . . . . . . . . . . . . . . . . . . .  53,231 5.4 25.2 5.7 
Disorders, acid/peptic . . . . . . . . . . . . . . . . . . . . . . .  48,754 5.0 30.0 6.2 
Blood glucose regulators . . . . . . . . . . . . . . . . . . . . .  45,933 4.7 46.8 9.1 
Antiasthmatics/bronchodilators . . . . . . . . . . . . . . . . . .  43,060 4.4 10.6 1.9 
Antihistamines . . . . . . . . . . . . . . . . . . . . . . . . . . . .  42,789 4.4 44.5 8.0 
Penicillins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  41,294 4.2 –46.0 –8.0 
Diuretics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  40,619 4.1 14.2 2.4 
Hyperlipidemia . . . . . . . . . . . . . . . . . . . . . . . . . . .  36,514 3.7 67.3 10.4 
ACE3 inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . .  36,450 3.7 35.6 5.5 
Calcium channel blockers . . . . . . . . . . . . . . . . . . . . .  34,021 3.5 –10.1 –1.5 
Estrogens/progestins . . . . . . . . . . . . . . . . . . . . . . .  32,361 3.3 21.9 3.0 
Adrenal corticosteroids . . . . . . . . . . . . . . . . . . . . . .  31,650 3.2 19.0 2.5 
Cephalosporins . . . . . . . . . . . . . . . . . . . . . . . . . . .  30,693 3.1 –21.7 –2.8 
Topical steroids . . . . . . . . . . . . . . . . . . . . . . . . . . .  30,316 3.1 17.1 2.2 
Vitamins/minerals . . . . . . . . . . . . . . . . . . . . . . . . . .  29,910 3.1 10.0 1.3 
Antianxiety agents . . . . . . . . . . . . . . . . . . . . . . . . .  27,445 2.8 13.5 1.6 
Antihypertensive agents . . . . . . . . . . . . . . . . . . . . . .  25,157 2.6 65.5 7.0 
Beta blockers . . . . . . . . . . . . . . . . . . . . . . . . . . . .  24,564 2.5 40.1 4.2 
Replenishers/regulators of electrolytes/water . . . . . . . . .  24,318 2.5 32.5 3.3 
Nasal decongestants . . . . . . . . . . . . . . . . . . . . . . .  23,580 2.4 –31.0 –3.1 
Erythromycins/lincosamides/macrolides . . . . . . . . . . . .  23,136 2.4 –0.4 0.0 
Thyroid/antithyroid . . . . . . . . . . . . . . . . . . . . . . . . .  21,369 2.2 37.8 3.4 
Corticosteroid-inhalation/nasal . . . . . . . . . . . . . . . . . .  20,039 2.0 36.3 3.1 
Anticonvulsants . . . . . . . . . . . . . . . . . . . . . . . . . . .  19,826 2.0 47.2 4.0 
Antitussives/expectorants/mucolytics . . . . . . . . . . . . . .  18,403 1.9 14.3 1.1 
Alpha agonist/alpha blockers . . . . . . . . . . . . . . . . . . .  17,442 1.8 20.5 1.5 
Sedatives and hypnotics . . . . . . . . . . . . . . . . . . . . .  15,994 1.6 24.6 1.7 
Ocular anti-infective/anti-inflammatory . . . . . . . . . . . . .  15,925 1.6 9.7 0.7 
Anticoagulants/thrombolytics . . . . . . . . . . . . . . . . . . .  15,005 1.5 40.7 2.6 
Dermatologics, miscellaneous . . . . . . . . . . . . . . . . . .  14,852 1.5 –12.9 –0.8 
Topical anti-infectives . . . . . . . . . . . . . . . . . . . . . . .  14,627 1.5 –30.9 –1.9 
1Based on the standard drug classification used in the National Drug Code Directory, 1995 edition (NDC) (19). 
2Drug mention rate is number of drugs per 100 visits. 
3ACE is angiotensin converting enzyme. 
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Table 22. Annual population rates of drug mentions at ambulatory care visits for the top 20 specific therapeutic classes, by patient age and 
sex: United States, 1999–2000 
Patient age in years Sex 
All Under 75 
Therapeutic class1 ages 15 15–24 25–44 45–64 65–74 and over Female Male 
Number of mentions per 1,000 persons2 
NSAID3 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  291.8 153.9 202.8 285.4 374.9 466.4 574.2 333.0 248.4 
Analgesics, non-narcotic . . . . . . . . . . . . . . . . . .  264.4 210.2 151.2 200.2 306.6 500.0 680.3 274.9 253.3 
Antidepressants . . . . . . . . . . . . . . . . . . . . . . .  219.8 28.7 103.5 247.1 370.4 338.0 397.5 287.2 148.9 
Antihistamines . . . . . . . . . . . . . . . . . . . . . . . .  199.3 184.0 150.7 184.6 231.5 265.0 259.4 245.2 151.0 
Vaccines/antisera . . . . . . . . . . . . . . . . . . . . . .  196.5 644.5 82.5 51.2 53.8 119.7 141.8 193.9 199.3 
Antiasthmatics/bronchodilators . . . . . . . . . . . . . .  171.5 206.0 93.1 113.2 171.7 346.1 346.9 190.2 151.9 
Blood glucose regulators . . . . . . . . . . . . . . . . .  168.3 5.8 15.1 69.2 302.0 683.9 618.5 174.6 161.7 
Disorders, acid/peptic . . . . . . . . . . . . . . . . . . . .  166.4 23.9 39.4 109.4 259.0 521.6 591.6 188.1 143.6 
Penicillins . . . . . . . . . . . . . . . . . . . . . . . . . . .  151.3 365.6 126.1 89.7 71.9 78.6 93.0 157.7 144.6 
ACE4 inhibitors . . . . . . . . . . . . . . . . . . . . . . .  147.8 *2.8 7.1 47.7 251.9 572.0 730.0 155.4 139.9 
Hyperlipidemia . . . . . . . . . . . . . . . . . . . . . . . .  133.7 *1.0 *3.2 34.8 255.1 609.5 500.7 127.0 140.7 
Calcium channel blockers . . . . . . . . . . . . . . . . .  130.9 *1.9 *4.7 29.1 213.4 538.9 724.5 143.2 118.0 
Beta blockers . . . . . . . . . . . . . . . . . . . . . . . .  122.6 *2.7 8.7 45.4 205.4 437.7 621.3 135.9 108.5 
Diuretics . . . . . . . . . . . . . . . . . . . . . . . . . . . .  119.3 *4.7 2.0 21.4 149.9 475.3 882.1 139.9 97.7 
Estrogens/progestins . . . . . . . . . . . . . . . . . . . .  118.6 *1.3 35.6 46.4 307.8 316.9 212.8 230.5 1.1 
Adrenal corticosteroids . . . . . . . . . . . . . . . . . . .  115.9 74.7 49.1 91.7 146.9 237.9 319.0 131.0 100.0 
Cephalosphorins . . . . . . . . . . . . . . . . . . . . . . .  112.5 137.6 94.2 101.0 99.4 128.0 154.7 122.4 102.0 
Analgesics, narcotic . . . . . . . . . . . . . . . . . . . . .  109.8 8.2 73.8 125.5 145.3 214.8 260.0 131.4 87.1 
Vitamins/minerals . . . . . . . . . . . . . . . . . . . . . .  109.5 27.6 122.8 104.0 106.5 280.9 244.9 165.5 50.6 
Replenishers/regs of electrolytes/water balance . . . 88.2 33.8 33.4 44.4 109.4 259.1 403.6 115.2 59.8 
Standard error of rate 
NSAID3 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13.9 13.2 12.8 16.2 22.5 38.5 47.4 16.5 13.6 
Analgesics, non-narcotic . . . . . . . . . . . . . . . . . .  11.9 14.7 9.9 11.5 17.9 39.3 48.0 12.8 13.2 
Antidepressants . . . . . . . . . . . . . . . . . . . . . . .  13.6 4.0 10.8 18.1 25.9 34.1 35.5 18.0 11.2 
Antihistamines . . . . . . . . . . . . . . . . . . . . . . . .  12.9 20.5 13.6 14.6 19.0 30.9 23.8 17.5 10.3 
Vaccines/antisera . . . . . . . . . . . . . . . . . . . . . .  14.0 58.0 10.8 5.5 6.9 18.5 23.7 14.8 16.7 
Antiasthmatics/bronchodilators . . . . . . . . . . . . . .  11.0 24.5 10.5 11.7 14.8 34.9 43.2 14.1 10.3 
Blood glucose regulators . . . . . . . . . . . . . . . . .  12.2 1.5 3.7 9.3 25.4 68.4 52.2 14.2 11.9 
Disorders, acid/peptic . . . . . . . . . . . . . . . . . . . .  10.0 4.2 5.1 8.9 18.3 46.3 52.7 12.5 10.3 
Penicillins . . . . . . . . . . . . . . . . . . . . . . . . . . .  8.4 25.6 10.9 7.9 6.2 11.0 15.4 8.7 9.5 
ACE4 inhibitors . . . . . . . . . . . . . . . . . . . . . . .  8.3 0.9 1.8 4.6 17.5 44.9 51.8 10.2 7.9 
Hyperlipidemia . . . . . . . . . . . . . . . . . . . . . . . .  7.9 0.5 1.4 4.7 17.6 47.8 42.8 9.1 8.9 
Calcium channel blockers . . . . . . . . . . . . . . . . .  8.3 0.8 1.6 3.3 15.3 43.6 56.4 10.0 8.1 
Beta blockers . . . . . . . . . . . . . . . . . . . . . . . .  7.3 0.9 2.4 5.0 16.0 34.5 45.0 8.8 7.6 
Diuretics . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6.6 1.5 0.6 2.4 9.9 37.9 59.6 8.1 6.3 
Estrogens/progestins . . . . . . . . . . . . . . . . . . . .  8.0 0.4 5.9 4.8 22.6 31.9 24.7 15.6 0.3 
Adrenal corticosteroids . . . . . . . . . . . . . . . . . . .  8.2 8.5 7.5 8.6 13.1 24.0 34.5 10.3 7.5 
Cephalosphorins . . . . . . . . . . . . . . . . . . . . . . .  6.6 13.1 8.6 8.8 7.0 21.5 17.0 8.7 5.9 
Analgesics, narcotic . . . . . . . . . . . . . . . . . . . . .  6.5 1.0 9.4 7.9 11.3 23.2 22.8 8.1 6.4 
Vitamins/minerals . . . . . . . . . . . . . . . . . . . . . .  8.0 6.0 17.5 10.7 10.6 35.1 26.7 13.3 4.9 
Replenishers/regs of electrolytes/water balance . . . 5.8 3.9 4.4 5.4 8.8 27.3 39.3 8.1 4.9 
* Figure does not meet standard of reliability or precision. 
1Based on the standard drug classification used in the National Drug Code Directory, 1995 edition (NDC) (19). 
2Based on U.S. Census Bureau monthly postcensal estimates of the civilian noninstitutionalized population of the United States as of July 1, 1999, and July 1, 2000. Figures are consistent with the 
downloadable series, ‘‘U.S. Population Estimates by Age, Sex, Race, and Hispanic Origin: 1980–1999 (with short-term projection to dates in 2000)’’ and are available at the U.S. Census Bureau 
Internet site: http://www.census.gov/popest/archives/1990s/nat_detail.html.. Figures have been adjusted for underenumeration using the 1990 National Population Adjustment Matrix. 
3NSAID is non-steroidal anti-inflammatory drug. 
4ACE is angiotensin converting enzyme. 
NOTE: Figures are annual averages. 
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Table 23. Annual population rates of drug mentions at ambulatory care visits for the top 20 specific therapeutic classes, by selected patient 
and provider characteristics: United States, 1999–2000 




insurance MSA Non-MSATherapeutic class1 All visits White Black Medicare Medicaid Uninsured 
Number of mentions per 1,000 persons3,4 
NSAID5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  291.8 284.9 380.1 382.9 288.1 175.4 198.8 290.9 295.8 
Analgesics, non-narcotic . . . . . . . . . . . . . . . . . . . .  264.4 263.9 285.7 444.4 353.7 161.6 162.2 259.4 284.3 
Antidepressants . . . . . . . . . . . . . . . . . . . . . . . . .  219.8 240.7 139.9 348.8 208.0 166.6 148.1 219.1 222.8 
Antihistamines . . . . . . . . . . . . . . . . . . . . . . . . . .  199.3 203.3 180.8 184.5 224.4 92.1 171.9 199.0 200.5 
Vaccines/Antisera . . . . . . . . . . . . . . . . . . . . . . . .  196.5 190.7 225.0 90.9 388.9 81.4 156.2 203.5 169.5 
Antiasthmatics/bronchodilators . . . . . . . . . . . . . . . .  171.5 174.0 183.0 278.4 245.6 72.3 120.0 178.6 144.0 
Blood glucose regulators . . . . . . . . . . . . . . . . . . .  168.3 157.4 241.7 466.4 178.3 35.7 95.4 161.0 197.0 
Disorders, acid/peptic . . . . . . . . . . . . . . . . . . . . . .  166.4 175.3 129.3 425.8 174.8 48.8 102.5 163.6 177.3 
Penicillins . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  151.3 150.8 170.8 67.3 268.4 98.2 124.5 141.9 188.2 
ACE6 inhibitors . . . . . . . . . . . . . . . . . . . . . . . . .  147.8 150.9 151.7 475.2 92.6 38.0 84.1 141.7 172.0 
Hyperlipidemia . . . . . . . . . . . . . . . . . . . . . . . . . .  133.7 141.5 98.6 417.8 63.7 25.4 82.2 132.5 138.7 
Calcium channel blockers . . . . . . . . . . . . . . . . . . .  130.9 123.3 191.1 466.1 94.8 31.2 64.0 127.8 143.1 
Beta blockers . . . . . . . . . . . . . . . . . . . . . . . . . .  122.6 127.9 98.2 377.9 66.6 30.2 72.8 119.8 133.4 
Diuretics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  119.3 120.6 138.6 507.8 70.7 22.6 48.2 113.1 143.9 
Estrogens/progestins . . . . . . . . . . . . . . . . . . . . . .  118.6 129.9 65.6 193.3 65.6 42.8 99.6 114.9 133.6 
Adrenal corticosteroids . . . . . . . . . . . . . . . . . . . . .  115.9 120.8 100.9 213.1 102.8 51.5 85.8 113.5 125.3 
Cephalosporins . . . . . . . . . . . . . . . . . . . . . . . . .  112.5 117.9 103.4 108.1 133.5 84.2 86.4 105.0 141.7 
Analgesics, narcotic . . . . . . . . . . . . . . . . . . . . . . .  109.8 113.2 115.3 186.9 113.0 83.4 68.8 105.0 128.5 
Vitamins/minerals . . . . . . . . . . . . . . . . . . . . . . . .  109.5 113.4 102.7 197.7 158.0 31.7 76.3 106.9 119.8 
Replenishers/regs of electrolytes/water balance . . . . .  88.2 91.9 90.3 253.3 63.5 30.6 53.9 84.7 101.9 
Standard error of rate 
NSAID5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13.9 14.2 31.9 30.9 21.6 13.5 10.1 15.1 32.8 
Analgesics, non-narcotic . . . . . . . . . . . . . . . . . . . .  11.9 13.0 21.2 30.6 33.0 11.3 19.1 11.9 36.7 
Antidepressants . . . . . . . . . . . . . . . . . . . . . . . . .  13.6 15.7 15.5 29.3 25.7 19.9 14.0 14.0 38.0 
Antihistamines . . . . . . . . . . . . . . . . . . . . . . . . . .  12.9 13.2 23.5 16.2 30.2 9.6 8.0 14.1 26.5 
Vaccines/antisera . . . . . . . . . . . . . . . . . . . . . . . .  14.0 14.7 37.9 13.7 58.1 15.2 11.5 16.5 28.4 
Antiasthmatics/bronchodilators . . . . . . . . . . . . . . . .  11.0 11.9 18.1 26.3 26.1 8.1 6.0 12.3 19.9 
Blood glucose regulators . . . . . . . . . . . . . . . . . . .  12.2 11.8 33.8 40.0 23.5 5.4 4.4 12.8 31.7 
Disorders, acid/peptic . . . . . . . . . . . . . . . . . . . . . .  10.0 10.9 15.0 37.5 21.5 5.8 6.8 10.8 26.5 
Penicillins . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  8.4 8.8 22.5 8.0 23.4 8.9 8.4 8.1 27.3 
ACE6 inhibitors . . . . . . . . . . . . . . . . . . . . . . . . .  8.3 8.8 18.3 33.4 11.9 6.3 8.8 8.2 26.1 
Hyperlipidemia . . . . . . . . . . . . . . . . . . . . . . . . . .  7.9 8.8 12.6 29.7 8.3 6.0 3.7 8.4 23.1 
Calcium channel blockers . . . . . . . . . . . . . . . . . . .  8.3 7.9 22.7 36.8 13.9 5.3 5.6 8.4 22.8 
Beta blockers . . . . . . . . . . . . . . . . . . . . . . . . . .  7.3 7.9 11.5 29.7 9.1 6.0 6.0 7.1 22.6 
Diuretics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6.6 7.2 15.6 33.9 8.6 3.6 4.5 6.6 20.1 
Estrogens/progestins . . . . . . . . . . . . . . . . . . . . . .  8.0 9.2 7.7 19.0 8.9 7.1 6.7 8.6 21.6 
Adrenal corticosteroids . . . . . . . . . . . . . . . . . . . . .  8.2 9.2 11.0 20.7 10.9 6.8 6.6 8.5 20.2 
Cephalosphorins . . . . . . . . . . . . . . . . . . . . . . . . .  6.6 7.1 11.6 13.5 14.5 8.2 8.2 7.2 16.3 
Analgesics, narcotic . . . . . . . . . . . . . . . . . . . . . . .  6.5 7.2 13.4 13.8 11.1 7.3 8.4 7.0 16.3 
Vitamins/minerals . . . . . . . . . . . . . . . . . . . . . . . .  8.0 8.7 16.5 21.7 25.5 4.7 4.1 7.9 23.6 
Replenishers/regs of electrolytes/water balance . . . . .  5.8 6.3 10.9 23.2 6.7 3.8 7.6 5.5 16.9 
1Based on the standard drug classification used in the National Drug Code Directory, 1995 edition (NDC) (19). 
2MSA is metropolitan statistical area. 
3Based on U.S. Census Bureau monthly postcensal estimates of the civilian noninstitutionalized population of the United States as of July 1, 1999, and July 1, 2000. Figures are consistent with the 
downloadable series, ‘‘U.S. Population Estimates by Age, Sex, Race, and Hispanic Origin: 1980–1999 (with short-term projection to dates in 2000)’’ and are available at the U.S. Census Bureau 
Internet site: http://www.census.gov/popest/archives/1990s/nat_detail.html.. Figures have been adjusted for underenumeration using the 1990 National Population Adjustment Matrix. 
4Denominators for primary expected source of payment rates are from the 1999 and 2000 estimates of heatlh insurance coverage from the Current Population Survey. 
5NSAID is non-steroidal anti-inflammatory drug. 
6ACE is angiotensin converting enzyme. 
NOTE: Figures are annual averages. 
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Table I. Coefficients appropriate for determining approximate relative standard errors by 
type of estimate and ambulatory care setting: National Ambulatory Medical Care Survey 
and National Hospital Ambulatory Medical Care Survey, 1999–2000 
Coefficient for use with 
estimates in thousands Lowest reliable 
estimate 
Setting and type of estimate A B in thousands1 
Combined settings 
Visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.001441 19.799 224 
Drug mentions . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.002840 25.825 296 
Physician offices 
Visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.001963 46.186 525 
Drug mentions . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.003452 111.412 1,287 
Outpatient departments 
Visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.008124 4.591 56 
Drug mentions . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.010701 9.322 118 
Emergency departments 
Visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.001519 3.828 43 
Drug mentions . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.002419 9.180 105 
1Estimates with relative standard errors of greater than 30 percent are considered to be unreliable. The lowest reliable estimates 
shown here were determined by approximating relative standard errors from the generalized variance curves for each data set. 
However, estimates based on fewer than 30 cases are considered to be unreliable regardless of the size of the relative standard
error and have been indicated in this report with an asterisk (no number shown). Appendix I 
Technical Notes 
Data collection 
The National Ambulatory Medical 
Care Survey (NAMCS) and National 
Hospital Ambulatory Medical Care 
Survey (NHAMCS) data collection is 
authorized under Section 308(d) of the 
Public Health Service Act (42 United 
States Code Section 306 [242K]). 
Participation is voluntary. A total of 
2,466 in-scope, or eligible, physicians 
participated in the 1999 and 2000 
NAMCS, which corresponds to an 
average response rate of 65.3 percent, 
and 48,129 Patient Record forms (PRFs) 
were collected. 
The 1999 NHAMCS sample 
consisted of 489 hospitals. Of these, 427 
were in-scope. The overall hospital 
response rate was 95 percent. There 
were 376 participating EDs that 
provided data for 452 emergency service 
areas, and 241 participating OPDs 
provided data for 858 clinics. The 
overall response rate was 92 percent for 
EDs and 82 percent for OPDs. The 2000 
NHAMCS sample consisted of 488 
hospitals. Of these, 413 were eligible to 
participate. The overall hospital response 
rate was 96 percent. There were 376 
participating EDs that provided data for 
446 emergency service areas, and 221 
participating OPDs provided data for 
829 clinics. The overall response rate 
was 97 percent for EDs and 91 percent 
for OPDs. In all, 46,725 ED PRFs and 
56,997 OPD PRFs were collected from 
the participating hospitals. 
The U.S. Census Bureau, acting as 
the data collection agent for both 
surveys, provided training to field 
representatives (FRs) throughout the 
Nation who, in turn, oversaw data 
collection at physician offices and 
hospitals. FRs contacted physicians and 
hospitals for induction into the surveys 
after NCHS mailed an advance letter 
notifying the providers of their selection 
in the survey. For the NAMCS, medical 
staff most often provided the	
information requested on the PRFs 
(‘‘Appendix III’’); however, in some cases, FRs performed data abstraction 
from medical records. For the 
NHAMCS, FR abstraction was the 
predominant method of data collection. 
Neither the patient’s name nor address 
was collected. Confidentiality of the 
data collected in the survey is protected 
under the Privacy Act, Public Health 
Service Act, and Title 42 of the United 
States Code, Section 242m(d). 
Sampling errors 
The standard error is primarily a 
measure of the sampling variability that 
occurs by chance when only a sample, 
rather than an entire universe, is 
surveyed. The standard error also 
reflects part of the measurement error 
but does not measure any systematic 
biases in the data. The chances are 95 
out of 100 that an estimate from the 
sample differs from the value that would 
be obtained from a complete census by 
less than twice the standard error. 
The standard errors that were used 
in tests of significance for this report 
were calculated using SUDAAN 
software. SUDAAN computes standard 
errors using a first-order Taylor 
approximation of the deviation of 
estimates from their expected values. A description of the software and the 
approach it uses has been published 
(25). The relative standard error (RSE) 
of an estimate is obtained by dividing 
the standard error by the estimate itself. 
The result is then expressed as a 
percentage of the estimate. 
Approximate RSEs for aggregate 
estimates may be calculated using the 
following general formula, where x is 
the aggregate of interest in thousands, 
and A and B are the appropriate 
coefficients from table I. 
RSE(x) = 100 cŒA + B x 
Similarly, approximate RSEs for 
estimates of percentages may be 
calculated using the following general 
formula, where p is the percentage of 
interest expressed as a proportion, and x 
is the denominator of the percentage in 
thousands, using the appropriate 
coefficient from table I. 
RSE (x) = 100 c Œ B c (1−p) p c x 
The standard error for a rate may be 
obtained by multiplying the RSE of the 
total estimate by the rate. 
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Estimates are not presented unless a 
reasonable assumption regarding their 
probability distributions is possible on 
the basis of the Central Limit Theorem. 
The Central Limit Theorem states that, 
given a sufficiently large sample size, 
the sample estimate approximates the 
population estimate and, upon repeated 
sampling, its distribution would be 
approximately normal. 
In this report, estimates are not 
presented if they are based on fewer 
than 30 cases in the sample data; only 
an asterisk (*) appears in the tables. 
Estimates based on 30 or more cases are 
asterisked only if the estimate’s RSE 
exceeds 30 percent. Approximate RSEs 
were computed using a generalized 
variance curve and the computed curve 
coefficients as described above. 
Estimation 
Estimates from the 1999 and 2000 
NAMCS and NHAMCS were derived 
by multistage estimation procedures that 
produce essentially unbiased estimates. 
The estimation for NAMCS has four 
basic components: 1) inflation by 
reciprocals of the probabilities of 
selection; 2) adjustment for 
nonresponse; 3) a ratio adjustment to 
fixed totals; and 4) weight smoothing. 
The estimation for NHAMCS has three 
basic components: 1) inflation by 
reciprocals of the sampling selection 
probabilities; 2) adjustment for 
nonresponse; and 3) a population 
weighting ratio adjustment. The 
population weighting ratio adjustment 
for OPD estimates was replaced by an 
adjustment that controls for effects of 
rotating hospital sample panels into and 
out of the sample each year. (The full 
NHAMCS hospital sample is partitioned 
into 16 panels that are rotated into the 
sample over 16 periods of 4 weeks each 
so that only 13 panels are used in any 
single year.) The sampling weights of 
some OPDs were permanently trimmed 
to prevent single OPDs from 
contributing more than 15 percent of 
their region’s total to OPD visit 
estimates. Nonsampling errors 
As in any survey, results are subject 
to both sampling and nonsampling 
errors. Nonsampling errors include 
reporting and processing errors as well 
as biases due to nonresponse and 
incomplete response. The magnitude of 
the nonsampling errors cannot be 
computed. However, these errors were 
kept to a minimum by procedures built 
into the operation of the survey. To 
eliminate ambiguities and encourage 
uniform reporting, attention was given 
to the phrasing of questions, terms, and 
definitions. Also, most data items and 
survey procedures were pretested. 
Quality control procedures and 
consistency and edit checks reduced 
errors in data coding and processing. 
The error rate (which includes coding 
and keying errors) ranged from 0.0 to 
2.0 for both surveys. 
Adjustments for survey 
nonresponse—Estimates from NAMCS 
data were adjusted to account for 
sample physicians who were in-scope 
but did not participate in the study. This 
adjustment was calculated to minimize 
the impact of nonresponse on final 
estimates. The weights of visits for 
physicians similar to the nonrespondent 
physicians were inflated to account for 
visits represented by the nonrespondent 
physicians. For this purpose, physicians 
were judged similar if they had the 
same specialty designation and practiced 
in the same primary sampling unit. 
NHAMCS data were adjusted to 
account for two types of nonresponse. 
The first type of nonresponse occurred 
when a sample hospital refused to 
provide information about its ED or 
OPD that was publicly known to exist. 
In this case, the weights of visits to 
hospitals similar to the nonrespondent 
hospitals were inflated to account for 
visits represented by the nonrespondent 
hospitals. Beginning with 1998 data, 
hospitals were judged to be similar if 
they were in the same region and, 
except in the West, if they had the same 
MSA status (in an MSA vs. not in an 
MSA). Similarity of hospitals also 
required being in the same ownership 
control group (voluntary nonprofit vs. 
other). This adjustment was made 
separately by department type. The second type of nonresponse 
occurred when a sample emergency 
service area (ESA) within a respondent 
hospital failed to provide completed 
PRFs for a sample of patient visits. In 
the ED, the weights of visits from 
responding ESAs were inflated to 
account for visits to similar 
nonresponding ESAs where ESAs were 
judged to be similar if they were in the 
same region. Except in the West, ESA 
similarity also required having the same 
MSA status and, in MSAs, being in the 
same ownership control group 
(voluntary nonprofit vs. other). 
For the OPD, weights of visits from 
responding OPD clinics were inflated to 
account for visits to similar 
nonresponding OPD clinics where OPD 
clinics were judged to be similar if they 
were in the same region, clinic type, and 
ownership control group (voluntary 
nonprofit vs. other). There were six 
OPD clinic types: general medicine, 
pediatrics, surgery, obstetrics and 
gynecology, alcohol and/or substance 
abuse, and other OPD clinic. Beginning 
with 1998 data, formation of groups of 
similar clinics also considered the MSA 
status of the clinic (in an MSA vs. not 
in an MSA) with the following two 
exceptions: in the West, MSA status was 
not considered; and in non-MSA clinics 
in the other three regions, ownership 
control group (voluntary nonprofit vs. 
other) was not considered. 
Adjustments for item nonresponse— 
Missing data for several of the items 
mentioned in this report were imputed 
by randomly assigning a value from a 
PRF with similar characteristics. These 
items include patient’s birth date (used 
to determine age), sex, and race. In the 
NAMCS, imputations were based on 
physician specialty, geographic region, 
and 3-digit ICD–9–CM code for primary 
diagnosis. In the NHAMCS, imputations 
for ED data were based on ED size, 
geographic region, immediacy with 
which patient should be seen, and 
3-digit ICD–9–CM code for primary 
diagnosis; for OPD data, imputations 
were based on geographic region, OPD 
size by clinic, and 3-digit ICD–9–CM 
code for primary diagnosis. 
Additional information on item 
nonresponse for data items not included 
in this report and for item nonresponse 
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9–12). 
Tests of significance and 
rounding 
In this report, the determination of 
statistical inference is based on the 
two-tailed t-test and the chi-square test. 
The Bonferroni inequality was used to 
establish the critical value for 
statistically significant differences (0.05 
level of significance) based on the 
number of possible comparisons within 
a particular variable (or combination of 
variables) of interest. Terms relating to 
differences such as ‘‘greater than’’ or 
‘‘less than’’ indicate that the difference 
is statistically significant. A lack of 
comment regarding the difference 
between any two estimates does not 
mean that the difference was tested and 
found to be not significant. Chi-square 
tests and logistic regression models were 
performed using the SUDAAN routine 
PROC CROSSTAB, which takes into 
account the complex sample designs 
used in the NAMCS and NHAMCS. 
In the tables, estimates of visits 
have been rounded to the nearest 
thousand. Consequently, estimates will 
not always add to totals. Rates and 
percentages were calculated from 
original unrounded figures and do not 
necessarily agree with percentages 
calculated from rounded data. 
Diagnosis and injury groupings 
Physicians’ diagnoses, shown in 
table 9 of this report, are grouped 
according to a classification system 
developed for use with NAMCS and 
NHAMCS data. This grouping is based 
on the International Classification of 
Diseases, 9th Revision, Clinical 
Modification (ICD–9–CM) (17) and 
reflects the frequency of particular 
diagnoses occurring in the NAMCS and 
NHAMCS data. It is meant to provide 
additional detail on the diagnostic 
content of ambulatory care as 
characterized by the surveys. Table II 
shows the groupings used to categorize 
data in table 9. 
Table 14 of this report presents data 
on the intent and mechanism producing 
injuries that resulted in ambulatory care visits to physician offices, EDs, and 
OPDs. Cause of injury is collected for 
each sampled visit in the NAMCS and 
NHAMCS and is coded according to the 
ICD–9–CM’s ‘‘Supplementary 
Classification of External Causes of 
Injury and Poisoning.’’ For table 14, 
however, the first-listed cause of injury 
data were regrouped to highlight the 
interaction between intentionality of the 
injury and the mechanism that actually 
produced the injury. Table III displays 
the groupings used in table 14. 
Estimates on injury-related visits by 
body part and type of injury are 
presented in table 15. First-listed 
diagnosis codes were used and 
regrouped according to the ‘‘Barell 
Injury Diagnosis Matrix: Classification 
by Body Region and Nature of the 
Injury’’ (26). Table IV in the ‘‘Technical 
Notes’’ displays the regrouped diagnosis 
codes used in table 15. 
Physician specialty groupings 
The NAMCS survey design grouped 
physicians into 15 strata, or specialty 
groups, for sampling purposes. One 
stratum, doctors of osteopathy, was 
based on information from the American 
Osteopathic Association (AOA). The 
other groups (general and family 
practice, internal medicine, pediatrics, 
general surgery, obstetrics and 
gynecology, orthopedic surgery, 
cardiovascular diseases, dermatology, 
urology, psychiatry, neurology, 
ophthalmology, otolaryngology, and a 
residual category of other specialties) 
were developed based on information 
from the American Medical Association 
(AMA). Estimates presented in this 
report combine doctors of osteopathy 
with doctors of medicine, unless 
otherwise noted. 
In this report, the data on office 
visits are presented using the broader 
categories of primary care, surgical, and 
medical specialties. Table V shows the 
specialties used to define these 
categories. 
Race 
The instruction for the race item on 
the Patient Record form was changed in 
1999 to be consistent with standards issued by the Office of Management and 
Budget to promote comparability of data 
among Federal data sources and so that 
more than one race could be recorded 
per person (27). The new race item 
includes the following groups: white, 
black or African American, Asian, 
Native Hawaiian or other Pacific 
Islander, and American Indian or Alaska 
Native. Respondents could check 
multiple categories for each patient. 
Prior to 1999, only a single race 
category could be checked per person. 
Because of the difference between 
single and multiple race reporting, 
race-specific estimates prior to 1999 are 
not strictly comparable with those from 
1999 and subsequent years. From 1999 
to the present, only a small proportion 
of records had multiple races indicated. 
For this report, multiple race estimates 
are included in the ‘‘Other’’ race 
category. Estimates for specific race 
categories reflect visits where only a 
single race was reported. According to 
the same standards, race and Hispanic 
origin were collected separately. 
Consequently, all race categories include 
visits by persons of Hispanic and not 
Hispanic origin. Persons of Hispanic 
origin may be of any race. 
Population figures and rate 
calculation 
The population figures used in 
computing annual visit rates by age, sex, 
and race for this report are shown in 
table VI. Table VII shows the population 
figures used to compute annual visit 
rates by geographic region and MSA 
status. The figures represent 2-year 
averages of the estimates of the civilian 
noninstitutionalized population of the 
United States as of July 1, 1999, and 
July 1, 2000. Figures are 1990-based 
monthly postcensal estimates and are 
consistent with the downloadable series, 
‘‘U.S. Population Estimates by Age, 
Sex, Race, and Hispanic Origin: 1980 to 
1999 (with short-term projection to 
dates in 2000)’’ available at the U.S. 
Census Bureau’s Web site: http:// 
www.census.gov/popest/archives/1990s/ 
nat_detail.html. 
Figures have been adjusted for net 
underenumeration using the 1990 
National Population Adjustment Matrix. 
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obtained from the Division of Health 
Interview Statistics (DHIS), NCHS. 
DHIS estimates differ slightly from 
monthly postcensal estimates because of 
differences in the adjustment process. 
Population estimates for 2000 could 
have been based on Census 2000 rather 
than using the post-censal 1990-based 
estimates provided in the 1999 and 2000 
NAMCS and NHAMCS public use 
documentation. However, the latter 
estimates were chosen for consistency 
and averaging purposes. Research has 
shown that the change in visit rates due 
to switching from the 1990 census-based 
population estimates to Census 
2000-based population estimates for age, 
sex, and race is minimal. To evaluate 
the effect of the change in base year, the 
2000 NAMCS and NHAMCS visit rates 
were calculated using both the 
1990-based population estimates and the 
2000-based population estimates. In no 
case were differences in the two rates 
statistically significant. Therefore, it is 
reasonable to conclude that using the 
1990-based estimates has little impact 
on observed rates and trends that cross 
these survey years. For more 
information on rate comparisons, see 
http://www.cdc.gov/nchs/about/major/ 
ahcd/ahcd1.htm. 
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Table II. Reclassification of primary diagnosis codes for use with National Ambulatory Medical Care Survey and National Hospital 
Ambulatory Medical Care Survey data 
Primary diagnosis ICD–9–CM code1 
Infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Streptococcal sore throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
HIV infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Viral warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Unspecified viral and chlamydial infections . . . . . . . . . . . . . . . . . . . . . . . .  
Dermatophytosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Candidiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . .  
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of colon and rectum . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Malignant neoplasm of lymphatic and hematopoietic tissue . . . . . . . . . . . . . .  
Other malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Benign neoplasm of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other benign neoplasm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Neoplasm of uncertain behavior and unspecified nature . . . . . . . . . . . . . . . .  
Endocrine, nutritional and metabolic diseases, and immunity disorders . . . . . . . .  
Acquired hypothyroidism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the thyroid gland . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of lipoid metabolism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other endocrine, nutritional and metabolic diseases and immunity disorders . . . 
Diseases of the blood and blood–forming organs . . . . . . . . . . . . . . . . . . . . .  
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other diseases of the blood and blood-forming organs . . . . . . . . . . . . . . . . .  
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Schizophrenic disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Major depressive disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other psychoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Anxiety states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Neurotic depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Alcohol dependence syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Drug dependence and nondependent use of drugs . . . . . . . . . . . . . . . . . . .  
Acute reaction to stress and adjustment reaction . . . . . . . . . . . . . . . . . . . .  
Depressive disorder, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . .  
Attention deficit disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Diseases of the nervous system and sense organs . . . . . . . . . . . . . . . . . . . .  
Migraine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the central nervous system . . . . . . . . . . . . . . . . . . . . . .  
Carpal tunnel syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the nervous system . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Retinal detachment and other retinal disorders . . . . . . . . . . . . . . . . . . . . . .  
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of refraction and accommodation . . . . . . . . . . . . . . . . . . . . . . . .  
Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of eyelids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the eye and adnexa . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of external ear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . .  
Other diseases of the ear and mastoid process . . . . . . . . . . . . . . . . . . . . .  
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Table II. Reclassification of primary diagnosis codes for use with National Ambulatory Medical Care Survey and National Hospital 
Ambulatory Medical Care Survey data—Con. 
Primary diagnosis ICD–9–CM code1 
Diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Angina pectoris . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Coronary atherosclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cardiac dysrhythmias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Congestive heart failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cerebrovascular disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Diseases of the arteries, arterioles, and capillaries . . . . . . . . . . . . . . . . . . .  
Hemorrhoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . .  
Diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Acute sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Acute tonsillitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Acute bronchitis and bronchiolitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other acute respiratory infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other chronic obstructive pulmonary disease and allied conditions . . . . . . . . .  
Other diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . .  
Diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Diseases of the teeth and supporting structures . . . . . . . . . . . . . . . . . . . . .  
Gastritis and duodenitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Esophagitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Ulcer of stomach and small intestine . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Hernia of abdominal cavity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Noninfectious enteritis and colitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Diverticula of intestine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Constipation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Irritable colon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Anal and rectal diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of the gallbladder and biliary tract . . . . . . . . . . . . . . . . . . . . . . .  
Gastrointestinal hemorrhage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . . .  
Diseases of the genitourinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Calculus of kidney and ureter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cystitis and other disorders of the bladder . . . . . . . . . . . . . . . . . . . . . . . .  
Urinary tract infection, site not specified . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other diseases of the urinary system . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of male genital organs . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Inflammatory disorders of female pelvic organs . . . . . . . . . . . . . . . . . . . . .  
Noninflammatory disorders of female genital organs . . . . . . . . . . . . . . . . . .  
Disorders of menstruation and abnormal bleeding . . . . . . . . . . . . . . . . . . . .  
Menopausal and postmenopausal disorders . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the female genital tract . . . . . . . . . . . . . . . . . . . . . . . .  
Complications of pregnancy, childbirth, and the puerperium . . . . . . . . . . . . . . .  
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Table II. Reclassification of primary diagnosis codes for use with National Ambulatory Medical Care Survey and National Hospital 
Ambulatory Medical Care Survey data—Con. 
Primary diagnosis ICD–9–CM code1 
Diseases of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . . . . . .  
Cellulitis and abscess . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other infection of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . .  
Contact dermatitis and other eczema . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Psoriasis and similar disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other inflammatory conditions of skin and subcutaneous tissue . . . . . . . . . . .  
Corns, callosities, and other hypertrophic and atrophic skin conditions . . . . . . .  
Actinic and seborrheic keratosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Sebaceous cyst . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Urticaria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other disorders of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . .  
Diseases of the musculoskeletal system and connective tissue . . . . . . . . . . . . .  
Rheumatoid arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Osteoarthrosis and allied disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other arthropathies and related disorders . . . . . . . . . . . . . . . . . . . . . . . . .  
Derangements and other and unspecified joint disorders . . . . . . . . . . . . . . .  
Intervertebral disc disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Lumbago . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Peripheral enthesopathies and allied disorders . . . . . . . . . . . . . . . . . . . . . .  
Synovitis and tenosynovitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Myalgia and myositis, unspecified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Disorders of bone and cartilage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other diseases of the musculoskeletal system and connective tissue . . . . . . . .  
Congenital anomalies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Certain conditions originating in the perinatal period . . . . . . . . . . . . . . . . . . . .  
Symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . . . . . . . .  
Syncope and collapse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Convulsions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Dizziness and giddiness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Pyrexia of unknown origin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Symptoms involving skin and other integumentary tissue . . . . . . . . . . . . . . .  
Headache . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Epistaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Abnormal heart sounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Dyspnea and respiratory abnormalities . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Chest pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Symptoms involving urinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . . .  
Injury and poisoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Fracture of radius and ulna . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Fracture of hand and fingers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Sprains and strains of wrist and hand . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Sprains and strains of knee and leg . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Sprains and strains of ankle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Sprains and strains of neck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other sprains and strains of back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other sprains and strains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Intracranial injury, excluding those with skull fracture . . . . . . . . . . . . . . . . . .  
Open wound of head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Open wound of hand and fingers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other open wound . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Superficial injury of cornea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other superficial injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
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Table II. Reclassification of primary diagnosis codes for use with National Ambulatory Medical Care Survey and National Hospital 
Ambulatory Medical Care Survey data—Con. 
Primary diagnosis ICD–9–CM code1 
Injury and poisoning—Continued 
Contusions with intact skin surfaces . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Poisonings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other and unspecified effects of external causes . . . . . . . . . . . . . . . . . . . .  
Complications of surgical and medical care, not elsewhere classified . . . . . . . .  
Supplementary classification of factors influencing health status and contact with 
health services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Potential health hazards related to communicable diseases . . . . . . . . . . . . . .  
Potential health hazards related to personal and family history . . . . . . . . . . . .  
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Postpartum care and examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Encounter for contraceptive management . . . . . . . . . . . . . . . . . . . . . . . . .  
Other encounter related to reproduction . . . . . . . . . . . . . . . . . . . . . . . . . .  
Lens replaced by pseudophakos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Artificial opening status and other postsurgical states . . . . . . . . . . . . . . . . . .  
Attention to surgical dressing and sutures . . . . . . . . . . . . . . . . . . . . . . . . .  
Follow-up examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Observation and evaluation for suspected conditions not found . . . . . . . . . . .  
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  













































1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (17). 
Table III. Reclassification of cause-of-injury codes for use with National Ambulatory Medical Care Survey and National Hospital Ambulatory 
Medical Care Survey data 
Intent and mechanism of injury Cause-of-injury code1 
Unintentional injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Falls . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Motor vehicle traffic . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Struck against or struck accidentally by objects or persons . . . .  
Overexertion and strenuous movements . . . . . . . . . . . . . . . .  
Cutting and piercing instruments or objects . . . . . . . . . . . . . .  
Natural and environmental factors . . . . . . . . . . . . . . . . . . .  
Poisoning by drugs, medicinal substances, biologicals, other solid 
and liquid substances, gases, and vapors . . . . . . . . . . . . . .  
Fire and flames, hot substance or object, caustic or corrosive 
material, and steam . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Machinery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Pedal cycle, nontraffic and other . . . . . . . . . . . . . . . . . . . .  
Motor vehicle, nontraffic . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other transportation . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Suffocation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Foreign body accidentally entering eye or other orifice . . . . . . .  
Firearm missile . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Drowning/submersion . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other and not elsewhere classified . . . . . . . . . . . . . . . . . . .  
Mechanism unspecified . . . . . . . . . . . . . . . . . . . . . . . . . .  
Intentional injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Assault . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Unarmed fight or brawl, striking by blunt or thrown object . . . .  
Cutting and piercing instrument . . . . . . . . . . . . . . . . . . . .  
Firearms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Other mechanism . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Mechanism unspecified . . . . . . . . . . . . . . . . . . . . . . . . . .  
Self-inflicted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Poisoning by solid or liquid substances, gases, and vapors . . 
Cutting and piercing instrument . . . . . . . . . . . . . . . . . . . .  
Other and unspecified mechanism . . . . . . . . . . . . . . . . . .  
Other causes of violence . . . . . . . . . . . . . . . . . . . . . . . . .  
Injuries of undetermined intent . . . . . . . . . . . . . . . . . . . . . . .  



































E846–E848, E918, E921, E923, E925–E926, E928.3, E928.8, E929.0–E929.5

E887, E928.9, E929.8, E929.9





























1Based on the ‘‘Supplementary Classification of External Causes of Injury and Poisoning,’’ International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (17). 
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Table IV. Reclassification of primary diagnosis codes by body site and type of injury for use with National Ambulatory Medical Care Survey 
and National Hospital Ambulatory Medical Care Survey data 
Body site and type of injury Primary diagnosis ICD–9–CM codes 
Head and neck . . . . . . . . . . . 	 800.1–800.4, 800.6–800.9, 800.03–800.05, 800.53–800.55, 801.1–801.4, 801.6–801.9, 801.03–801.05, 801.53–801.55, 
803.1–803.4, 803.6–803.9, 803.03–803.05, 803.53–803.55, 804.1–804.4, 804.6–804.9, 804.03–804.05, 804.53–804.55, 
850.2–850.4, 851–854, 950.1–950.3, 995.55, 800.00, 800.02, 800.06, 800.09, 801.00, 801.02, 801.06, 801.09, 803.00, 
803.02, 803.06, 803.09, 804.00, 804.02, 804.06, 804.09, 800.50, 800.52, 800.56, 800.59, 801.50, 801.52, 801.56, 801.59, 
803.50, 803.52, 803.56, 803.59, 804.50, 804.52, 804.56, 804.59, 850.0, 850.1, 850.5, 850.9, 800.01, 800.51, 801.01, 801.51, 
803.01, 803.51, 804.01, 804.51, 951, 873.0, 873.1, 873.8, 873.9, 941.06, 959.01, 802, 830, 848.0, 848.1, 872, 873.2–873.7, 
941.01, 941.03–941.05, 941.07, 950.0, 950.9, 870–871, 921, 918, 940, 941.02, 807.5–807.6, 848.2, 925.2, 953.0, 954.0, 874, 
941.08, 925.1, 900, 957.0, 910, 920, 947.0, 959.09, 941.00, or 941 
Fractures . . . . . . . . . . . . . .  800–829 
Internal organs . . . . . . . . . .  860–869, 850–854, 952, or 995.55 
Open wounds . . . . . . . . . . .  870–884 or 890–894 
Superficial contusions . . . . . .  910–924 
Burns . . . . . . . . . . . . . . . .  940–949 
Nerves . . . . . . . . . . . . . . .  950–951 or 953–957 
Unspecified . . . . . . . . . . . .  959 
Spine and back . . . . . . . . . . . 	 806.0–806.1, 952.0, 806.2–806.3, 952.1, 806.4–806.5, 952.2, 806.6–806.7, 952.3–952.4, 806.8–806.9, 952.8–952.9, 
805.0–805.1, 839.0–839.1, 847.0, 805.2–805.3, 839.21, 839.31, 847.1, 805.4–805.5, 839.20, 839.30, 847.2, 805.6–805.7, 
839.41, 839.42, 839.51–839.52, 847.3–847.4, 805.8–805.9, 839.40, 839.49, or 839.50–839.59 
Fractures . . . . . . . . . . . . . .  800–829 
Sprains and strains . . . . . . . .  840–848 
Internal organ . . . . . . . . . . .  860–869, 850–854, 952, or 995.55 
Torso . . . . . . . . . . . . . . . . . . 	 807.0–807.4, 839.61, 839.71, 848.3–848.4, 926.19, 860–862, 901, 953.1, 875, 879.0, 879.1, 922.0, 922.1, 922.33, 942.01, 
942.02, 863–866, 868, 902.0–902.4, 953.2, 953.5, 879.2–879.5, 922.2, 942.03, 947.3, 808, 839.69, 839.79, 846, 848.5, 
926.0, 926.12, 867, 902.5, 902.81–902.82, 953.3, 877–878, 922.4, 942.05, 947.4, 809, 926.8–926.9, 954.1, 954.8–954.9, 
879.6–879.7, 922.8–922.9, 911, 942.00, 942.09, 959.1, 847.9, 926.11, 876, 922.32, 922.31, or 942.04 
Fractures . . . . . . . . . . . . . .  800–829 
Sprains and strains . . . . . . . .  840–848 
Internal organ . . . . . . . . . . .  860–869, 850–854, 952, or 995.55 
Open wounds . . . . . . . . . . .  870–884 or 890–894 
Superficial contusions . . . . . .  910–924 
Burns . . . . . . . . . . . . . . . .  940–949 
Unspecified . . . . . . . . . . . .  959 
Upper extremity . . . . . . . . . . . 	 810–812, 831, 840, 880, 887.2–887.3, 943.03–943.06, 912, 923.0, 927.0, 959.2, 813, 832, 841, 881.00–881.01, 887.0–887.1, 
923.1, 927.1, 943.01–943.02, 814–817, 833–834, 842, 881.02, 882–883, 885–886, 914–915, 923.2–923.3, 927.2–927.3, 944, 
959.4–959.5, 818, 884, 887.4–887.7, 903, 913, 959.3, 923.8–923.9, 927.8–927.9, 953.4, 955, 943.01, or 943.09 
Fractures . . . . . . . . . . . . . .  800–829 
Dislocation . . . . . . . . . . . . .  830–839 
Sprains and strains . . . . . . . .  840–848 
Open wounds . . . . . . . . . . .  870–884 or 890–894 
Amputations . . . . . . . . . . . .  885–887 or 895–897 
Superficial contusions . . . . . .  910–924 
Crushing . . . . . . . . . . . . . .  925–929 
Burns . . . . . . . . . . . . . . . .  940–949 
Nerves . . . . . . . . . . . . . . .  950–951 or 953–957 
Unspecified . . . . . . . . . . . .  959 
Lower extremity . . . . . . . . . . . 	 820, 835, 843, 924.01, 928.01, 821, 897.2–897.3, 924.00, 928.00, 945.06, 822, 836, 844.0–844.3, 924.11, 928.11, 945.05, 
823–824, 897.0–897.1, 837, 845.0, 924.10, 924.21, 928.10, 928.21, 945.03–945.04, 825–826, 838, 845.1, 892–893, 895–896, 
917, 924.20, 924.3, 928.20, 928.3, 945.01–945.02, 827, 844.8–844.9, 890–891, 894, 897.4–897.7, 904.0–904.8, 916, 
924.4–924.5, 928.8, 928.9, 959.6–959.7, 945.00, or 945.09 
Fractures . . . . . . . . . . . . . .  800–829 
Dislocations . . . . . . . . . . . .  830–839 
Sprains and strains . . . . . . . .  840–848 
Open wounds . . . . . . . . . . .  870–884 or 890–894 
Superficial contusions . . . . . .  910–924 
Crushing . . . . . . . . . . . . . .  925–929 
Burns . . . . . . . . . . . . . . . .  940–949 
Unspecified . . . . . . . . . . . .  959 
Other and unspecified body sites	 828, 819, 902.87, 902.89, 953.8, 947.1–947.2, 956, 829, 839.8–839.9, 848.8–848.9, 869, 879.8–879.9, 902.9, 904.9, 919, 
924.8, 924.9, 929, 946, 947.8–947.9, 948–949, 953.9, 957.1, 957.8–957.9, or 959.8–959.9 
Fractures . . . . . . . . . . . . . .  800–829 
Dislocation . . . . . . . . . . . . .  830–839 
Sprains and strains . . . . . . . .  840–848 
Open wounds . . . . . . . . . . .  870–884 or 890–894 
Superficial contusions . . . . . .  910–924 
Crushing . . . . . . . . . . . . . .  925–929 
Burns . . . . . . . . . . . . . . . .  940–949 
Nerves . . . . . . . . . . . . . . .  950–951 or 953–957 
Unspecified . . . . . . . . . . . .  959 
See footnotes at end of table. 
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Table IV. Reclassification of primary diagnosis codes by body site and type of injury for use with National Ambulatory Medical Care Survey 
and National Hospital Ambulatory Medical Care Survey data—Con. 
Body site and type of injury Primary diagnosis ICD–9–CM codes 
Foreign bodies . . . . . . . . . .  930–939 
Poisoning . . . . . . . . . . . . .  960–989 
Other and unspecified effects of 
external causes . . . . . . . . .  990–994 
Late effects . . . . . . . . . . . .  905–908, 909.4, 909.9, or 909.0–909.2 
Early complications of trauma . 958 
Child abuse . . . . . . . . . . . .  995.50–995.54 or 995.59 
Adverse effects . . . . . . . . . . .  909.3–909.5, 995.86–995.89, 995.0–995.4, 995.6, or 996–999 
Anaphylactic shock . . . . . . . .  995.0–995.4 or 995.6 
Surgical and medical 
complications . . . . . . . . . .  996–999 
All other body sites 
Musculoskeletal . . . . . . . . . .  710–739 
Ill–defined symptoms . . . . . .  780–799 
Skin and subcutaneous tissue . 680–709 
Mental disorders . . . . . . . . .  290–319 
Nervous system . . . . . . . . . .  320–389 
Other illness . . . . . . . . . . . .  001–289, 390–677, or 740–770 
Supplementary classification . . . V01–V82 
Unknown . . . . . . . . . . . . . . .  000.00 or V99.00–V99.99 
NOTE: This schematic is based on the ‘‘Barell Injury Diagnosis Matrix: Classification by Body Region and Nature of the Injury,’’ which uses a two-dimensional array that includes all International 
Classification of Diseases (ICD–9–CM) codes describing trauma. For more information about the matrix, see Barell V. et al. ‘‘An introduction to the Barell body region by nature of injury diagnosis 
matrix.’’ Inj Prev 2002;8:91–6. Or visit http://www.cdc.gov/nchs/about/otheract/ice/barellmatrix.htm. 
Table V. Reclassification of physician specialty for use with National Ambulatory Medical Care Survey data 
Physician specialty group Physician specialty 
Primary care specialties . . . . . . . . 	 Family practice, geriatric medicine (familiy practice), sports medicine (family practice), general practice, internal medicine, 
adolescent medicine (internal medicine), geriatric medicine (internal medicine), sports medicine (internal medicine), 
adolescent medicine, pediatrics, pediatric sports medicine, gynecology, maternal and fetal medicine, obstetrics and 
gynecology, obstetrics. 
Surgical specialties . . . . . . . . . . . 	 General surgery, gynecological oncology, critical care medicine (obstetrics and gynecology), hand surgery (orthopedic 
surgery), adult reconstructive orthopedics, foot and ankle orthopedics, musculoskeletal oncology, pediatric orthopedics, 
orthopedic surgery, sports medicine (orthopedic surgery), orthopedic surgery of the spine, orthopedic trauma, urology, 
pediatric urology, ophthalmology, pediatric ophthalmology, otology/neurotology, otology, otolaryngology, pediatric 
otolaryngology, abdominal surgery, cardiovascular surgery, colon and rectal surgery, cardiothoracic surgery, craniofacial 
surgery, critical care surgery, dermatologic surgery, facial plastic surgery, head and neck surgery, hand surgery (plastic 
surgery), hand surgery (surgery), critical care (neurological surgery), neurological surgery, pediatric surgery (neurology), 
pediatric cardiothoracic surgery, pediatric surgery, plastic surgery, surgical oncology, thoracic surgery, transplant surgery, 
traumatic surgery, vascular surgery. 
Medical specialties . . . . . . . . . . . 	 Critical care pediatrics, developmental-behavioral pediatrics, neurodevelopmental disabilities, neonatal-perinatal medicine, 
pediatric allergy, pediatric cardiology, pediatric endocrinology, pediatric infectious diseases, pediatric pulmonology, medical 
toxicology (pediatrics), pediatric emergency medicine, pediatric gastroenterology, pediatric hematology/oncology, internal 
medicine (pediatrics), pediatric nephrology, pediatric rehabilitation medicine, pediatric rheumatology, reproductive 
endocrinology, cardiovascular diseases, dermatology, psychiatry, addiction psychiatry, child psychiatry, forsenic psychiatry, 
psychoanalysis, geriatric psychiatry, neurology, child neurology, clinical neurophysiology, neurology (diagnostic radiology), 
addiction medicine, aerospace medicine, allergy, allergy and immunology, allergy and immunology/diagnostic laboratory 
immunology, cardiac electrophysiology, clinical genetics, clinical biochemical genetics, clinical cytogenetics, clinical molecular 
genetics, critical care medicine, dermatological immunology/diagnostic laboratory immunology, diabetes, emergency medicine, 
epidemiology, endocrinology, gastroenterology, general preventive medicine, hematology, hepatology, hematology/oncology, 
infectious diseases, internal medicine/diagnostic laboratory immunology, immunology, interventional cardiology, legal medicine, 
medical management, medical genetics, medical toxicology (emergency medicine), medical toxicology (preventive medicine), 
medical oncology, nephrology, nutrition, occupational medicine, osteopathic manipulative medicine, pain medicine, palliative 
medicine, pedatric emergency medicine (emergency medicine), pediatric/diagnostic laboratory immunology, pharmaceutical 
medicine, public health, public health and general preventive medicine, clinical pharmacology, physical medicine and 
rehabilitation, pulmonary critical care medicine, pulmonary diseases, sports medicine (emergency medicine), sports medicine 
(physical medicine and rehabilitation), rheumatology, spinal cord injury, sleep medicine, undersea medicine, vascular 
medicine. 
Series 13, No. 157 [ Page 63 
Table VI. U.S. population estimates used in computing annual visit rates for the National Ambulatory Medical Care Survey and National 
Hospital Ambulatory Medical Care Survey, by age, race, and sex: United States, 1999–2000 
All Under 15 15–24 25–44 45–64 65–74 75 years 
Characteristic ages years years years years years and over 
All races . . . . . . . . . . . . . . . . . . . . . . . . . . . .  272,943,591 60,274,678 38,225,543 82,256,472 59,604,833 17,773,207 14,808,859 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  133,080,065 30,824,777 19,239,220 40,351,914 28,826,700 8,043,307 5,794,148 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . .  139,863,526 29,449,901 18,986,323 41,904,559 30,778,133 9,729,901 9,014,711 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  224,056,460 47,206,493 30,366,797 66,934,275 50,672,374 15,550,611 13,325,911 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  110,065,102 24,183,547 15,425,247 33,322,301 24,798,190 7,100,715 5,235,103 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . .  113,991,358 23,022,947 14,941,550 33,611,974 25,874,184 8,449,896 8,090,808 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  35,330,301 9,657,987 5,757,292 10,813,134 6,349,827 1,641,542 1,110,521 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  16,453,829 4,899,360 2,750,232 4,894,459 2,815,512 692,078 402,189 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . .  18,876,472 4,758,627 3,007,060 5,918,675 3,534,315 949,464 708,332 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13,556,831 3,410,199 2,101,455 4,509,064 2,582,632 581,055 372,428 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,561,134 1,741,871 1,063,742 2,135,154 1,212,999 250,514 156,856 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,995,697 1,668,328 1,037,713 2,373,910 1,369,634 330,541 215,572 
SOURCE: Based on U.S. Census Bureau monthly postcensal estimates of the civilian noninstitutionalized population of the United States as of July 1, 1999, and July 1, 2000. 
NOTES: Figures are consistent with the downloadable series, ‘‘U.S. Population Estimates by Age, Sex, Race, and Hispanic Origin: 1980 to 1999 (With short-term projection to dates in 2000)’’ available 
at the U.S. Census Bureau Internet site: http://www.census.gov/popest/archives/1990s/nat_detail.html.. Regional estimates were provided by the Division of Health Interview Statistics (DHIS), National 
Center for Health Statistics, and are based on U.S. census estimates of the civilian noninstitutionalized population as of July 1, 1999, and July 1, 2000. DHIS estimates differ slightly from monthly 
postcensal estimates because of differences in the adjustment process. These figures are based on the 1990 Census; they do not reflect Census 2000 counts. Figures have been adjusted for 
underenumeration using the 1990 National Population Adjustment Matrix. 
Table VII. U.S. population estimates used in computing annual visit rates for the National 
Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, by 




Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  52,370,103 
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  67,203,636 
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  96,712,390 
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  56,568,886 
MSA1 status 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  217,317,667 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  27,503,054 
1MSA is metropolitan statistical area. 
SOURCE: Based on U.S. Census Bureau monthly postcensal estimates of the civilian noninstitutionalized population of the United 
States as of July 1, 1999, and July 1, 2000. 
NOTES: Figures are consistent with the downloadable series, ‘‘U.S. Population Estimates by Age, Sex, Race, and Hispanic Origin: 
1980 to 1999 (With short-term projection to dates in 2000)’’ available at the U.S. Census Bureau Internet site: http:// 
www.census.gov/popest/archives/1990s/nat_detail.html.. Regional estimates were provided by the Division of Health Interview 
Statistics (DHIS), National Center for Health Statistics, and are based on U.S. census estimates of the civilian noninstitutionalized 
population as of July 1, 1999, and July 1, 2000. DHIS estimates differ slightly from monthly postcensal estimates because of 
differences in the adjustment process. These figures are based on the 1990 Census; they do not reflect Census 2000 counts. 
Figures have been adjusted for underenumeration using the 1990 National Population Adjustment Matrix. 
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Definition of Terms 
Ambulatory patient—An ambulatory 
patient is an individual seeking personal 
health services who is not currently 
admitted to any health care institution 
on the premises. 
Drug mention—A drug mention is 
the physician’s entry on the Patient 
Record form of a pharmaceutical 
agent—by any route of administration— 
for prevention, diagnosis, or treatment. 
Generic as well as brand-name drugs are 
included, as are nonprescription and 
prescription drugs. Along with all new 
drugs, the physician also records 
continued medications if the patient was 
specifically instructed during the visit to 
continue the medication. Physicians may 
report up to six medications per visit. 
Drug visit—A drug visit is a visit at 
which medication was prescribed or 
provided by the physician. 
Emergency department (ED) —An 
ED is a hospital facility for the 
provision of unscheduled outpatient 
services to patients whose conditions 
require immediate care and that is 
staffed 24 hours a day. If an ED 
provided emergency services in different 
areas of the hospital, all of these areas 
were selected with certainty into the 
sample. Offsite EDs that are open less 
than 24 hours are included if staffed by 
the hospital’s ED. 
Emergency service area (ESA)—An 
emergency service area is the smallest 
administrative unit of an ED where 
separate patient statistics are kept. It 
may be located on hospital grounds or 
operated off site by the hospital. 
Geographic region—The 50 States 
and the District of Columbia are 
grouped for statistical purposes by the 
U.S. Census Bureau into four 
geographic regions as follows: 
Region States included 
Northeast	 Maine, New Hampshire, 
Vermont, Massachusetts, 
Rhode Island, Connecticut, 
New York, New Jersey, and 
Pennsylvania Midwest	 Ohio, Indiana, Illinois, 
Michigan, Wisconsin, 
Minnesota, Iowa, Missouri, 
North Dakota, South Dakota, 
Nebraska, and Kansas 
South	 Delaware, Maryland, District 
of Columbia, Virginia, West 
Virginia, North Carolina, 
South Carolina, Georgia, 
Florida, Kentucky, Tennessee, 
Alabama, Mississippi, 
Arkansas, Louisiana, 
Oklahoma, and Texas 
West	 Montana, Idaho, Wyoming, 
Colorado, New Mexico, 
Arizona, Utah, Nevada, 
Washington, Oregon, 
California, Alaska, and 
Hawaii 
Hospital—A hospital is eligible for 
inclusion in the NHAMCS if it has an 
average length of stay for all patients of 
less than 30 days (short-stay) or if it has 
a specialty of general (medical or 
surgical) or children’s general. The 
survey excludes Federal hospitals, 
hospital units of institutions, and 
hospitals with less than six beds staffed 
for patient use. 
Injury-related visit—A visit is 
considered related to an injury if ‘‘yes’’ 
was checked on the PRF in response to 
the question, ‘‘Is this visit injury 
related?’’ or if any of the following 
information was provided on the 
form—place of injury, cause of injury, 
an injury-related reason for visit, or a 
nature of injury diagnosis. 
Metropolitan status— Providers are 
classified by their location in a 
metropolitan statistical area or 
nonmetropolitan statistical area as 
follows: 
+	 Metropolitan statistical area 
(MSA)— As defined by the U.S. 
Office of Management and Budget, 
the definition of an individual MSA 
involves two considerations: first, a 
city or cities of specified population 
that constitute the central city and 
identify the county in which it is 
located as the central county; 
second, economic and social 
relationships with contiguous 
counties that are metropolitan in 
character so that the periphery of the specific metropolitan area may be 
determined. MSAs may cross State 
lines. In New England, MSAs 
consist of cities and towns rather 
than counties. 
+	 Non-MSA—Non-MSA areas are 
those not defined as MSAs. 
Office—An office is the space 
identified by a physician as a location 
for his or her ambulatory practice. 
Offices customarily include consultation, 
examination, or treatment spaces that 
patients associate with the particular 
physician. 
Office-based physician—A physician 
is a duly licensed doctor of medicine 
(M.D.) or doctor of osteopathy (D.O.) 
who is currently in office-based practice 
and who spends some time caring for 
ambulatory patients. The NAMCS 
sample excludes physicians who: are 
hospital-based; specialize in 
anesthesiology, pathology, or radiology; 
are federally employed; treat only 
institutionalized patients; or are 
employed full time by an institution and 
spend no time seeing ambulatory 
patients. 
Outpatient department (OPD)—An 
OPD is a hospital facility where 
nonurgent and ambulatory medical care 
is provided under the supervision of a 
physician. 
Primary expected source of 
payment—The primary expected source 
of payment is the source that, to the best 
of the provider’s knowledge, describes 
how charges incurred during this visit 
will be paid. 
+	 Private insurance—This category 
includes charges that are paid in part 
or in full by a private insurance 
company or by a health maintenance 
organization (HMO) plan or other 
prepayment plan, including 
independent practice associations 
(IPAs) and preferred provider 
organizations (PPOs). 
+	 Medicare—This category includes 
charges that are paid in part or in 
full by a Medicare plan, including 
payments made directly to the 
hospital as well as payments to the 
patient. 
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charges that are paid in part or in 
full by a Medicaid or State 
Children’s Health Insurance Program 
(SCHIP), including payments made 
directly to the hospital as well as 
payments to the patient. SCHIP, 
enacted as part of the Balanced 
Budget Act of 1997, gave States the 
opportunity to provide free or 
low-cost insurance coverage to 
low-income children not otherwise 
eligible to be covered by Medicaid. 
States began enrolling children in 
1998 using Medicaid or State-
specific programs separate from 
Medicaid or both. By 2000, all 
States had implemented SCHIP 
programs. 
+	 Worker’s compensation—This 
category includes programs designed 
to enable employees injured on the 
job to receive financial 
compensation regardless of fault. 
+	 Self-pay—This category includes 
charges that are billed directly to the 
patient and will not be reimbursed 
by a third party. Self-pay does not 
include prepaid plans for which a 
copayment is charged. 
+	 No charge—No fee is charged for 
these visits. This category does not 
include visits paid for as part of a 
total care package (e.g., post-
operative visits included in a 
surgical fee, pregnancy visits for 
which a flat fee was charged, and 
HMO and prepaid systems). 
+	 Other—This category includes other 
sources of payment not in the 
preceding categories, including 
charges paid under CHAMPUS, 
State and local governments, private 
charitable organizations, and other 
liability insurance. 
+	 Unknown—This category includes 
cases for which none of the previous 
sources of payment categories was 
checked. 
For the purposes of this report, 
visits were designated ‘‘uninsured’’ if 
either self-pay or no charge was 
indicated. ‘‘Other’’ sources included 
worker’s compensation, other, and 
unknown. Visit—For NAMCS, a visit is a 
direct, personal exchange between an 
ambulatory patient and a physician or a 
staff member working under the 
physician’s supervision, for the purpose 
of seeking care and rendering personal 
health services. The NAMCS sample 
excludes visits where medical care was 
not provided (e.g., visits made to drop 
off specimens, pay bills, make 
appointments, and walkouts). For 
NHAMCS, a visit is a direct, personal 
exchange between a patient and a 
physician or other health care provider 
working under the physician’s 
supervision, for the purpose of seeking 
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Appendix IV

Table VIII. Adjusted odds ratios from logistic regression analysis modeling visit to each setting 
Primary Surgical Medical Outpatient Emergency 
Patient and provider characteristics care offices specialty offices specialty offices departments departments 
Intercept . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.315 0.185 0.160 0.041 0.069 
Patient race 
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (1) (1) (1) (1) (1) 
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.970 0.594 0.639 1.543 1.831 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.428 0.759 0.778 0.980 0.842 
Primary expected source of payment 
Medicare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.665 0.869 1.303 1.699 1.712 
Medicaid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.597 0.553 0.850 2.713 1.966 
Uninsured . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.399 1.077 1.079 1.859 3.150 
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.818 0.890 1.114 1.961 1.007 
Private insurance . . . . . . . . . . . . . . . . . . . . . . . . . . .  (1) (1) (1) (1) (1) 
MSA2 status of provider 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.619 1.279 2.285 1.168 0.794 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (1) (1) (1) (1) (1) 
Type of condition 
Injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.364 1.992 0.680 0.676 4.693 
Illness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (1) (1) (1) (1) (1) 
Patient age 
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.878 0.462 0.411 1.121 1.042 
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.052 0.728 0.802 1.147 1.354 
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (1) (1) (1) (1) (1) 
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.774 1.660 1.234 0.487 0.632 
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.802 2.551 1.064 0.960 0.604 
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.782 3.012 0.831 0.579 0.441 
Patient sex 
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.298 0.775 0.895 1.046 0.858 
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (1) (1) (1) (1) (1) 
Education 
Low . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.399 0.839 0.596 1.010 1.308 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.210 0.993 0.699 1.004 1.235 
High . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (1) (1) (1) (1) (1) 
Income 
Low . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.696 1.013 1.036 1.964 1.437 
Medium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.945 0.852 1.006 1.355 1.189 
High . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (1) (1) (1) (1) (1) 
Number of conditions 
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (1) (1) (1) (1) (1) 
2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.050 0.967 0.978 0.982 0.856 
3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.664 0.499 1.045 1.114 0.590 
0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1.195 0.361 1.597 0.986 0.787 
1Reference characteristic. 
2MSA is metropolitan statistical area. 
NOTE: Odds ratios in bold type are significant (p<.05). 
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Table IX. Adjusted odds ratios from logistic regression analysis modeling visit to each setting including distance traveled and supply of 
providers 
Primary Surgical Medical Outpatient Emergency 
Patient or provider characteristic care offices specialty offices specialty offices departments departments 
Intercept . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3.110 0.105 0.105 0.030 0.132 
MSA1 status 
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  0.832 0.953 1.482 1.023 0.810 
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (2) (2) (2) (2) (2) 
Provider/patient proximity 
Different ZIP Code . . . . . . . . . . . . . . . . . . . . . . . . . .  0.540 1.677 1.795 1.616 0.881 
Same ZIP Code . . . . . . . . . . . . . . . . . . . . . . . . . . . .  (2) (2) (2) (2) (2) 
Rate per population 
Primary care physicians . . . . . . . . . . . . . . . . . . . . . . .  0.998 1.000 0.998 1.002 1.002 
Medical specialists . . . . . . . . . . . . . . . . . . . . . . . . . .  1.005 0.986 0.990 1.006 1.001 
Surgical specialists . . . . . . . . . . . . . . . . . . . . . . . . . .  0.982 1.030 1.019 1.000 0.999 
Visits to the emergency department . . . . . . . . . . . . . . . .  1.017 0.874 0.794 1.069 1.021 
1MSA is metropolitan statistical area. 
2Reference characteristic. 
NOTE: Odds ratios in bold type are significant (p <.05). 
Vital and Health Statistics 
series descriptions 
SERIES 1.	 Programs and Collection Procedures—These reports 
describe the data collection programs of the National Center 
for Health Statistics. They include descriptions of the methods 
used to collect and process the data, definitions, and other 
material necessary for understanding the data. 
SERIES 2.	 Data Evaluation and Methods Research—These reports 
are studies of new statistical methods and include analytical 
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countries. 
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Data from direct examination, testing, and measurement on 
representative samples of the civilian noninstitutionalized 
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States and the distributions of the population with respect to 
physical, physiological, and psychological characteristics, and 
(2) analyses of trends and relationships among various 
measurements and between survey periods. 
SERIES 12.	 Data From the Institutionalized Population Surveys— 
Discontinued in 1975. Reports from these surveys are 
included in Series 13. 
SERIES 13.	 Data From the National Health Care Survey—These 
reports contain statistics on health resources and the public’s 
use of health care resources including ambulatory, hospital, 
and long-term care services based on data collected directly 
from health care providers and provider records. 
SERIES 14.	 Data on Health Resources: Manpower and Facilities— 
Discontinued in 1990. Reports on the numbers, geographic 
distribution, and characteristics of health resources are now 
included in Series 13. 
SERIES 15.	 Data From Special Surveys—These reports contain 
statistics on health and health-related topics collected in 
special surveys that are not part of the continuing data 
systems of the National Center for Health Statistics. 
SERIES 16.	 Compilations of Advance Data From Vital and Health 
Statistics—Advance Data Reports provide early release of 
information from the National Center for Health Statistics’ 
health and demographic surveys. They are compiled in the 
order in which they are published. Some of these releases 
may be followed by detailed reports in Series 10–13. 
SERIES 20.	 Data on Mortality—These reports contain statistics on 
mortality that are not included in regular, annual, or monthly 
reports. Special analyses by cause of death, age, other 
demographic variables, and geographic and trend analyses 
are included. 
SERIES 21.	 Data on Natality, Marriage, and Divorce—These reports 
contain statistics on natality, marriage, and divorce that are 
not included in regular, annual, or monthly reports. Special 
analyses by health and demographic variables and 
geographic and trend analyses are included. 
SERIES 22.	 Data From the National Mortality and Natality Surveys— 
Discontinued in 1975. Reports from these sample surveys, 
based on vital records, are now published in Series 20 or 21. 
SERIES 23.	 Data From the National Survey of Family Growth—These 
reports contain statistics on factors that affect birth rates, 
including contraception, infertility, cohabitation, marriage, 
divorce, and remarriage; adoption; use of medical care for 
family planning and infertility; and related maternal and infant 
health topics. These statistics are based on national surveys 
of women of childbearing age. 
SERIES 24.	 Compilations of Data on Natality, Mortality, Marriage, 
Divorce, and Induced Terminations of Pregnancy— 
These include advance reports of births, deaths, marriages, 
and divorces based on final data from the National Vital 
Statistics System that were published as supplements to the 
National Vital Statistics Report (NVSR). These reports provide 
highlights and summaries of detailed data subsequently 
published in Vital Statistics of the United States. Other 
supplements to the NVSR published here provide selected 
findings based on final data from the National Vital Statistics 
System and may be followed by detailed reports in Series 20 
or 21. 
For answers to questions about this report or for a list of reports published 
in these series, contact: 
Information Dissemination Staff

National Center for Health Statistics

Centers for Disease Control and Prevention
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